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 Chronic pain includes debilitating conditions affecting large populations of people 
throughout the world. These diseases are further complicated by comorbid psychological 
disorders which make chronic pain conditions difficult to treat. Nonpharmacological 
treatment options have more recently become an important mainstay of effective therapies 
and are currently being used to supplement or replace traditional pharmacological 
treatment methods.  Exercise-based therapies in particular are of interest due to their 
demonstrated success in reducing pain symptoms as well as improving psychological 
outcomes. Dose is an important factor in being able to effectively prescribe treatments in 
the context of specific exercise interventions and specific pain populations. Finally, in an 
effort to synergize the effects of multiple therapy modalities (i.e. aerobic exercise and 
psychological interventions), integrative approaches have become of key interest in 
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multidisciplinary pain treatment plans. Our efforts have sought to characterize the effect of 
exercise dosing and the role of integrative nonpharmacological programs in treating 
chronic pain. Our approach involved (1) examining different variables of exercise dose 
using a meta-analytical approach to determine which component was the most likely to 
influence pain effect in chronic pain groups, (2) testing multiple doses of the frequency 
aspect of exercise dosing in a cohort of healthy humans to determine the best dose for 
analgesic benefits, (3) testing the outcomes of integrating the exercise program with a 
psychological intervention in a cohort of chronic low back pain patients. (1) In our meta-
analysis studies, we analyzed existing data, examining exercise dose defined by minutes of 
exercise per week (time), frequency of exercise bouts per week, number of weeks that the 
intervention lasted (duration) and estimated intensity of the exercise. Our analysis revealed 
significant positive correlations with exercise duration and analgesic effect in the context 
of chronic neck pain studies. Multiple linear regression modeling allowed us to predict 
increasing the frequency or bouts of exercise sessions per week had the greatest influence 
on increasing pain effect size. (2) We then tested the effect of different doses (frequencies) 
of walking exercise in a cohort of healthy female subjects. Forty females were allocated 
into 4 groups: control (no exercise), low dose exercise, moderate dose exercise and a high 
dose of exercise. Moderate and high dose groups of exercise had the greatest improvements 
in pain ratings, suggesting that the low dose was insufficient to provide analgesia, and the 
high dose was no more beneficial than the moderate dose. (3) Lastly, we integrated the 
moderate dose of exercise used in the previous study with mindfulness meditation and 
tested the impact of this combined therapy in a group of chronic low back pain patients.  
Thirty-eight adults completed meditation and exercise treatment (MedExT) or an 
 
 vi 
audiobook control condition over a four-week period. Post-intervention, MedExT 
participants exhibited significant improvements in disability compared to the control group 
and showed increased mindfulness and improved ratings of low back pain. Overall, our 
results suggest that increasing the frequency of exercise dose is a critical component in 
exercise prescription and that integrative nonpharmacological therapies are effective in 
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Chronic pain is a major problem in the U.S. affecting 116 million adults (Steglitz et al., 
2012); more than diabetes, cancer, and heart disease combined (Gaskin and Richard, 2012). Recent 
estimates claim that chronic pain affects 1.5 billion people worldwide, and these figures are 
steadily on the rise (Steglitz et al., 2012). As a result, chronic pain remains a pervasive medical 
problem consuming a vast amount of health care resources. Treatments for chronic pain in the U.S. 
can cost up to $635 billion dollars annually (Gaskin and Richard, 2012) imposing a substantial 
economic burden on healthcare systems and society.  
Chronic pain is further complicated by the potential for comorbid psychological disorders 
(Leo, 2005; Kroenke et al., 2013). The prevalence of depression, for example, is estimated to be 
as high as 55% in chronic pain patients (Koenig and Clark, 1996; Fishbain, 1999). Musculoskeletal 
pain in particular is often associated with fear avoidance anxiety behavior and kinesiophobia  
(Lundberg et al., 2011). This fear of movement can further worsen symptoms of pain and 
disability. Kinesiophobia may also reduce the potential benefit of physical therapies in patients by 
increasing state anxiety surrounding treatment. In chronic pain management, a major gap exists in 
not only treating the physical pain, but also addressing the interplay with psychological etiologies.  
Treatment for many complex pain disorders includes both pharmacologic and non-
pharmacologic interventions, with pharmacological interventions prescribed more frequently. 
Although numerous pharmacological interventions exist to treat chronic pain, not all have proven 
to be effective for the majority of chronic pain patients (Hauser et al., 2012; Pedersen and 
Fredheim, 2015). New and effective treatments for chronic pain syndromes are imperative to 
improve long-term treatment outcomes. Current pharmacologic treatments for chronic pain 
include the use of non-steroidal anti-inflammatory drugs (NSAIDs), topical agents such as 
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capsaicin and lidocaine, antidepressants (e.g. SSRIs, SNRIs and tricyclics), anticonvulsants, 
opioids, calcium channel 2- ligands (gabapentin and pregabalin), NMDA receptor antagonists 
and tramadol (Kroenke et al., 2009; Park and Moon, 2010; Hauser et al., 2012; Pedersen and 
Fredheim, 2015). However, there are several pitfalls to prescribing pharmacologic treatments for 
chronic pain conditions. Opioids, for example, can lead to an unsatisfactory end point, resulting in 
little improvement in pain symptoms, unacceptable adverse side effects, and symptoms of 
addiction and dependence (Pedersen and Fredheim, 2015). Other pharmacologic treatments have 
been found to provide an insufficient amount of pain relief failing to outweigh undesirable side 
effects produced by such therapies (Hauser et al., 2012). As a result, non-pharmacological 
interventions such as exercise and psychological interventions are becoming an important 
mainstay of comprehensive pain management. Common non-pharmacological therapies for 
chronic pain include aerobic exercise, tai chi, yoga, mindfulness-based stress reduction (MBSR), 
progressive relaxation, electromyography biofeedback, operant therapy, cognitive behavioral 
therapy, multidisciplinary rehabilitation, acupuncture, spinal manipulation and massage with many 
of these showing significant positive effects (Chang et al., 2015a; Chou et al., 2017). The focus of 
this dissertation is on two of these options, exercise and meditation (“mind-based”) approaches. 
MECHANISMS OF EXERCISE EFFECTS IN PAIN 
Increasing evidence purports exercise as a primary and viable therapeutic modality for the 
treatment of nearly all types of chronic pain conditions (Fransen et al., 2002; Schachter et al., 2003; 
Edmonds et al., 2004; Busch et al., 2007; Chou et al., 2007; Geneen et al., 2017). Regular physical 
activity and exercise improve many aspects of a person’s general health, including 
cardiorespiratory function, mental health, and pain (Penedo and Dahn, 2005). Exercise has been 
found to be effective in relieving pain and benefiting patients’ daily physical function in various 
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chronic musculoskeletal pain disorders, including chronic neck pain (Childs et al., 2008; Cuesta-
Vargas et al., 2013), osteoarthritis (Jansen et al., 2011; Cuesta-Vargas et al., 2013), fibromyalgia 
(Brosseau et al., 2008), and chronic low back pain (van Middelkoop et al., 2010; Cuesta-Vargas et 
al., 2013). Aerobic exercise plans have been found to reduce pain, fatigue, and depression as well 
as improve peak oxygen uptake, health-related quality of life, and physical fitness in chronic pain 
patients (Dinler et al., 2009; Hauser et al., 2010). Another significant benefit of exercise for chronic 
pain conditions is the reduction in health-care seeking and workplace absenteeism (van 
Amelsvoort et al., 2006; Lambeek et al., 2010; Zavanela et al., 2012). Aerobic exercise at a level 
of at least 70% of the maximum aerobic capacity generates the production of endorphins and elicits 
other pain inhibitory mechanisms synthesized by the brain (Millan, 2002; Bender et al., 2007). 
Physical activity has also been shown to be associated with decreased symptoms of depression and 
anxiety further suggesting that exercise could be particularly advantageous in the context of 
chronic pain comorbid with psychiatric illness (Bhui and Fletcher, 2000; Dunn et al., 2005).  
Additionally, levels of activity are inversely correlated with depression symptoms in fibromyalgia 
patients (Andrade et al., 2017).  
Prescribing exercise as therapy provides challenges in determining the correct form of 
exercise best suited for the chronic pain condition and subsequently for each patient. Common 
exercise therapies include walking exercise, aquatic exercise, meditative movement therapies, 
strengthening and stabilization exercises, and other aerobic exercises. It is known that low-to 
moderate-intensity exercise (50-60% of maximum heart rate) is sufficient to improve chronic pain 
symptoms (Ambrose and Golightly, 2015). Although there is a significant amount of evidence in 
the literature suggesting exercise as an efficacious modality for the treatment of chronic pain, there 
is virtually no knowledge of the appropriate dose of exercise for a given disease or patient type. 
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That is, almost all studies compare a single dose of exercise to control conditions or other 
alternative treatments. This is a notable gap in the use of exercise as an evidence-based therapy. 
The lack of dosing studies for exercise means that patients may not be receiving the optimal 
therapy and/or be receiving a therapy that actually increases pain. Therefore, it is necessary that 
the appropriate dose be evaluated.  
Dosing of exercise interventions 
As described above, prescription of physical exercise presents itself as an advantageous 
treatment plan in effectively reducing chronic pain (Geneen et al., 2017). Often cited, the American 
College of Sports Medicine and the American Heart Association both recommend “30 minutes of 
moderate-intensity walking exercise five days per week for healthy adults” (Garber et al., 2011). 
These recommendations are based on large prospective cohort studies which reveal that an energy 
expenditure of approximately 150 minutes per week of moderate intensity physical activity is 
associated with lower rates of cardiovascular disease and premature mortality (Lee et al., 2000; 
Sesso et al., 2000; Manson et al., 2002; Tanasescu et al., 2002).  
However, these recommendations are not based in the context of chronic or acute pain and 
may be too high of a starting dose for persons experiencing chronic pain, especially conditions 
associated with movement-induced pain (Umeda et al., 2015). Persons with chronic pain are more 
sedentary and it would likely be difficult, and potentially pain inducing, if they start an exercise 
program at this high dose. Consequently, it is necessary to critically evaluate the most appropriate 
dose of exercise in chronic pain. A graded exercise program may be beneficial, however, at this 
time there are no clear guidelines which suggest a starting point for exercise dose for persons with 
chronic pain. Consequently, it is necessary to critically evaluate the most appropriate dose of 
exercise in chronic pain.  
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Dosing of pharmacologic interventions is common across all diseases. Dosing studies for 
new drugs are a necessary component of FDA drug approval (U.S. FDA, 2016). In the context of 
chronic pain, all pharmacological agents show dose effects many of which are specific to 
individual patient populations (e.g. fibromyalgia versus chronic low back pain). Thus, it is striking 
that essentially no exercise studies for pain have been done in the context of different doses or 
comparison of multiple patient populations in the same study using the same intervention. This is 
a significant gap in the literature that may have negative consequences for patients and caregivers.  
Literature analysis of exercise dose 
In this dissertation, we took two approaches to evaluating the potential of dosing of exercise 
in chronic pain. In both approaches, I have analyzed published data evaluating the impact of 
different exercise modalities across different types of pain. First was a pilot preliminary literature 
analysis. The methods and results of this analysis can be seen in Appendix A. Second, these 
preliminary data gave us enough confidence to perform a rigorous meta-analysis of the existing 
exercise literature. In Chapter 2, Section 1, I will describe this more extensive comprehensive 
meta-analysis that we completed to evaluate exercise dosing. In both cases, the overall objective 
was to summarize and analyze studies to help identify evidence for the optimal dosing for exercise 
and physical movement-based therapy in chronic pain.  
Conclusions of Exercise Dosing 
Prescribing exercise as therapy provides challenges in determining the correct form of 
exercise best suited for the chronic pain condition and subsequently for each patient. Common 
exercise therapies include walking exercise, aquatic exercise, meditative movement therapies, 
strengthening and stabilization exercises, and other aerobic exercises. It is known that low-to 
moderate-intensity exercise (50-60% of maximum heart rate) is sufficient to improve chronic pain 
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symptoms (Ambrose and Golightly, 2015). Although there is a significant amount of evidence in 
the literature suggesting exercise as an efficacious modality for the treatment of chronic pain, there 
is virtually no knowledge of the appropriate dose of exercise for a given disease or patient type. 
That is, almost all studies compare a single dose of exercise to control conditions or other 
alternative treatments. This is a notable gap in the use of exercise as an evidence-based therapy. 
The lack of a dosing studies for exercise means that patients may not be receiving the optimal 
therapy and/or be receiving a therapy that actually increases pain.    
MEDITATION THERAPIES AS A NONPHARMACOLOGICAL TREATMENT  
Meditation is a “mind-body” practice with spiritual origins that has been used for over a 
thousand years as a method of healing. Meditation as a whole encompasses an array of practices 
that can be generally categorized into three main groups: constructive (compassion or loving 
kindness meditation) deconstructive (object-oriented insight) and attentional (i.e. mindfulness 
meditation) (Dahl et al., 2015). The primary cognitive mechanisms that distinguish each grouping 
from each other are (1) perspective taking and reappraisal, (2) self-inquiry and (3) attention 
regulation and meta-awareness, respectively (Dahl et al., 2015). Other well-known forms of 
meditation, not specifically mentioned above include focused attention (FA), open monitoring 
(OM), zen, transcendental meditation (TM), body scan or progressive relaxation, breath 
awareness, Hindu-inspired meditation movements and Christian contemplative prayer traditions.  
Meditation practices have traditionally been adopted to reduce psychological stress and 
stress-related disorders to promote overall health (Barnes et al., 2008; Goyal et al., 2010). 
Meditation programs have been shown to reduce negative dimensions of psychological stress such 
as anxiety and stress in the context of a number of disease states (Goyal et al., 2014). Specifically, 
mindfulness meditation interventions showed improvements in anxiety, depression and pain with 
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small improvements in stress/distress (Goyal et al., 2014). Additionally, studies incorporating 
mindfulness foster increased subjective well-being, reduced psychological symptoms and 
improved behavioral regulation (Keng et al., 2011). Due to its success in achieving positive mental 
and physical health outcomes, mindfulness meditation has become a more popular form of therapy 
for treating conditions such as chronic pain.  
Mindfulness meditation 
Forms of attentional meditation include FA and OM, which can by sub-divided into object-
oriented OM and awareness-oriented OM (Dahl et al., 2015).  Mindfulness meditation, a form of 
object-oriented OM refers to the sustained recognition of the knowing quality of awareness itself 
(Dahl et al., 2015). A key component to the cognitive mechanism of mindfulness is meta-
awareness or heightened awareness of the processes of consciousness, including the processes of 
thinking, feeling and perceiving (Smallwood et al., 2007). The general practice of mindfulness 
centers around a self-regulated stance oriented to experiences in the present moment, which is 
defined by curiosity, openness, and acceptance (Dahl et al., 2015). Although mindfulness practice 
has originated in Buddhist traditions centuries ago, the application of mindfulness practices in 
Western Medicine mental health outcomes began in recent decades (Kabat-Zinn, 1982). Since 
then, studies incorporating mindfulness have largely caused improvements in pain, depression, 
quality of life, well-being and mobility, and functioning (Hilton et al., 2017; Majeed et al., 2017). 
Mechanistically, meditation with mindfulness has been associated with decreased levels of cortisol 
(Jacobs et al., 2013), has protective effects on the brain against mental illness (i.e. increases 
signaling connections in the brain (axonal density) and myelin in the anterior cingulate cortex) 
(Tang et al., 2012), improved pain processing and emotional control (Kerr et al., 2013), and altered 
amygdalar response to emotional stimuli (Desbordes et al., 2012).  
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 It is thought that mindfulness meditation is comprised of three main interacting 
components that establishes a process of enhanced self-regulation: enhanced attention control, 
improved emotion regulation, and altered self-awareness (Hölzel et al., 2011). Although the 
underlying neural mechanisms of mindfulness meditation are not completely understood, more 
recent neuroimaging studies have revealed the brain areas and networks that arbitrate these positive 
benefits (Tang et al., 2015). An activation likelihood estimation meta-analysis determined eight 
specific brain regions to be consistently altered in meditators (Fox et al., 2014). These areas 
included the frontopolar cortex, which is postulated to be involved in enhanced meta-awareness; 
the sensory cortices and insula, regions associated with body awareness; the hippocampus, an area 
associated with memory formation; the anterior cingulate cortex (ACC), mid-cingulate cortex and 
orbitofrontal cortex, domains related to self and emotion regulation; and the superior longitudinal 
fasciculus and corpus callosum, areas involved in intra- and inter-hemispherical communication 
(Fox et al., 2014). Although a more thorough understanding of the mechanisms that underlie the 
effects of meditation is still premature, there is budding evidence suggesting mindfulness to induce 
neuroplastic changes in the structure and function of the brain regions involved.  
Integrative therapies in treating pain and psychological disorders 
As exercise and mindfulness meditation have proven to independently improve disability 
and pain, it is hypothesized that integrating them together would have benefits that are additive or 
synergistic. In treating chronic pain, there has been substantial interest in therapies that integrate 
elements of various types of interventions. A well-known example of such a program that includes 
components of stress reduction, exercise and meditation is the 8-week MBSR course, which is 
known to improve pain, depression and quality of life (Hilton et al., 2017). Originally developed 
by Jon Kabat-Zinn at the University of Massachusetts Medical Center in the 1970s (Kabat-Zinn, 
 
 11 
1990), MBSR broadly consists of a combination of mindfulness meditation, body awareness, yoga 
and exploration of behavior patterns. This program is taught by certified trainers involving weekly 
2.5 hour group meetings, a one-day retreat involving a 7-hour mindfulness practice, and daily 
homework sessions across the 2-month long intervention (Will et al., 2015). Because MBSR-type 
programs involve extensive training and time commitment, this specific therapy may not easily 
accessible to all individuals especially those with chronic pain.  
Only one study has used a more accessible meditation program combined with exercise. In 
that study, the combined therapy improved depression and anxiety in clinically depressed patients 
(Alderman et al., 2016). In the context of cLBP, the only integrative programs that have been tested 
use MBSR (Morone et al., 2009; Esmer et al., 2010; Banth and Ardebil, 2015; Schmidt et al., 2015; 
Cherkin et al., 2016; Morone et al., 2016). As a whole, these studies resulted in improved disability, 
sleep quality, psychological function, depression, affective pain perception, fitness, pain severity, 
and reduced need for pain medications. Considering the lack of accessible combined meditation 
and exercise therapies in the literature or the clinic, we believed that integrating a more feasible 
approach to mindfulness with an aerobic exercise program would prove to be efficacious in 
promoting positive mental and physical health outcomes in cLBP. This is tested in Chapter 2, 
Section 2. 
CONCLUSIONS  
In our preliminary analysis of the exercise literature, we found statistically significant 
positive correlations between dose of exercise and therapeutic benefit across varying exercise 
interventions. However, the appropriate dose and treatment modality is virtually unknown for 
individual disorders. Because of these findings, additional dosing studies must be done in order to 
verify the best treatment option specific to exercise intervention and patient population. We 
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hypothesize that beginning exercise therapy at a lower dose and subsequently increasing physical 
activity as tolerated may be the most favorable to the patient. Previously done intensive integrative 
studies incorporating mindfulness and exercise have proven to be efficacious at reducing negative 
symptoms associated with cLBP. We hypothesize that mindfulness programs involving less 
training combined with exercise will also improve pain and disability while increasing 





























































The data and results section of the text contained within this chapter is adapted from the 
following publication: 
Kostek, MC,  Polaski, AM, Kolber, BJ. Ramsey, AM, Kranjec, A, Szucs, KA. 2016. A protocol 
of manual tests to measure sensation and pain in humans. J Vis Exp. DOI:10.3791/54130. 
 
Photographs of testing sites in Figure 1 were taken by BJK. AMR served as the male experimenter 
for the data generated in Table 1 and Figure 3.  AMP was responsible for participant screening, 
study management, data acquisition, analysis and writing. BJK, MK, and KS were responsible for 
original development, methodology and draft editing. AK was involved in original study 












New technologies have made the measurement of pain and neural sensation precise and 
reliable within well-equipped laboratories that have established internal protocols. However, many 
of these technologies are not easily portable and are cost-prohibitive for new or small research 
laboratories and medical clinics. The goal of this study was to demonstrate effective and reliable 
pain and sensory measures that can be conducted at a minimal cost. Our rationale for the 
development of the current protocol is that while many people suffer from chronic pain conditions 
and accurate assessment of pain is needed for diagnosis and treatment, there are few published 
protocols that include reliability data with demonstration of cost-effective assays. Sensory nerve 
and pain threshold testing are common and necessary measures of clinical practice and pain 
research. While sophisticated equipment exists to make these measures, it can be cost prohibitive.  
Here, we demonstrate and test the reliability of cost-effective quantitative techniques of sensory 
and pain measures in humans. We measure the reliability of several pain and sensory assays 
between different experimenters (same subject tested twice in one day) and within subjects (same 
subject tested on multiple days by the same experimenter). Our results reveal inter-experimenter 
testing for all pain assays except mechanical sensitivity to be significantly correlated between 
experimenters. Within-subjects reliability for constant heat unpleasantness, radiant heat sensitivity 
and pressure pain threshold are significantly correlated between trials, whereas all other tests are 
not. In conclusion, we have demonstrated a protocol of reliable cost-effective QST testing that are 











Quantitative sensory testing (QST) has become a frequently used tool in assessing pain and 
neurological function in chronic pain groups and healthy volunteers. In recent years, standardized 
QST protocols have been established by the German Research Network on Neuropathic Pain 
(DFNS) (Rolke et al., 2006b; Rolke et al., 2006a; Magerl et al., 2010; Pfau et al., 2014). However, 
many of these protocols are not standardized across testing sites and may not be easily portable 
and cost-effective for smaller research facilities (Svensson et al., 2011). Due to the expansion of 
use in experimental clinical research, there is a critical need for such assessments that demonstrate 
uniform accuracy and reliability.  
The protocol used in this study is focused on transportable, low-cost QST measures for 
assessment of chronic pain (Kostek et al., 2016). The assays chosen for the current study included 
von Frey filaments for measuring cutaneous sensitivity, a radiant (“Hargreaves” method) and 
contact heat technique for thermal testing, and pressure algometry to assess deep tissue pain. These 
tests are common widely-accepted assessments for human QST across research labs and clinical 
settings (Fowler et al., 1988; Sternberg et al., 2001; Rolke et al., 2006a; Kinser et al., 2009; Tena 
et al., 2012). Mechanical sensitivity is examined with von Frey filaments that are known to 
stimulate A-beta fibers (Burke et al., 1975). To avoid variability of the application procedure, 
multiple trails can be performed to obtain an accurate sensitivity threshold. Because contact and 
radiant heat activate thermal receptors differently and can confound one another (Green, 2009), 
one measure of thermal sensation and two measures of thermal pain were administered. For radiant 
heat assessment the “Hargreaves” method involved visible light and ramping temperature 
(Sternberg et al., 2001). Radiant heat was first used to determine the threshold for temperature 
change detection (starting from room temperature) and then utilized to determine the threshold for 
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heat pain. In the contact heat assay, a constant nociceptive temperature is applied to determine the 
qualitative intensity and unpleasantness of the painful stimulus (Fowler et al., 1988). The detection 
of non-nociceptive thermal change is regulated partly by transient receptor potential (TRP) 
channels on C fibers, while heat pain is mediated by TRPV1/V2 and other higher-threshold 
channels on C and A-delta fibers (Fowler et al., 1988; Yarnitsky and Ochoa, 1991; Tominaga, 
2007). Pressure algometry is the most regularly-used method for the quantification of pressure 
pain in soft tissue (Staahl et al., 2006; Reddy et al., 2012). Both A-delta and C fibers facilitate pain 
induced by pressure stimulation (Adriaensen et al., 1984). These measures are among the most 
commonly-used and are inexpensive enough for most clinics and research laboratories.  
Precise reliability is crucial for the use of QST in clinical and experimental practice. The 
reliability of QST is affected by error that can be attributed to the experimenter or rater and the 
occasion by which the test is performed (O'Neill and O'Neill, 2015). Inter-rater or inter-
experimenter reliability refers to the accuracy of multiple experimenters performing the same test. 
Intra-reliability or within-subjects reliability accounts for the accuracy of testing by a single 
experimenter of a single subject on multiple occasions. Reliability for these tests is commonly 
reported as intraclass correlation coefficients (ICCs), where “good” reliability is typically in the 
range of 0.6 to 0.9 (Wessel, 1995; Lewis et al., 2012). In utilizing these pain assays, many clinics 
may need to employ several technicians and perform testing over multiple occasions. Because of 
this, inter-experimenter and within-subjects reliability data would be useful in selecting a protocol 
of tests.  
The purpose of this study was to demonstrate a protocol of reliable pain and sensory 
assessments that employ easily-accessible and cost-effective equipment for smaller research 
clinics. For each assay, we determined the reliability of multiple experimenters performing the 
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same test (inter-experimenter) and the reliability of the same experimenter performing the same 
test on multiple occasions (within-subjects). Because these assessments were based on widely-
used methods, we hypothesized that we would determine these measures to be reliable between 




Prior to testing, all sites were marked with a marker, to ensure, testing between sessions 
are performed in the exact same location. Individual sites were spread out to avoid overlapping 
receptive field activation (Figure 1). Testing for the forearm was performed on the T1 dermatome 
on the ulnar side of the antecubital fossa, proximal to the medial epicondyle of the humerus. 
Testing for the leg was done on the L3 dermatome located at the medial epicondyle of the femur. 
This was done to avoid variability caused by activating multiple spinal nerves.  
 
 
Figure 1. Illustration of sensory testing sites on the left and right forearm and calf. Sites for 
individual testing are marked with a standard surgical marker. M = mechanical; H = Hargreaves 
radiant heat; Pp = Pressure pain; Pt = Pressure pain threshold; T = Constant temperature pain. BJK 




Visual Analog Scale (VAS) display 
A Visual Analog Scale (VAS) was used to qualitatively assess constant heat pain and 
constant pressure pain (Figure 2). Following application of the stimulus, subjects were instructed 
to rate the intensity and unpleasantness of the pain they had experienced. The visual representation 
is important, because accurate and precise results of these examinations are dependent upon correct 












Figure 2. Illustration of the Visual Analog Scale (VAS). This figure represents a standard 0-10 
visual analog scale (VAS) with a 10-cm line. This scale is used to represent the intensity of pain, 
where “0” represents “no pain” and “10” represents “the worst pain imaginable,” and the 
unpleasantness of pain, where “0” represents “not unpleasant” and “10” represents “the most 







All subjects completed the study with no adverse events. The subjects’ average age was 
21.8 yrs (SD = 2.0) and the average BMI was 23.5 (SD = 3.3); three of the six subjects were female. 
Inter-experimenter reliability analysis 
It is valuable to know if multiple technicians performing the technique as described can 
collect reproducible data.    To test the inter-experimenter reliability of the assays, two individual 
experimenters (one male and one female), tested six subjects. The results of inter-experimenter 








Table 1. Intraclass correlation coefficients [ICC(3,2)] for the eight pain and sensitivity 
measures. Individual subjects (n=6) were assayed by two investigators (one male and one female). 
All tests were performed on the same day (30 min apart). ICC(3,2) and corresponding P-values 
are given for each measure. AMP, AMR – data collection. AMP, BJK, MK, KS – experimental 
design.  
 
 ICC(3,2) revealed significant correlations for constant heat intensity (Figure 3B, 
ICC=0.96, **p=0.001), constant heat unpleasantness (Figure 3C, ICC=0.97, **p=0.001), radiant 
heat sensitivity (Figure 3D, ICC=0.95, **p=0.003), radiant heat pain (Figure 3E, ICC=0.89, 
*p=0.021), pressure pain threshold (Figure 3F, ICC=0.86, **p=0.002), constant pressure intensity 
(Figure 3G, ICC=0.98, **p=0.001), and constant pressure unpleasantness (Figure 3H, ICC=0.97, 
**p=0.001). Although the p-value for mechanical sensitivity is not significant, the ICC value 
represents a “strong” correlation (Figure 3A, ICC=0.76, p=0.075).  
QST Test site ICC p-value 
Mechanical sensitivity R forearm 0.76       0.075 
Constant heat intensity L forearm 0.96    **0.001 
Constant heat unpleasantness L forearm 0.97    **0.001 
Radiant heat sensitivity R forearm 0.95    **0.003 
Radiant heat pain R forearm 0.89  *0.021 
Pressure pain threshold  L forearm 0.86 **0.002 
Constant pressure intensity R forearm 0.98 **0.001 






Figure 3. Evaluation of inter-experimenter reliability of sensory testing in human 
participants. Individual subjects (n=6) were assayed for (A) mechanical sensation (p=0.075), (B) 
constant heat visual analog scale (VAS) intensity (p=0.001), (C) constant heat VAS unpleasantness 
(p=0.001), (D) radiant heat temperature sensitivity (p=0.003), (E) radiant heat pain threshold 
(p=0.021), (F) pressure threshold (p=0.002), (G) constant pressure VAS intensity (p=0.001), and 
(H) constant pressure VAS unpleasantness (p=0.001) on a single day (>30 min between tests) by 
two separate experimenters. P-values represent intraclass correlation coefficient significance. The 
dotted lines are lines of best fit.  AMP, AMR – conducted experiment. AMP, BK, MK, KS – 
designed experiment. 
 
Figure 3: Evaluation of within-subjects reliability of sensory testing in human participants. 
Individual subjects (n=6) were assayed for (A.) mechanical sensation (p=0.497), (B.) constant heat visual 
analog scale (VAS) intensity (p=0.080), (C.) constant heat visual analog scale (VAS) unpleasantness 
(p=0.027), (D.) radiant heat temperature sensitivity (p=0.006), (E.) radiant heat pain threshold (p=0.077),
(F.) pressure threshold (p=0.027), (G.) constant pressure visual analog scale (VAS) intensity (p=0.060),
(H.) constant pressure visual analog scale (VAS) unpleasantness (p=0.057) on two separate days by an 
individual experim nter. P-values re resent intraclass correlation coef ficient significance. Dotted lines 
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Within-subjects reliability analysis 
Here, we tested the reliability of a single experimenter performing multiple tests on the 










Table 2. Intraclass correlation coefficients [ICC(3,1)] for the eight pain and sensitivity 
measures. Individual subjects (n = 6) were assayed by one investigator (2 separate times). All tests 
were performed on the same day (30 min apart). ICC(3,1) and corresponding P-values are given 
for each measure. AMP – data collection. AMP, BK, MK, KS – experimental design.  
 
ICC(3,1) revealed significant correlations for constant heat unpleasantness (Figure 4C, 
ICC=0.69, *p=0.027), radiant heat sensitivity (Figure 4D, ICC=0.87, **p=0.006) and pressure 
pain threshold (Figure 4F, ICC=0.78, **p=0.027). Although the p-values for constant heat 
intensity (Figure 4B, ICC=0.60, p=0.080), radiant heat pain (Figure 4F, ICC=0.64, p=0.077), 
constant pressure intensity (Figure 4G, ICC=0.68, p=0.060) and constant pressure unpleasantness 
(Figure 4H, ICC=0.61, p=0.057) are not significant, the ICC values represent “moderate to strong” 
correlations. Figure 4 illustrates these correlations for within subjects testing.  
 
 
QST Test site ICC p-value 
Mechanical sensitivity R forearm 0.004 0.497 
Constant heat intensity L forearm 0.60 0.080 
Constant heat unpleasantness L forearm 0.69    *0.027 
Radiant heat sensitivity R forearm 0.87   **0.006 
Radiant heat pain R forearm 0.64 0.077 
Pressure pain threshold  L forearm 0.78    *0.027 
Constant pressure intensity R forearm 0.68 0.060 






Figure 4. Evaluation of intra-experimenter reliability of sensory testing in human 
participants. Individual subjects (n=6) were assayed for (A) mechanical sensation (p=0.0497), 
(B) constant heat visual analog scale (VAS) intensity (p=0.080), (C) constant heat VAS 
unpleasantness (p=0.027), (D) radiant heat temperature sensitivity (p=0.006), (E) radiant heat pain 
threshold (p=0.077), (F) pressure threshold (p=0.027), (G) constant pressure VAS intensity 
(p=0.060), and (H) constant pressure VAS unpleasantness (p=0.057) on a single day (>30 min 
between tests) by one experimenter. P-values represent intraclass correlation coefficient 
significance. The dotted lines are lines of best fit.  AMP – conducted experiment. AMP, BJK, MK, 
KS – designed experiment. 
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This study tested the inter-experimenter and within-subjects reliability of simple cost-
effective qualitative and quantitative sensory testing methods that are commonly used in 
experimental clinical settings. We have demonstrated several reliable assays that are statistically 
significant between experimenters and between test occasions. Each experimenter received a 
minimal amount of training (one trial observation and one trial implementation). Because of this, 
multiple technicians could be trained in a single day. Overall, our results suggest both strong inter-
experimenter and within-subject reliability. These assessments prove valuable because they are 
feasible to implement and require little training.  
Our results showed significant correlations for inter-experimenter reliability for all tests 
except mechanical sensitivity. However, this assay had a strong correlation that was close to 
significance (Figure 3A, ICC=0.76, p=0.08). For reliability between subjects, although not all 
tests were significant, all assays except mechanical sensitivity had moderate to strong ICC’s with 
near significant p-values (Table 2). It is likely that the significance of all tests could be improved 
with a higher sample size as we did not perform a power analysis for this experiment. It is worth 
noting that the mechanical sensitivity test was the least reliable for both analyses. We hypothesize 
that this test is less reliable due to the nature of the test measuring a higher sensitivity compared 
to the other assays implemented. One group found the testing of mechanical sensitivity using 
manually applied von Frey monofilaments to only have fair to moderate reproducibility between 
observers and within experimenters, whereas electronic von Frey was found to have better 
reproducibility (Tena et al., 2012). Thusly, clinics that have more resources may consider 
implementation of electronic von Frey as a more reliable option.  
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Limitations to the current study include low sample size, the sample choice of healthy 
volunteers and the lack of post-hoc p-value corrections. As mentioned previously, a power analysis 
was not performed to determine sample size. In our study, we had an “n” of 6 subjects, whereas 
similarly designed studies recruited anywhere from 20-30 subjects (Lewis et al., 2012; Tena et al., 
2012). Therefore, it is likely that increasing the sample size could improve our results. In limiting 
our sample to healthy volunteers, our data is not necessarily applicable to chronic pain groups. 
However, we chose to test healthy subjects to establish a controlled general model. Although we 
did not perform a priori corrections, post-hoc ICC p-value corrections was determined to be 
p<0.005 for each set of assays performed (inter-experimenter, within-subjects). We calculated this 
by dividing the standard significant p-value (p=0.05) by the number of tests performed (8) and 
round this value down. Using this correction, all but one inter-experimenter reliability test (radiant 
heat pain; p=0.021) is still considered significant. For within-subjects reliability, no tests are 
considered significant using this correction.  
Notable strengths of our study include the applicability of these tests and the lack of a 
gender effect. For large clinics, these data show that multiple trained experimenters can reliably 
implement these tests. For inter-experimenter reliability testing, one experimenter was male and 
the other was female. Due to our overall significant reliability between experimenters, the gender 
of the tester does not appear to influence the response of the subjects being tested. The protocol is 
thus largely relevant to clinics or research laboratories where employee turn-over and the training 
of new technicians occurs, as this is unlikely to affect the results of these basic analog QST assays. 
Overall, we have demonstrated significant reliability of these tests between experimenters and 
between test occasion for a set of reasonably priced portable testing equipment. The protocol of 
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manual tests described here has high applicability to research labs and small clinics interested in 







 Participants included 6 healthy adults between the ages of 18-40 from the Duquesne 
University campus. Subjects were recruited through flyers displayed on campus. Initial pre-
screening and informed consent documentation were performed by AMP and AMR. Inclusion 
criteria included individuals 1) between the age of 18 and 40 years, and 2) with a BMI within the 
normal range (18.5-25). Exclusion criteria included individuals that had 1) aged less than 18 or 
greater than 40 years, 2) cardiac, respiratory, neurological or musculoskeletal diseases, 3) presence 
of acute pain, 4) a chronic pain condition, 5) diabetes, 6) a BMI greater than or equal to 25.1 or 
less than or equal to 18.4, 7) regularly participated in high intensity athletic or sporting activities, 
8) anxiety or depression disorders, 9) a tape allergy, and 10) been currently pregnant. 
Protocol 
During the enrollment period, participants were given a full description of all sensory and 
pain measures that would be used.  Following consent, all participants were allowed to experience 
all sensory and pain measures before full enrollment. All assays involved either innocuous (non-
painful stimuli) or acute noxious stimuli (painful stimuli) that did not damage tissue. The time 
between different tests was > 5 min, to allow the subject to rest and to reduce the potential for 
 
 28 
sensory fatigue or sensitization.  The sequential order of tests was the same during each testing 
session; starting with the least invasive test (mechanical sensitivity) and ending with the most 
invasive assay (pressure algometry). Specific sites of testing were limited to the T1 dermatome on 
the left and right forearms and L3 dermatome on the left and right legs. All sites for testing were 
marked with a marker, and individual sites were spread out to avoid overlapping receptive field 
activation (Figure 2). Two assays involved qualitative assessments of pain  
(constant heat pain and constant pressure pain).  Before the stimulus was applied, the standard (0-
10) VAS was explained to the subject. On the quality or “intensity scale,” “0” represents “no pain” 
and “10” represents “the worst pain imaginable,” and that on the “unpleasantness scale,” “0” 
represents “not unpleasant” and “10” represents “the most unpleasant sensation imaginable” 
(Figure 2). Following the stimulus, subjects would rate the pain they experienced on these two 
scales. For retest reliability studies, individual subjects were tested by two experimenters in a 
single day, with 30 min between the tests. The order of experimenter testing (male first versus 
female first) was randomized across the six subjects. All testing described for the current study 
was approved by the Duquesne University Institutional Review Board for human subject research.  
Cutaneous mechanical sensitivity assay  
Stimulation was provided with standard sensory evaluator von Frey filaments (Touch 
Test). These small nylon filaments each applied a single force (ranging from 0.078 mN (0.008 g) 
to 4.08 mN (1.0 g)). During each trial, the subject was asked to look away from their forearm or 
calf. The filament was applied to the subject’s forearm or calf until it bows at a 30° angle, while 
the subject was asked if they could feel the filament.  Starting with the smallest filament (0.078 
mN; below the sensory threshold for human detection), five trials were conducted on the subject’s 
forearm or calf for each filament. There were four applications of each filament in the “positive” 
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trials. For the other trial, no filament was applied, but the subject was still asked if they feel the 
filament. This “negative” trial was randomly inserted with the four “positive” trials and was 
designed to test for false responses (i.e. the subject thinks they feel something even though no 
stimulus is applied). If a subject detects ≥ 3 of the positive trials and 0 negative trials for a filament, 
that filament was recorded as the subject’s “mechanical sensory threshold.” For a single filament, 
if the subject detects < 2 of the real trials and/or > 0 of the false trials, another round of 5 trials 
were started with the next-biggest filament until the sensory threshold was reached.  
Radiant heat sensitivity assay  
This assay involved determining the sensitivity threshold for non-painful heat change and 
for painful thermal stimulation. Stimulation was provided with a radiant heat device (Sternberg et 
al., 2001). This device used a focused light beam to slowly heat a subject’s skin through a piece of 
0.64-mm-thick safety glass (DuPont). The “Hargreaves-type” testing apparatus consisted of one 
complete base and four supporting columns that are used to form a platform for a sheet of safety 
glass through which the heat source directs heat to the subjects’ arm or leg that is resting on the 
glass. The heat lamp was placed beneath the glass. The heat source and timer for Hargreaves testing 
has an “idle state” that allows exact placement of the heat source. The heat source was radiant light 
and the light beam was focused to the top of the glass to create a 4 mm x 6 mm intense spot on the 
arm or leg. (IITC Plantar Analgesia Meter, Life Science Inc. Woodland Hills, Cat. #390). A 
thermocouple was placed on the glass underneath the subject’s arm or leg to measure the 
temperature at the glass level (IIB Fluke, Cat. #3821062). 
Before the start of the trials, the device was shown to the subject; allowing them to feel the 
stimulus with their hand. The subject was asked to rest their forearm or calf on the room 
temperature glass plate, which was covered with a rubber-insulating sheet except for the small 
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window for stimulus presentation. Using a mirror, the light source was positioned under a marked 
area on the subject’s forearm or calf (Figure 1).  Two trials for each test on each limb were 
completed (innocuous temperature detection and pain threshold) in two distinct marked areas to 
avoid retesting at a single site. For the innocuous temperature detection trial, the subject was asked 
to raise their leg or arm or depress the “stop” button when they feel the temperature change. The 
device was set so that the typical withdrawal threshold occurs at approximately 10 seconds into 
the trial and so that the device shuts off after 20 seconds. To accomplish this withdrawal threshold, 
the device was set to ramp the temperature such that the stimulus reaches 47°C at 10 seconds. In 
the pain threshold trial, subjects were told to raise their leg or arm or depress the “stop” button 
when they feel the stimulus transition from “innocuous warmth or heat” to “painful heat.” The 
maximum temperature of the trial at the 20 second cutoff time point was 50°C, which is well below 
the cumulative temperature that causes tissue damage in humans (Yarmolenko et al., 2011).   
Constant heat pain assay  
Constant heat was used to evaluate both the intensity and unpleasantness of thermal pain. 
A heat block was set to a constant temperature of 45°C for the stimulus (Benchmark Scientific, 
BR10-00). 45°C is a standard temperature that is the typical minimal stimulus necessary to feel 
thermal pain and is known to activate TRPV1 nociceptive receptors (Tominaga, 2007). The 
stimulus (3 cm x 5 cm heating block) was applied for 3 seconds to the marked location on the left 
forearm or calf (as shown in Figure 1 at the site marked “T”). Immediately following the stimulus, 
the subject was asked to evaluate the intensity and unpleasantness of the pain using a standard (0-
10) VAS.  
Pressure sensitivity assay  
The assay involved determining the sensitivity threshold for painful pressure stimulation 
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and then determining the intensity and unpleasantness of that same pressure in a separate trial. 
Stimulation was provided with a standard clinical pressure algometer (Wagner Instruments, FDK 
20).  This device consists of a 2-cm rubber probe connected to a pressure meter. The dial records 
the pressure and is reset after each measurement. For the pain threshold trial, the probe was placed 
on the subject’s forearm or calf and pressure was applied gradually. Two trials were completed 
each to the forearm and calf at two distinct sites (on each limb) to avoid damage to a single area. 
During a trial, pressure was applied gradually, until the stimulus transitions from “innocuous 
pressure” to “painful pressure”. The subject was asked to say “stop” at this point and the stimulus 
was removed from the subject’s forearm or calf. The device automatically records the greatest 
pressure applied.  This pressure was recorded as the “pressure pain threshold” for the trial.   
Constant pressure pain trials: After determining the pressure threshold for the subject, an 
additional trial was applied on the opposite limb to determine the subject’s pain associated with a 
painful pressure stimulus (in a third testing site). The exact stimulus was matched to the subject’s 
pain threshold determined during the baseline trials. In this trial, the subject was asked to evaluate 
the intensity and unpleasantness of the painful pressure stimulus given for 3 seconds.  
Reliability testing 
To examine the reliability of these assays, we compared the ratings of subjects between 
one male and one female examiner (inter-reliability) and within one single experimenter (intra-
reliability). The two examiners for this study (AMP and AMR) were laboratory technicians (one 
female and one male) who were trained by study investigators who have experience from the 
clinic and laboratory in pain measurement and management and in neural sensation. Testing for 
inter-reliability included two testing sessions (one by the female experimenter, AMP and one by 
the male experimenter, AMR) on a single subject. These examinations were at least 30 minutes 
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apart. Testing for intra-reliability included two testing sessions performed by AMP on separate 
days on a single subject.  
Statistical analysis 
 To statistically assess reliability, intraclass correlation coefficients (ICC) were calculated 
using IBM SPSS Version 25. ICC is commonly applied in the assessment of reproducibility or 
consistency of quantitative measurements made by different observers measuring the same 
quantity. ICC (model 3,k) [ICC(3,k)] using a two-way mixed analysis of variance (ANOVA) with 
absolute agreement for each dependent variable were chosen for analysis (8 total) (Portney, 2009). 
The ICC(3,2) model was used for inter-rater analysis and ICC(3,1) was used for assessment of 













































The majority of the text contained within this chapter is adapted from the following publication: 
Polaski AM, Phelps AL, Kostek MC, Szucs KA, Kolber BJ. 2019. Exercise-induced 




Organization of data generated for Figure 2 and Figure 3 was done in assistance by Abigail Cox.  
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Increasing evidence purports exercise as a first-line therapeutic for the treatment of nearly 
all forms of chronic pain. However, knowledge of efficacious dosing respective to treatment 
modality and pain condition is virtually absent in the literature. The purpose of this analysis was 
to calculate the extent to which exercise treatment shows dose-dependent effects similar to what 
is seen with pharmacological treatments. A recently published comprehensive review of exercise 
and physical activity for chronic pain in adults was identified in May 2017. This report reviewed 
different physical activity and exercise interventions and their effectiveness in reducing pain 
severity and found overall modest effects of exercise in the treatment of pain. We analyzed this 
existing data set, focusing specifically on the dose of exercise intervention in these studies. We re-
analyzed data from 75 studies looking at benefits of time of exercising per week, frequency of 
exercise per week, duration of intervention (in weeks), and estimated intensity of exercise. 
Analysis revealed a significant positive correlation with exercise duration and analgesic effect on 
neck pain. Multiple linear regression modeling of these data predicted that increasing the 
frequency of exercise sessions per week is most likely to have a positive effect on chronic pain 
patients. Modest effects were observed with one significant correlation between duration and pain 
effect for neck pain. Overall, these results provide insufficient evidence to conclude the presence 
of a strong dose effect of exercise in pain, but our modeling data provide testable predictions that 
can be used to design future studies to explicitly test the question of dose in specific patient 







Approximately 1.5 billion people worldwide suffer from chronic pain (Steglitz et al., 
2012). In the U.S., chronic pain is thought to affect over 116 million adults, about a third of the 
population (Steglitz et al., 2012). Because of this, chronic pain continues to be a widespread burden 
on healthcare resources. In European countries, national healthcare and socioeconomic costs 
associated with chronic pain total billions of dollars a year (Christensen, 2011; Gustavsson et al., 
2012; Raftery et al., 2012), whereas treatment costs in the U.S. can accrue up to $635 billion dollars 
annually (Gaskin and Richard, 2012), generating a considerable economic weight on healthcare 
systems and society. 
Increasing evidence cites exercise as an accessible, cost-effective, and practical therapeutic 
modality for the treatment of nearly all chronic pain conditions (Fransen et al., 2002; Schachter et 
al., 2003; Edmonds et al., 2004; Hayden et al., 2005; Busch et al., 2007; Chou et al., 2007; 
Hurkmans et al., 2009; Boldt et al., 2014; Lane et al., 2014; Gross et al., 2015; Koopman et al., 
2015; van der Heijden et al., 2015). Regimented physical activity and exercise has been found to 
benefit several general health outcomes, including cardiorespiratory function, mental health, and 
pain (1996; Penedo and Dahn, 2005; 2009). In general terms, physical activity can include various 
tasks of daily living, such as work, mobility, leisure, and recreational activities. These are activities 
that require musculoskeletal activity and energy expenditure. More specifically, exercise is a 
subset of physical activity, and is defined as structured activity with a goal of improving physical 
performance and/or health (WHO, 2017). Common forms of exercise that are studied for the relief 
of pain include running, walking, resistance training, aquatic exercise, and Tai Chi. Exercise has 
been successful in promoting pain relief and improving patients’ daily physical function in several 
chronic pain conditions including chronic neck pain (Childs et al., 2008; Cuesta-Vargas et al., 
 
 37 
2013), osteoarthritis (Jansen et al., 2011; Cuesta-Vargas et al., 2013), fibromyalgia (Brosseau et 
al., 2008), and chronic low back pain (van Middelkoop et al., 2010; Cuesta-Vargas et al., 2013). 
A dual effect is thus realized for patients with chronic pain because aerobic exercise reduces pain 
and fatigue as well as improves peak oxygen uptake, health-related quality of life, and physical 
fitness (Dinler et al., 2009; Hauser et al., 2010). Physical activity has been shown to be associated 
with decreased symptoms of depression and anxiety, further suggesting that exercise could be 
particularly advantageous in the context of chronic pain comorbid with psychiatric illness (Bhui 
and Fletcher, 2000; Dunn et al., 2005).  This is particularly important considering that levels of 
physical activity are inversely correlated with depression symptoms in fibromyalgia patients 
(Andrade et al., 2017).  
Although overall evidence shows exercise to be at least moderately beneficial in chronic 
pain (Ambrose and Golightly, 2015), there exists a number of compliance issues related to the 
prescription of physical exercise. One of the most pressing issues, especially for individuals with 
musculoskeletal conditions, is the presence of fear-avoidance behavior or kinesiophobia. 
Additional issues include limited access to training for safe exercise, limited access to equipment, 
failure to account for the presence of acute pain during exercise, and the lack of data specific for 
each individual condition. Surprisingly, there is almost a complete lack of studies in the exercise 
and pain literature testing multiple doses of exercise in a single patient (or control) group.  
The four components of dose that can be adjusted for exercise prescription include: 1.) the 
frequency of which exercise is performed in one week, 2.) the time in minutes exercises is 
performed in one week, 3.)  the duration in weeks that the exercise intervention is performed, and 
4.) the intensity of exercise. It is important to note that duration is not typically prescribed or 
examined as a component of exercise dose, but is included here because evaluating the duration of 
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a study allows for a novel examination of exercise effects from an acute to a chronic perspective. 
One caveat to this definition of dose is that it does not accurately describe all variables incorporated 
into resistance exercise programs. Common variables in resistance training interventions include: 
training volume (i.e. period, frequency, number of sets per exercise, number of repetitions per set), 
training intensity (i.e. intensity, time under tension) and rest (rest in between sets and repetitions) 
(Baechle TR, 2000; Kraemer WJ, 2002). However, we chose the 4 variables for dose as mentioned 
above (frequency, time, duration, intensity), because these factors were common across all forms 
of exercise assessed in this analysis. 
The American College of Sports Medicine recommends 30 minutes of moderate-intensity 
exercise five days per week (or 150 MET-minutes) in order to maintain cardiorespiratory, 
musculoskeletal, and neuromotor fitness for healthy adults (Garber et al., 2011). Ideally, this dose 
of exercise would be implemented and maintained long-term for continued health benefits. 
However, these recommendations may be too high of a starting dose for persons experiencing 
chronic pain, especially conditions associated with movement-induced pain and movement-
associated fear-avoidance behavior (Umeda et al., 2015; Larsson et al., 2016). It is necessary to 
critically evaluate the most appropriate dose of exercise for chronic pain.  
In this review, we analyze published data evaluating the impact of different exercise 
modalities across different types of pain. A recent meta-analysis, (Geneen et al., 2017), was 
published in the Cochrane Database of Systematic Reviews, which is among the leading resources 
for meta-analyses in health care. This review assessed physical activity and exercise in chronic 
pain patients utilizing data from 21 other individual meta-analyses (6495 total studies screened).  
Rather than starting de novo, we took a unique approach of performing additional analyses on this 
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already existing study. This adds consistency to the literature; papers included in the above meta -
analysis were already peer-reviewed and had met the Cochrane rigorous criteria for inclusion.  
  The purpose of the present analysis was to evaluate how changing the measured dose of 
exercise correlates with a measured pain effect size. In this unique analysis, we treat each study as 
a single data point in which the measured outcome is the standardized effect size for pain. Data 
from (Geneen et al., 2017) was used to conduct correlation analyses with linear and multivariate 
linear regression evaluating dose of exercise with effect size for pain. The overall objective of this 
review was to test the hypothesis that the dose of exercise would impact the efficacy of exercise 






Characteristics of included studies 
Of the 381 studies identified in Geneen et al(Geneen et al., 2017), 75 individual studies 
met the inclusion criteria for our analysis (Figure 1). Most of the studies that were omitted from 
this analysis, but were included in Geneen et al., did not contain an effect size for a pain related 
outcome, did not report such effect size at the immediate post-intervention time point, and/or did 
not reflect the relationship for the control vs. exercise group comparison. See Table 1 for a 
compilation of each study’s characteristics. Studies identified in more than one Cochrane Review 
(i.e. a duplicate study) were only analyzed once. Some studies reported a range of TIME (minutes 
per week) and subsequently IxD (Intensity x Dose or TIME) (MET-min per week) for the exercise 
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intervention which can be seen in Table 3. Due to the variability in dosage, these particular data 
points were not included in analysis. 
 
Figure 1. Flow chart diagram showing reference screening and study selection based on 
exclusion and inclusion criteria. Inclusion/exclusion criteria development – AMP, BJK. Study 
screening – AMP.  




analyses, n=15 meta-analyses, 
n=6495 articles identified, n=350 
articles included in meta-analysis
Studies from meta-analysis 
assessed for eligibility, n=82
Meta-analyses excluded, n=6
- Paper withdrawn, n=1
- No pain effect sizes, n=3
- Effect sizes not compared to 
control, n=1
- No analysis performed, n=1
Eligible studies included in meta-
analysis, n=75
Studies excluded, n = 7
- Not published in English, n=3
- Variable dosage Rx, n=2
- Control had manipulation, n=1
- Review data not matched with 
orginal article, n=1
Studies excluded, n=268
- No pain effect size reported for
immediate post-intervention time
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Table 1. Characteristics and data from studies included in analysis.  
INT shows categories for intervention type. (#) denotes the intervention group for studies that 
included multiple interventions. * denotes duplicates found. EX, exercise (group); FREQ, # of 
exercise sessions per week; TIME, minutes of exercise per week; IxD, intensity x dose MET -
minutes of intervention per week; DUR, # of weeks the intervention lasts; C, control (group); SD, 
standard deviation; ROM, range of motion exercise; FLEX, flexibility exercise; RA, rheumatoid 
arthritis; PFPS, patellofemoral pain syndrome; OA, osteoarthritis; FMS, fibromyalgia syndrome; 
IC, intermittent claudication; NP, neck pain; LBP, low back pain; SCI, spinal cord injury; VAS, 
visual analog scale; WOMAC, Western Ontario McMaster Osteoarthritis index; SF-36, The Short 
Form (36) Health Survey; AIMS, Arthritis Impact Measurement Scale; MPQ, McGill Pain 
Questionnaire; KOOS, Knee Injury and Osteoarthritis Outcome Score; HAQ, The Health 
Assessment Questionnaire; NRS, Numerical Ratings Scale; WHYMPI, West Haven-Yale 
Multidimensional Pain Inventory. Cohen’s d is represented as standardized mean effect sizes. Data 
compilation – AMP.  
 
 
Most of the studies included in this review demonstrated some positive benefits of exercise 
on pain outcomes (69 of 75 studies); of which 30 were statistically significant (e.g. according to 
the C.I. accompanying the effect size). Of the statistically non-significant studies, 39 of 45 
described positive trending benefits of exercise while only six studies reported worse pain with 
exercise (Minor et al., 1989; Hansen et al., 1993; Talbot et al., 2003; Helewa et al., 2007; Beer et 
al., 2012; Bruce-Brand et al., 2012).  
Risk of bias analysis 
We assessed the risk of bias of the 75 included studies in accordance with The Cochrane 
Collaboration’s recommended methods (Higgins JPT, 2011) using the Review Manager 
assessment tool (2014). We evaluated articles according to the following domains: 1) random 
sequence generation, 2) allocation concealment, 3) blinding of participants and personnel, 4) 
blinding of outcome assessment, 5) incomplete outcome data, 6) selective outcome reporting and 
7) other biases (i.e. baseline imbalances between allocation groups in participant characteristics. 




Figure 3A-C for a complete list of each assessment of risk of bias for each study included. Both 
figures were generated using Cochrane’s ‘risk of bias’ tool in Review Manager. Random sequence 
generation was adequately described in over 75% of included studies. Low risk of bias for 
allocation concealment, incomplete outcome data, selective reporting and other bias existed in over 
50% of the studies.  A high risk of bias was found in over 75% of the studies due to lack of blinding 
of participants and personnel (performance bias), which was unavoidable in most studies due to 
the nature of the interventions. Also present in 25% of the included studies were higher levels of 
detection bias due to participants being un-blinded for self-assessment outcomes (i.e. VAS pain 




Figure 2. ‘Risk of bias’ graph: review authors’ assessments for each risk of bias item 
presented as percentages across all included studies. RoB organization – AMP, Abigail Cox. 
















































































































































































































































































































































































































































































































Figure 3. ‘Risk of bias’ complete assessment: review authors’ judgements for each risk of 
bias item for each included study. RoB organization – AMP, Abigail Cox. RoB analysis (figure 
generated through Review Manager software from the Cochrane database) – AMP.  
 
Analysis by pain state 
We began by first analyzing the impact of dose for each specific chronic pain disease state 
combining data across different types of exercise for a single state. Pain states for these analyses 
included NP (Takala et al., 1994; Viljanen et al., 2003; Helewa et al., 2007; von Trott et al., 2009; 
Rendant et al., 2011; Beer et al., 2012), FMS (Wigers et al., 1996; Buckelew et al., 1998; 
Mannerkorpi et al., 2000; Hakkinen et al., 2001; Schachter et al., 2003; Altan et al., 2004; Sencan, 
2004; Gusi et al., 2006; Munguia-Izquierdo and Legaz-Arrese, 2007; Tomas-Carus et al., 2008; 
Mannerkorpi et al., 2009; Kayo et al., 2012), OA (Ettinger et al., 1997; van Baar et al., 1998; 
Hopman-Rock and Westhoff, 2000; Patrick et al., 2001; Foley et al., 2003; Talbot et al., 2003; 
Hughes et al., 2004; Cochrane et al., 2005; Tak et al., 2005; Brismee et al., 2007; Fransen et al., 
2007; Wang et al., 2007; Yip et al., 2007; An et al., 2008; Doi et al., 2008; Jan et al., 2008; Lund 
et al., 2008; Lin et al., 2009; Bezalel et al., 2010; Fernandes et al., 2010; Foroughi et al., 2011; 
Juhakoski et al., 2011; Wang et al., 2011; Bruce-Brand et al., 2012; Salacinski et al., 2012; French 
et al., 2013), and LBP (Turner et al., 1990; Risch et al., 1993; Soukup et al., 1999; Alexandre et 
al., 2001; Gladwell et al., 2006; Rydeard et al., 2006; Costa et al., 2009; da Fonseca et al., 2009; 
Rasmussen-Barr et al., 2009; Quinn et al., 2011; Rhee et al., 2012; Miyamoto et al., 2013; Natour 
et al., 2015). Analyses for the remaining pain states; RA, PFPS, IC and SCI, were not performed 
due to having too few studies. Shapiro-Wilk Goodness of Fit for Normality revealed all pain state 
analyses to meet the normality assumption, with the exception of the analysis for FMS with 




exercise dose (i.e. FREQUENCY, TIME, and DURATION) in relation to pain effect sizes for each 
respective study. 
Data for neck pain patients showed a statistically significant positive correlation for 
DURATION (Figure 4, PCC R=0.8619, **p=0.0059) of intervention with analgesic effect. 
Longer duration studies were associated with more positive analgesic effects. See Table 2 for a 
comprehensive list of all analyses performed by pain state.  
 
 
Figure 4. Pain effect size vs. DURATION of exercise for neck pain patients for all exercise 
modalities. DURATION of intervention is measured in weeks, n=8, shows a statistically 
significant positive correlation with analgesic effect (**p=0.0059). R represents Pearson’s 
correlation coefficient. Dotted line represents line of best fit. Data acquisition and analysis – AMP. 






































Table 2. Comprehensive list of results for all univariate correlation analyses performed for 
pain effect size versus dose of exercise intervention. Analysis grouping is shown in the left 
column. R represents value of Pearson’s correlation coefficient. (N) represents the number of 
individual studies included in the analysis. **p<0.01. Data acquisition and analysis – AMP. 
Experimental design – AMP, BJK.  
 
Analysis by exercise type 
Next, we analyzed the impact of dose on pain effect by evaluating each exercise type 
combined across different pain conditions for a single exercise type. Initial analyses were 
performed by grouping exercise modalities into broader categories (i.e. aquatic (Minor et al., 1989; 
Mannerkorpi et al., 2000; Patrick et al., 2001; Foley et al., 2003; Altan et al., 2004; Cochrane et 
al., 2005; Gusi et al., 2006; Munguia-Izquierdo and Legaz-Arrese, 2007; Wang et al., 2007; 
Tomas-Carus et al., 2008; Mannerkorpi et al., 2009; Wang et al., 2011), aerobic (Minor et al., 
1989; Turner et al., 1990; Hansen et al., 1993; Takala et al., 1994; van den Ende et al., 1996; 
Wigers et al., 1996; Ettinger et al., 1997; Buckelew et al., 1998; Mannerkorpi et al., 2000; Tsai et 
al., 2002; Schachter et al., 2003; Talbot et al., 2003; Hughes et al., 2004; Sencan, 2004; Cochrane 
et al., 2005; Collins et al., 2005; Zwierska et al., 2005; Gladwell et al., 2006; Gusi et al., 2006; 
 R  (N) 
Analyses FREQUENCY TIME DURATION 
Neck pain (NP) -0.6969  (6)      0.3035  (4)     **0.8619  (8) 
Fibromyalgia (FMS)   -0.2894  (12)      0.3739  (8)   -0.1541  (13) 
Osteoarthritis (OA)  -0.1540  (23) 0.3703  (16)    0.0165  (27) 
Low back pain (LBP)  -0.1979  (10)      0.1519  (9)    0.3819  (13) 
Aquatic exercise   0.0948  (12) 0.3519  (10)   -0.0458  (12) 
Aerobic exercise  -0.0585  (35) 0.2633  (26)   -0.1002  (36) 
Strength training  -0.1254  (41) 0.1202  (27)    0.1181  (49) 
Meditative movement   0.3453  (10) 0.5610  (10)   -0.2183  (12) 
Pilates-only 0.5624  (6)      0.6718  (6)       -0.3286  (6) 
Walking/jogging      -0.0074  (8)     -0.0725  (7)       -0.0392  (9) 




Rydeard et al., 2006; Brismee et al., 2007; Fransen et al., 2007; Yip et al., 2007; An et al., 2008; 
Tomas-Carus et al., 2008; da Fonseca et al., 2009; Mannerkorpi et al., 2009; von Trott et al., 2009; 
Guidon and McGee, 2010; Quinn et al., 2011; Rendant et al., 2011; Wang et al., 2011; Salacinski 
et al., 2012; French et al., 2013; Miyamoto et al., 2013; Moyano et al., 2013; Natour et al., 2015), 
and strengthening exercise (Zylbergold and Piper, 1981; Turner et al., 1990; Risch et al., 1993; 
Ettinger et al., 1997; Buckelew et al., 1998; van Baar et al., 1998; Soukup et al., 1999; Hopman-
Rock and Westhoff, 2000; Alexandre et al., 2001; Hakkinen et al., 2001; Patrick et al., 2001; Foley 
et al., 2003; Hicks et al., 2003; Viljanen et al., 2003; Altan et al., 2004; Hughes et al., 2004; Loudon 
et al., 2004; Tak et al., 2005; Gladwell et al., 2006; Rydeard et al., 2006; Helewa et al., 2007; 
Munguia-Izquierdo and Legaz-Arrese, 2007; Wang et al., 2007; Doi et al., 2008; Jan et al., 2008; 
Lund et al., 2008; Tomas-Carus et al., 2008; Costa et al., 2009; da Fonseca et al., 2009; Lin et al., 
2009; Rasmussen-Barr et al., 2009; von Trott et al., 2009; Bezalel et al., 2010; Fernandes et al., 
2010; Foroughi et al., 2011; Juhakoski et al., 2011; Mulroy et al., 2011; Quinn et al., 2011; Rendant 
et al., 2011; Beer et al., 2012; Bruce-Brand et al., 2012; Kayo et al., 2012; Rhee et al., 2012; French 
et al., 2013; Miyamoto et al., 2013; Moyano et al., 2013; Natour et al., 2015)).  
A secondary analysis was performed by grouping exercise interventions into more specific 
categories, with the aim of reducing experimental variability between exercise interventions. These 
categories consisted of meditative movement-based therapies (Gladwell et al., 2006; Rydeard et 
al., 2006; Brismee et al., 2007; Fransen et al., 2007; Yip et al., 2007; An et al., 2008; da Fonseca 
et al., 2009; von Trott et al., 2009; Quinn et al., 2011; Rendant et al., 2011; Miyamoto et al., 2013; 
Natour et al., 2015) (i.e. Pilates, tai chi and qigong), Pilates-only (Gladwell et al., 2006; Rydeard 
et al., 2006; da Fonseca et al., 2009; Quinn et al., 2011; Miyamoto et al., 2013; Natour et al., 2015), 




Tsai et al., 2002; Talbot et al., 2003; Hughes et al., 2004; Collins et al., 2005; Guidon and McGee, 
2010), and aquatic aerobics (Minor et al., 1989; Mannerkorpi et al., 2000; Cochrane et al., 2005; 
Gusi et al., 2006; Tomas-Carus et al., 2008; Mannerkorpi et al., 2009; Wang et al., 2011). Although 
there were other specific therapy types present in this cohort of studies, they were of an insufficient 
sample size to perform separate analyses. We found no statistically significant correlations for the 
primary or secondary analysis. See Table 2 for the complete list of results for analyses done by 
exercise type.  
Multivariate analysis of dose interactions 
Following the marginal effect seen in the univariate analysis, we sought to account for 
potential connections between the dose variables. We reasoned that FREQUENCY, TIME, and 
DURATION may interact to influence pain effect size. In developing this model, we also 
considered whether a study actually showed a statistically significant effect. Overall, the 
multivariate analysis allows us to predict the impact of varying one dose variable on the pain effect.  
Table 3 shows the results of the multivariate linear regression modeling. We found a 
statistically significant main effect of whether the study showed a significant effect size or not, a 
statistically significant main effect of dose as measured by FREQUENCY and by TIME as well 
as, statistically significant interaction effects of TIME in minutes per week by DURATION, and 
FREQUENCY per week by DURATION.  The linear regression equation is given by: 
Study Pain Effect = 0.374 – [0.36 FREQ] + [0.01 TIME] – [0.03 DUR] + [0.743 Sig]  
      –  [0.001 Dur*Time] + [0.04 Dur*Freq] 
 
It is noted that due to missing data, mostly in capturing TIME in minutes per week, that only 43 




significant studies included in these 43 reflected a similar 2-1 ratio of the total 75 studies selected. 
Of note, studies with both positive and negative effect sizes were used to develop this model. 
 
 
Table 3. Results of multivariate linear regression modeling for dose interactions.   
Shown are the multiple linear regression coefficients. Model F-statistic=9.628, p<0.001. Adjusted 
R2=0.552. Data acquisition – AMP. Statistical analysis – ALP. Experimental design – AMP, ALP, 
BJK. 
 
The adjusted R2 value of this analysis is 0.552 meaning that 55.2% of the variation in 
standardized effect size is due to the factors represented in this model.  Much of that is naturally 
attributed to studies which resulted in a significant effect size; however, the model does indicate 
that even for those studies which did not result in a significant effect size, changing exercise dose 
does significantly influence measured pain outcomes.  
The model predicts that for individual studies which resulted in a significant pain effect, 
one would expect to see an increase of 0.743 standardized effect size as indicated by the coefficient 
for the variable “Sig.” However, the statistically significant coefficients for the interaction of 
TIME by DURATION and FREQUENCY by DURATION (not the main effects coefficients) are 
the driving numerical forces in this model when using it to predict changes in analgesic effect 
between different exercise dosing. For all studies that resulted in a significant pain effect and that 
applied a similar exercise dose as measured in FREQUENCY per week and DURATION, 
increasing the TIME measured in minutes per week results in a statistically significant increased 
Parameter Estimate Std. Err. DF T-Stat p-value 
Intercept    0.374 0.244 36 1.536 0.1333 
Dose: FREQUENCY (x/wk)   -0.357 0.122 36   -2.913  **0.0061 
Dose: TIME (min/wk)    0.007 0.003 36 2.660 0.0116 
Dose: DURATION (wks)   -0.026 0.018 36   -1.443 0.1575 
Sig    0.743 0.114 36 6.516 ****<0.0001 
Dur*Time   -0.001   0.0002 36   -2.766  **0.0089 




standardized effect size; this predicted increase is countered by the negative interaction effect of 
DURATION by TIME. Thus, the overall net effect of increasing TIME in minutes per week 
predicts a decreased analgesic effect.  
For all studies that resulted in a significant pain effect and applied a similar exercise dose 
as measured by TIME in minutes per week and DURATION, increasing the FREQUENCY per 
week results in a statistically significant decreased effect size, however this predicted decrease is 
countered by the positive interaction effect of the exercise regimen duration by frequency. Thus, 
increasing FREQUENCY of the exercise performed per week predicts an overall net increased 
analgesic effect. Because of this, it is crucial to take all variables into account when thinking about 
frequency. Similar effects of changing doses are predicted when using this model for those studies 
in this meta-analysis which reported non-significant pain effect sizes.   
Table 4 gives an example of how the standardized effect size is predicted to change 
between studies that produced a significant result and those that did not produce a significant result 
when changing dose as measured by TIME, FREQUENCY and DURATION.  In the 43 studies 
used to develop the model above, the average TIME exercised was about 120 minutes per week, 
the average FREQUENCY was 3 times per week and the average DURATION was about 15 
weeks. Given these values, the multivariate model predicts a pain effect of 0.8 for studies that 
resulted in a significant pain effect compared to 0.04 for studies that did not result in a significant 





Table 4. Predicted pain effect values using the multiple linear regression model for 
significant and non-significant studies. The last two columns show predicted pain effect sizes 
for significant studies versus non-significant studies as a result of the exercise prescription shown 
in the second column. The highlighted cells indicate the variables being changed compared to the 
average values from the included studies. Data acquisition and analysis – AMP. Experimental 
design – AMP, BJK.  
 
Using the model, one can predict the impact of varying one of the three dose variables 
while keeping the other variables consistent with the average values (Table 4). In this way, one 
can evaluate the relative impact of varying FREQUENCY, TIME or DURATION on predicted 
pain effect in a hypothetical study. For example, increasing FREQUENCY per week to 6 times 












 Coefficient 0.374 -0.36 0.01 -0.03 -0.001 0.04 0.743 0 
Change  
FREQ by 1 
day 
         
 Less 2 day  1 120 15 1800 15 0.307 -0.436 
 Less 1 day  2 120 15 1800 30 0.547 -0.196 
 Average 
Values 
 3 120 15 1800 45 0.787 0.044 
 Add 1 day  4 120 15 1800 60 1.027 0.284 
 Add 2 day  5 120 15 1800 75 1.267 0.524 
 Add 3 day  6 120 15 1800 90 1.507 0.764 
Change 
TIME by 30 
min 
         
 Less 1.5 hr  3 30 15 450 45 1.237 0.494 
 Less 1 hr  3 60 15 900 45 1.087 0.344 
 Less 0.5 hr  3 90 15 1350 45 0.937 0.194 
 Average 
Values 
 3 120 15 1800 45 0.787 0.044 
 Add 0.5 hr  3 150 15 2250 45 0.637 -0.106 
 Add 1 hr  3 180 15 2700 45 0.487 -0.256 
 Add 1.5 hr   3 210 15 3150 45 0.337 -0.406 
Change 
DURATION 
by 1 wk 
         
 Less 6 wk  3 120 9 1080 27 0.967 0.224 
 Less 4 wk  3 120 11 1320 33 0.907 0.164 
 Less 2 wk  3 120 13 1560 39 0.847 0.104 
 Average 
Values 
 3 120 15 1800 45 0.787 0.044 
 Add 2 wk  3 120 17 2040 51 0.727 -0.016 
 Add 4 wk  3 120 19 2280 57 0.667 -0.076 




per week while holding TIME and DURATION constant results in a predicted pain effect of 1.5 
for significant studies compared to the average of 0.8 effect, and 0.8 for non-significant studies 
compared to the average of 0.04. In other words, doubling the number of exercise bouts from 3 to 
6 times per week suggests that the predicted pain effect would increase even in studies that did not 
result in a significant difference between the control and treatment groups.  
In contrast, increasing TIME exercised from the group average of 120 minutes to 210 
minutes per week, while holding FREQUENCY and DURATION constant resulted in smaller and 
slightly negative predicted pain effects of 0.3 and -0.4 for significant and non-significant studies, 
respectively. Decreasing the TIME spent exercising to 30 minutes per week predicted positive pain 
effects of 1.2 for significant studies and 0.5 for non-significant studies. Similar predictions were 
observed while manipulating DURATION (Table 4).  
Univariate analysis of dose intensity 
 Thus far, our analysis has shown a single univariate correlation with exercise study 
DURATION and neck pain effect. We also found some potentially interesting predictions from a 
multivariate analysis describing the interactions between different aspects of exercise dose. To 
complement this simplified analysis of dose and pain effect, we also sought to account for the 
intensity of exercise in an additional univariate analysis. Here, the intensity of each exercise (MET) 
was estimated and combined with dose of exercise (in TIME). This combined value 
(INTENSITYxTIME) was used to evaluate the intensity of exercise because the basic estimated 
metabolic equivalent of task (MET) intensity (from The 2011 Compendium of Physical Activities: 
Tracking Guide (Ainsworth et al., 2011)) for some types of exercise (e.g. qigong, tai chi and 
Pilates) were identical for all studies even though those studies varied considerably on other 




could be calculated for (n=43), we performed a new set of univariate analyses calculating the 
correlation between effect size and INTENSITYxTIME for studies grouped either by pain state or 



















Table 5. Results of univariate correlation analyses performed for pain effect size versus 
INTENSITY x TIME. Analysis grouping is shown in the left column. Dose of exercise is 
represented by TIME in minutes per week. R represents value of Pearson’s correlation coefficient. 
N represents the number of individual studies included in the analysis. Data acquisition and 













Neck pain (NP) -0.4768  (5) 
Fibromyalgia (FMS)  0.5178  (8) 
Osteoarthritis (OA)    0.1426  (16) 
Low back pain (LBP)  0.1727  (9) 
Aquatic exercise    0.0631  (11) 
Aerobic exercise    0.1482  (28) 
Strength training   -0.0559  (33) 
Meditative movement    0.5610  (10) 
Pilates-only  0.6718  (6) 
Walking/jogging  0.0001  (4) 




DISCUSSION   
Prescribing exercise as a first-line therapy for chronic pain presents numerous challenges. 
One significant challenge is determining the exercise therapy best suited for the chronic pain 
condition and subsequently for each individual patient. It is known that low-to moderate-intensity 
exercise (50-60% of maximum heart rate) is sufficient to improve chronic pain symptoms 
(Ambrose and Golightly, 2015). Although there is a significant amount of evidence in the literature 
suggesting exercise as an efficacious modality for the treatment of chronic pain, there is virtually 
no knowledge of the appropriate dose of exercise for a given disease or patient type. That is, almost 
all studies compare a single dose of exercise to control conditions or other alternative treatments. 
This is a notable and substantive gap in the use of exercise as an evidence-based therapy. The lack 
of dosing studies for exercise means that patients may not be receiving the optimal therapy and/or 
be receiving a therapy that actually increases pain. As described above, we have correlated the 
pain or analgesic effect size seen in patients with the prescribed dose to address this clinically-
relevant question.  
Although the linear regression analysis of this data found only one significant correlation, 
Neck pain effect vs. DURATION, the multivariate linear regression modeling allowed us to weigh 
the relative impact of FREQUENCY vs. TIME vs. DURATION on positive and negative pain 
effects (i.e. patients getting better or worse). When comparing changes to single dose 
measurements (FREQUENCY, TIME, or DURATION) while keeping the other variables 
constant, we found a substantive increased analgesic effect when frequency per week was 
increased. Conversely, when TIME in minutes exercised per week or DURATION of study was 
increased, the model predicts a decreased analgesic effect. The significant interactions of TIME 




capture optimal treatment exercise plans and that these are likely to vary between disease states 
and exercise modalities.  Generally, the model does support a modicum that daily exercise is likely 
to support an analgesic effect. 
Dose effects in exercise 
The general idea of dose effects in exercise is not controversial. Experimentally, several 
groups have found dose effects in acute pain, as well as effects of exercise dose in non-pain health-
related contexts. Three notable studies have discovered a dose response of isometric contraction 
on acute pain perception in healthy human participants (Hoeger Bement et al., 2008; Ring et al., 
2008; Misra et al., 2014). Hoffman et al. has shown dose effects for intensity and length of exercise 
session for aerobic exercise-induced analgesia (Hoffman et al., 2004). However, unlike other 
studies evaluated in the present review that evaluate exercise training, these studies assessed single 
bouts of physical activity or acute exercise effects on pain. In chronic pain populations, some 
recommendations have been provided in regards to exercise dose. In patients with knee OA, 
aerobic exercise programs were found to have analgesic effects dependent on frequency of 
sessions, with more sessions having a positive impact on pain reductions (Juhl et al., 2014). 
Macfarlane et al. describes typical protocols used in fibromyalgia research as interventions 
performed for 20 minutes or greater once a day or 10 minutes or more twice a day, 2 -3 days per 
week (Macfarlane et al., 2017). Others have also shown exercise dose-like effects on pain tolerance 
and pain threshold when comparing triathletes to amateur exercisers (Geva and Defrin, 2013), and 
regular runners to normally active controls, respectively (Janal et al., 1994). Other groups have 
found exercise to have positive dose-related effects on cardiovascular health (Machado et al., 
2017), metabolism (Machado et al., 2017), maximum strength (Borde et al., 2015; Turpela et al., 




mental health (Chekroud et al., 2018), depression (Helgadottir et al., 2017) and estrogen levels 
(Schmitz et al., 2015). Similar to the present analysis, these studies evaluated exercise dose in the 
context of frequency of exercise bouts per week and time (minutes) per week. Likewise, these 
studies assessed treadmill exercise, cycling, aerobic exercise and strength training, which were 
comparable to the modalities utilized in the studies that we investigated. Overall, the evidence of 
dose effects in multiple contexts of exercise suggests that other explanations may be responsible 
for the lack of large effects in our analyses. In a general context, there is a growing body of 
literature to support positive effects of exercise on numerous physiological and psychological 
outcomes (1996).  
Several animal studies have suggested dose effects of exercise in the context of metabolism 
and cardiovascular health (Machado et al., 2017) as mentioned above, as well as in the context of 
pain (Shyu et al., 1982; Stagg et al., 2011; Sluka et al., 2013; Grace et al., 2016). In a model of 
neuropathic pain, forced treadmill running was found to reverse tactile hypersensitivity in an 
intensity-dependent manner, where low intensity speed (10 m/min) corresponded to walking and 
high intensity speed (16 m/min) corresponded with running (Stagg et al., 2011). Rats with free 
access to running wheels were found to have increased pain thresholds that were positively 
correlated to the amount of running activity that was performed (Shyu et al., 1982). In a model of 
non-inflammatory muscle pain, five days of physical activity had no effect on pain, while eight 
weeks of the intervention prevented primary and secondary hyperalgesia, indicating that chronic 
exercise had positive effects on pain (Sluka et al., 2013). Comparing across studies, while two 
weeks of voluntary wheel running failed to reverse hyperalgesia in models of acute inflammatory 
pain and neuropathic pain (Sheahan et al., 2015), six weeks of voluntary wheel running prevented 




animal exercise literature is crucial, since it allows direct comparison of the effects of exercise 
dosing within and across studies in a similarly controlled environment.  
If dose effects of exercise do exist, the question remains why we were unable to see 
substantive evidence of these effects in our linear regression analysis. One potential explanation 
for the lack of effect could be due to similarity in the doses across studies. However, ranges were 
quite variable for each aspect of exercise dose; FREQUENCY: 1-7 bouts per week; TIME: 45-540 
minutes per week; DURATION: 4-104 weeks of intervention. This would suggest that dose 
similarity is not a reason for null effects. For the first univariate analysis, studies were grouped by 
exercise therapy across pain states and for the second analysis, studies were classified by pain state 
across exercise therapy types. This can greatly contribute to the variability amongst studies in their 
respective data sets. One way to account for this is to perform a sub-analysis by exercise type and 
pain state (i.e. Pilates exercise for low back pain patients). However, in doing so, the number of 
studies in each analysis greatly decreases, which reduces confidence in any significant changes 
observed. In addition, the studies included in this analysis were carried out at different institutions 
using multiple enrollment and monitoring methods which also contributes to the variability 
between studies. Other potential explanations for paucity of positive linear regression effects could 
be that, 1) these studies are incorporating a dose of exercise above or at a low threshold for exercise 
benefit (Arem et al., 2015; Kyu et al., 2016), 2) the specific mode of therapy may be an ineffective 
treatment method respective to patient pain condition, 3) exercise of any type may be generally 
beneficial and dose may have minimal effects in pain patients, and/or 4) the effects are patient 
specific.  
 The final explanation of why so few linear regression effects were found here is that it is 




there is a threshold effect of exercise on pain relief, meaning that there is a limit to which increased 
dose is able to cause a detectable difference in pain outcome. In comparing high intensity versus 
low intensity exercise in OA patients, one group’s analysis found a lack of short-term 
improvements in pain and physical function with higher intensity exercise (Regnaux et al., 2015). 
However, the authors acknowledge this as low quality evidence due to risk of bias and small 
number of studies and recommend additional studies investigating the dose-response relationship 
(Regnaux et al., 2015).  
 Most of the studies included in this review demonstrated positive benefits of exercise on 
pain outcomes (69 of 75 studies). In this analysis, there were only six studies that reported worse 
pain with exercise (Minor et al., 1989; Hansen et al., 1993; Talbot et al., 2003; Helewa et al., 2007; 
Beer et al., 2012; Bruce-Brand et al., 2012). There are likely two reasons for this. First, it is possible 
that null or harmful results for exercise-based therapy are not published with the same frequency 
as positive outcomes (Fanelli, 2011). Second, these studies may be incorporating a dose of exercise 
that is too high and may be causing exercise-induced pain. 
Although the multivariate modeling suggests dose effects, some animal dosing studies 
suggest a null effect of exercise dose in pain. In the context of neuropathic pain, Stagg et al. 
reported significant dose effects in respect to treadmill exercise intensity (low vs high), but not in 
frequency (3 vs. 5 days/week) (Stagg et al., 2011). While eight weeks of voluntary wheel running 
showed analgesic effects in models of chronic muscle pain and exercise-induced pain, these effects 
were absent in the context of acute inflammatory muscle pain (Sluka et al., 2013). Six weeks of 
voluntary wheel running was found to prevent allodynia in a model of neuropathic pain; the 
distance traveled by the animal running on the wheel did not correlate with allodynia reduction 




not alter acute nociceptive thresholds as measured by thermal and mechanical sensitivity assays 
(Sheahan et al., 2015). In addition, free-access to a running wheel for 2 hours/night for either one, 
two, or four weeks or 12 hours/night for two weeks did not prevent nocifensive responses to acute 
formalin-induced inflammatory pain-like behavior and failed to improve mechanical 
hypersensitivity in a model of neuropathic pain (Sheahan et al., 2015).  Although some studies 
show null or absent effects of exercise dose on pain, these data may be affected by the nature of 
the pain injury, the intensity or duration of the exercise, or the timing of the intervention in respect 
to injury.  
Strengths and limitations 
All studies included in this analysis were derived from reviews published in The Cochrane 
Database of Systematic Reviews of the Cochrane Library. Because of this, all reviews have been 
prepared in accordance with the strict guidelines detailed in the Cochrane Handbook for 
Systematic Reviews of Interventions (Higgins, 2011). In addition, the methodological quality of 
each review was evaluated by criteria specified in the assessment of multiple systematic reviews 
(AMSTAR) measurement tool (Shea et al., 2007). All 21 reviews included in Geneen et al. scored 
well with the AMSTAR assessment (Geneen et al., 2017). All exercise interventions considered 
in this meta-analysis are defined forms of physical activity by the WHO (WHO, 2017), many of 
which are highly accessible to the general public and do not require extensive equipment or 
training.  
While this analysis provides valuable data for exercise dosing in chronic pain, the review 
has drawbacks. As previously mentioned, studies included in this analysis were performed in 
different settings using various enrollment and examination techniques. Sample sizes for some 




they were receiving the treatment) was also present in the majority of these studies, which may 
have an impact on the lack of significant findings. Additionally, dosing for resistance exercise did 
not include all necessary variables, as previously mentioned in the introduction. This is a major 
caveat to the results of the dosing data respective to strength training programs. 
Our analyses combined data either across exercise intervention types or across pain 
conditions likely contributing to variability in the data. It is possible that additional papers not 
included in Geneen et al. could impact the results of this study. Studies implementing large samples 
of specific pain populations testing a specific exercise intervention will need to be performed in 
order to accurately address the issue of dose in exercise therapy for chronic pain.  
An additional limitation to our analysis was the potential for multi-collinearity. While the 
pain effect produced by the multi-collinear interaction terms may complicate the clinical 
application of prescribing exercise, the necessity to include these terms brings home the 
importance of considering all three dose measurements when prescribing an exercise regime. The 
initial multiple linear regression model which attempted to fit only the three main dose 
measurements resulted in a multiple linear regression equation in which only the DURATION 
coefficient was significant with R2=0.471. Removing the non-significant coefficients of 
FREQUENCY and TIME caused the R2 value to decrease substantially (R2=0.293), suggesting 
that TIME and FREQUENCY were somehow important when combined with DURATION. The 
resulting model brought their importance in focus by producing significant main effects and 
interaction effects, as well as strengthening the R2 value to 0.552.  
Clinical implications 
Even in the context where exercise is generally beneficial, the lack of any explicit dosing 




levels of exercise or missing the opportunity for additional therapeutic benefits.  The lack of dosing 
data may also lead to reduced patient compliance if patients are prescribed a less-than-efficacious 
exercise therapy (Jack et al., 2010). We hypothesize that, with special consideration for those 
persons with musculoskeletal pain, beginning exercise therapy at a lower dose and subsequently 
increasing physical activity as tolerated may be the most beneficial . Many chronic pain patients 
are not accustomed to exercising at a high level (Joelsson et al., 2017; Santos et al., 2017) and may 
experience significant fear-avoidance behavior and kinesiophobia (Antunes et al., 2013; Ulug et 
al., 2016; Malfliet et al., 2017). Others have recommended beginning exercise at a low intensity 
or dose and gradually progressing to a moderate intensity (Jones and Liptan, 2009). This “low and 
slow” approach to therapy may make patients more liable to adhere to exercise protocols.  
Overall, multivariate linear regression modeling allowed us to evaluate the interaction of 
different aspects of exercise dose, as well as the impact of the significance of the original study on 
pain effect. Increasing exercise dose as defined as FREQUENCY per week, is predicted to be the 
most likely to cause significant pain relief for patients (Table 4). It is important to note that the 
predicted decrease in effect size due to increased frequency is countered by the positive interaction 
effect of the exercise duration by frequency. Because of this, the overall net effect is an increased 
analgesic effect. Some caution needs to be used in carrying this result to the clinic as it is based on 
modeling of existing data. Nonetheless, the model makes valuable and, more importantly, testable 
predictions that can be addressed in future randomized controlled trials. While the present study 
cannot identify optimal values for dosing an exercise program or for detecting a  significant pain 
effect between treatment and control groups for chronic pain, these results do suggest that varying 
exercise dose as measured by TIME, FREQUENCY and DURATION significantly influences a 




influential analgesic effect, this dose measurement is largely limited to multiples of 7 days per 
week, although it is possible to exercise multiple times per day. Table 4 suggests that one might 
receive an analgesic effect by exercising a shorter amount of time daily; an exercise regimen that 
might be more acceptable to one experiencing chronic levels of pain and one that might be more 
amenable to sustained compliance. Furthermore, quality of life is an important outcome for pain 
patients. Even if exercise therapy is unable to effectively manage pain, it is essential to increasing 
health related quality of life in these patients by improving other aspects of their well-being 
including their physical fitness. Future studies should be mindful of incorporating these outcome 
measures when working to manage all aspects of the patient’s pain.  
Overall, this analysis of the existing literature demonstrated insufficient evidence for the 
presence of dose effects of exercise in relation to analgesia. Ultimately, the major problem in this 
area is that no studies identified in this analysis individually account for the dose of exercise in the 
trial. Specific randomized controlled studies with larger n’s, done in specific patient populations, 
and multiple doses are necessary to determine the effects of exercise dose on the efficacy of 
exercise for chronic pain conditions. Future studies should provide a high level of specificity in 
the prescribed dose of exercise by reporting the frequency of exercise, timespan of the session, 
intensity of the exercise and duration of the intervention. As a field, it is necessary to start 
incorporating multiple doses in exercise studies in order to obtain the best possible outcome for 
our patients. Based on our multi-variate analysis, idealized future studies should be performed 
testing varying frequencies (exercise bouts per week) of explicit aerobic exercise interventions that 
are performed less than 120 minutes per week for no more than 15 weeks to achieve optimal pain 




of specific exercise regimens due to the nature of the pathology of each chronic pain condition and 






MATERIALS AND METHODS 
A recently published comprehensive review of exercise and physical activity for chronic 
pain in adults written by Geneen et al. (Geneen et al., 2017) was identified in the Cochrane Library 
in May 2017. This paper reviewed 21 other Cochrane Library Meta-Analyses covering a total of 
381 individual studies (of 6495 studies screened) that assessed different physical activity and 
exercise interventions and their effectiveness in reducing pain severity across eight pain conditions 
(Han et al., 2004; Hayden et al., 2005; Bartels et al., 2007; Busch et al., 2007; Fransen and 
McConnell, 2008; Hurkmans et al., 2009; Brown and Brown, 2010; Silva et al., 2010; Busch et 
al., 2013; Cramp et al., 2013; Bidonde et al., 2014; Boldt et al., 2014; Fransen et al., 2014; Lane 
et al., 2014; Lauret et al., 2014; Fransen et al., 2015; Gross et al., 2015; Koopman et al., 2015; 
Regnaux et al., 2015; van der Heijden et al., 2015; Yamato et al., 2015; Saragiotto et al., 2016). 
All exercise interventions included in this meta-analysis are classified as discrete forms of physical 
activity by the WHO (WHO, 2017). The primary literature cited in these Cochrane Meta-Analyses 







Studies that were selected for our analysis from Geneen et al. (Geneen et al., 2017), met 
the following inclusion criteria: 1) Randomized control trial (RCT) assessing physical activity or 
exercise as the intervention, 2) chronic non-cancer pain lasting 3 months or longer (Merskey and 
Bogduk, 1994), 3) patients 18 years or older, 4) meta-analysis must report effect sizes for pain 
outcome that reflect post-intervention measure for that respective study, and 5) studies were 
published in peer-reviewed journals. Studies were excluded from analysis if: 1) not published in 
the English-language, 2) intervention featured multimodal treatments (e.g. walking and weight 
lifting), 3) study prescribed individualized exercise training plan (e.g. each patient in study 
received a different plan or dose), or 4) intervention not deemed exercise by WHO definition (i.e. 
manipulation, mobilization, or passive movement) (WHO, 2017).  
Data extraction  
Following selection of studies analyzed in Geneen et al. (Geneen et al., 2017), articles were 
systematically organized based on exercise modality and pain states. Exercise modalities consisted 
of broader non-mutually exclusive categories such as, strength/resistance training, aerobic exercise 
(land or water), aquatic exercise, and meditative movement therapy. More specific classification 
and analysis of exercise programs included walking, jogging, Pilates, tai chi, qigong, motor control 
exercises, range of motion (ROM) and flexibility exercises, aquatic aerobics, aquatic resistance 
training, and land aerobic exercise. These exercise interventions are defined as exercise training 
and not acute physical activity or singular bouts of exercise. Disease states included rheumatoid 
arthritis (RA), osteoarthritis (OA), fibromyalgia (FMS), low back pain (LBP), intermittent 




For each included study, effect sizes, means, standard deviation and 95% confidence 
interval (C.I.) were extracted from each pain-related outcome measure reported in Geneen et al. 
(Geneen et al., 2017). To avoid running multiple analyses on the same data sets, we extracted effect 
sizes that reflected the immediate post-intervention time point; this effect size reflected changes 
of the exercise group compared to the control. Geneen et al. effect sizes were presented as mean 
differences (e.g. effect size for each group) or standardized mean differences (experimental group 
versus control group) (Cohen, 1988). In the present analysis, all mean differences were converted 
to standardized mean differences. Standardized mean differences (Cohen’s d effect sizes) were 
calculated using the control and experimental group means, standard deviations, and sample sizes 
reported by referring back to the original primary source (Cohen, 1988). In addition, all 
standardized effect sizes were converted such that a reduction in pain is presented as a positive 
effect value.  
Pain-related outcome measures included: Visual Analog Scales (VAS) (Price et al., 1983), 
a numerical ratings scale (NRS) (McCaffery, 1994), McGill Pain Questionnaire (MPQ) (Melzack, 
1975), Arthritis Impact Measurement Scale 2 (AIMS2) (Guillemin et al., 1997), Western Ontario 
McMaster Osteoarthritis index (WOMAC) (Bellamy et al., 1988), the Short Form-36 Health 
Survey (SF-36) for bodily pain (Ware and Sherbourne, 1992), the Health Assessment 
Questionnaire (HAQ) (Fries et al., 1982), and the West-Haven Yale Multidimensional Pain 
Inventory (WHYMPI) (Kerns et al., 1985). For the surveys, pain effect sizes were calculated from 
the pain specific section or pain subscale of that survey. 
The dosage of the exercise intervention was extracted from each study. The dose of 
exercise was analyzed in three distinct methods. First, dose was defined as being the frequency or 




defined as the cumulative amount of time (minutes) that the exercise was being completed per 
week (TIME). Finally, dose was defined as the duration (weeks) that the exercise treatment was 
implemented in the study (DURATION). For example, if a protocol prescribed an exercise 
intervention for 3x/week, 30 minutes a session for 4 weeks, the (FREQUENCY) would be 3, 
(TIME) would be 90 minutes, and (DURATION) would be 4 weeks.  
Intensity of exercise was also evaluated in a separate analysis. Intensity was defined as 
absolute intensity (MET equivalent of the activity) multiplied by the number of minutes performed 
in one week. MET levels for each activity were derived from The 2011 Compendium of Physical 
Activities: Tracking Guide (Ainsworth et al., 2011). Although a more accurate method for 
measuring intensity for resistance exercise would incorporate the load, volume, rest periods and 
order of the exercises, this was not possible due to limited or absent information on these variables 
in the primary studies. 
Data analysis and statistics 
Statistical analyses included a set of univariate analyses followed by multivariate modeling 
informed by trends observed in the univariate analyses.  Univariate correlation analyses were 
performed to ascertain if there were any significant trends of standardized effect size. This was 
done by disease states or by exercise modality that might form interactions or dependencies in the 
independent variables used in the multivariate linear regression modeling to predict significant 
pain effect. Independent variables in the multivariate modeling included whether the study showed 
significant results or not, dose measured as TIME, FREQUENCY, and DURATION. 
Univariate Analysis 
Previously, linear dose-response relationships have been observed with physical activity 




relationships (Pandey et al., 2015). Here, we evaluate data by looking at the correlations between 
the dosage of exercise and the overall analgesic effect (e.g. standardized mean effect size). A 
Shapiro-Wilk Goodness of Fit for Normality was performed on each of the four pain groups 
analyzed by the three dose measurements to determine the appropriate statistical test. Linear 
regressions with Pearson’s Correlation Coefficients were performed using standardized pain effect 
size and exercise dose for all disease states. p<0.05 was considered statistically significant. Two 
primary analyses were completed. 
Analysis 1 – Pain State - Correlations were compared between studies within the same cohort of 
pain state classification (e.g. fibromyalgia, low back pain). Here, data were combined across 
exercise intervention type. Studies with unspecified or insufficient dosage information were not 
analyzed in regards to that classification of exercise dose. A distinct analysis of exercise dose 
within some disease states was not completed due to the low number of available studies for certain 
patient populations.  
Analysis 2 – Exercise Type - Correlations were compared between studies within the same cohort 
of exercise modality (e.g. Pilates, aquatic exercise). Data were combined across pain conditions to 
determine whether dosing effects of specific exercise types are generalizable across pain 
conditions.  
 After evaluating dose by univariate measurements, we also sought to account for effects of 
exercise intensity. This was done through a “Dose Intensity x Time” analysis. We assessed the 
relationship between exercise intensity and standardized pain effect size. This was done in a similar 
fashion to the other univariate analyses above where analyses were performed in respect to pain 
state and exercise type. Data were evaluated by looking at the correlations between the intensity 




with Pearson’s Correlation Coefficients were performed using standardized pain effect size and 
exercise dose for all disease states. p<0.05 was considered statistically significant. 
Multivariate Analysis 
 In order to control for studies that produced significant effect sizes and to model the effects 
of the three time-related dose measurements simultaneously, multivariate linear regression 
modeling was fit using a dummy variable for whether the study showed a significant (p<0.05) pain 
effect or not plus adding the three main effects of measured dose as TIME, FREQUENCY, and 
DURATION.   Two-way interactions between the three measured dose effects were also added to 
the model.  Selection of the best model fit was determined by significant main effects and 






















Determining the effects of exercise dose on experimental pain in 




















The majority of the text contained within this chapter is adapted from the following publication: 
Polaski AM, Phelps AL, Szucs KA, Ramsey AM, Kostek MC, Kolber BJ. 2019. The dosing of 
aerobic exercise therapy on experimentally-induced pain in healthy female participants. 
Scientific Reports. DOI:10.1038/s41598-019-51247-0. 
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Knowledge of efficacious dosing respective to exercise type and pain condition is 
extremely limited in the literature. This study aimed to determine the impact of dose of moderate 
intensity treadmill walking on experimentally-induced pain in healthy human participants. Forty 
females were divided into 4 groups: control (no exercise), low dose exercise (3x/wk), moderate 
dose exercise (5x/wk) or high dose exercise (10x/wk). Over a 7-day period, subjects performed 
treadmill walking during assigned exercise days. Both qualitative and quantitative measures of 
pain were measured at baseline, during the trial, and 24 hrs post-final intervention session via 
sensitivity thresholds to painful thermal and painful pressure stimulation. Significant effects of 
treatment were found post-intervention for constant pressure pain intensity and pain 
unpleasantness ratings. Post-hoc tests revealed significant differences between control and 5x/wk 
and control and 10x/wk dose groups for constant pressure pain intensity and constant pressure pain 
unpleasantness. 5x/wk and 10x/wk dose groups had the greatest reductions in ratings of pain, 
suggesting that our lowest dose of exercise was not sufficient to reduce pain and that the 5x/wk 












Exercise, or planned physical activity, has effects on nociception and pain in humans 
(Naugle et al., 2012; Geneen et al., 2017). Exercise has been increasingly reported as a first-line 
therapeutic intervention for the treatment of nearly all types of chronic pain (Geneen et al., 2017), 
which has been estimated to affect 116 million American adults (Steglitz et al., 2012).  Exercise 
as a viable therapy is particularly valuable given that the numerous pharmacological interventions 
that exist to treat chronic pain include severe limitations due to side-effects, abuse potential, and 
overall efficacy (Serpell, 2005; Sullivan and Howe, 2013). Physical activity has also been linked 
with decreased symptoms of depression and anxiety, suggesting that exercise could be especially 
beneficial in the context of chronic pain comorbid with psychiatric illness (Bhui and Fletcher, 
2000; Dunn et al., 2005). Overall, while evidence purports exercise to be at least moderately 
therapeutic in chronic pain (Ambrose and Golightly, 2015), adherence to exercise programs 
reveals a number of issues. These include limited access to equipment and training for safe exercise 
and the lack of dosing information specific to exercise type and chronic pain population. The issue 
of dose is particularly noteworthy due to the clear emphasis and importance of dosing for 
pharmacological development.  
Surprisingly, there is almost a complete lack of studies in the exercise and pain literature 
testing multiple doses of exercise training in a single patient group or in healthy control 
participants. In fact, the American College of Sports Medicine (ACSM) does not have a specific 
exercise recommendation for pain. The ACSM’s Position Stand (2011) recommends 30 minutes 
of moderate-intensity walking exercise five days per week (or 150 MET minutes) in order to 
maintain cardiorespiratory, musculoskeletal, and neuromotor fitness for healthy adults (Garber et 




recommendation may be too high of a starting dose for persons experiencing chronic pain, 
especially in specific conditions associated with movement-induced pain and movement-
associated fear avoidance behavior (Umeda et al., 2015; Larsson et al., 2016). Therefore, it is 
crucial that the field critically evaluate the most appropriate dose of exercise to reduce pain. 
Furthermore, there is a notable lack of pain studies performed in females, which makes this 
investigation especially relevant. 
A limited number of studies have tested the effect of different doses of acute or single bouts 
of exercise on pain perception in healthy participants (Koltyn et al., 1996; Koltyn and Arbogast, 
1998; Hoffman et al., 2004; Hoeger Bement et al., 2008; Ring et al., 2008; Misra et al., 2014), and 
only our recent meta-analysis has evaluated dose in the context of repeat exercise training on 
chronic pain (Polaski et al., 2019a). As a starting point for evaluating this gap in knowledge, this 
study investigated the effect of three different doses of repeated moderate intensity walking 
exercise: low (3x/week), moderate (5x/week) and high (10x/week) compared to a sedentary control 
on sensitivity to acute noxious stimuli in healthy female participants. We hypothesized that 
moderate intensity exercise would reveal dose-related effects in subjects’ sensitivity to acutely 













   Forty-one healthy female volunteers participated in this study. Recruitment began February 
2015 and ended June 2017. Subject characteristics are presented in Table 1. 1 subject dropped out 
of the study after 3 days (data not included). One-way ANOVA revealed no significant group 
differences for any of the demographic variables. A chi-square test of independence was calculated 
comparing handedness of subjects with treatment group. A significant interaction between 
treatment and handedness was found (2(6)=16.229, p=0.013). 
 
Table 1. Participant characteristics. Data are mean (SD). Abbreviations: BMI, body mass index; 
BPs, systolic blood pressure; BPd, diastolic blood pressure; IPAQ, International Physical Activity 
Questionnaire; SIAS, Social Interaction Anxiety Scale. Data acquisition and analysis – AMP. 






























































































Effect of exercise dose on quantitative sensory testing 
Primary outcome: Intervention effects on QST perceived pain 
We first analyzed the impact of exercise dosing on baseline versus post-intervention QST 
on each subject’s calf and forearm. Body site specific data for the primary outcome variables are 
shown in Table 2. Interestingly, the most robust dose effect of exercise was found for pressure 
pain on the forearm. Although there was no significant effect of treatment for pressure pain 
threshold for the forearm (Figure 1C, two-way ANOVA, p=0.262), a significant effect of 
treatment was found for constant pressure VAS pain intensity (Figure 1A, two-way ANOVA, 
**p=0.0016) and constant pressure pain VAS unpleasantness (Figure 1B, two-way ANOVA, 












Table 2. Intervention effects on QST. Data represent p-values from ANOVA. P-value correction, 
**p<0.01. Data acquisition and analysis – AMP. Experimental design – AMP, BJK, MK, KS. 
 
Tukey post-hoc tests revealed significant differences between the control and 5x/wk dose 
groups (Figure 1A, **p=0.0015) and control and 10x/wk dose groups (Figure 1A, **p=0.0094) 
for constant pressure pain intensity and significant differences between control and 5x/wk dose 
groups (Figure 1B, p=0.0040) and control and 10x/wk dose groups (Figure 1B, p=0.0040) for 
 ANOVA/Rank Sum, P 
QST Forearm Calf 
Mechanical Sensitivity 0.713 0.673 
Constant Heat Pain VAS Intensity 0.882 0.183 
Constant Heat Pain VAS Unpleasantness 0.813 0.304 
Radiant Heat Sensitivity 0.890 0.445 
Radiant Heat Pain 0.803 0.867 
Pressure Pain Threshold 0.262 0.883 
Constant Pressure VAS Intensity       **0.002 0.958 




constant pressure pain unpleasantness. Figure 1D shows a visual comparison of the apparent 
paradoxical impact of exercise on VAS measurements (i.e. perception) but not on pain threshold 




Figure 1. The effects of exercise intervention on qualitative and quantitative measures of 
pressure pain. (A) Percent baseline pressure pain intesnity (VAS) in the forearm was significantly 
different from the control group for 5x/wk and 10x/wk dose groups. (B) Percent baseline pressure 
pain unpleasantness (VAS) in the forearm was significantly different from the control group for 
the 5x/wk and 10x/wk dose groups. (C) There were no significant different between groups for 
percent baseline pressure pain threshold as measured in the forearm. Tukey post-hoc significant 
differences between groups at **p<0.01. Data shown as mean +/- SEM. (D) Model representation 
of average pressure pain thresholds (PPT) compared to their subsequent pain intensity rating 
(VAS) at baseline (Base) and post-intervention (Post) for the 5x/wk and 10x/wk groups.  Data 
acquisition and analysis – AMP. Experimental design – AMP, BJK, MK, KS. 





















A. Pressure Pain Intensity






















B. Pressure Pain Unpleasantness
































Secondary outcomes: Acute effects of intervention 
 In addition to the primary outcomes of this trial, we also evaluated a number of secondary 
outcomes related to physiology, fitness, and pain-effect. First, there was no significant effect of 
treatment for the exercise groups on percent change in HR (two-way ANOVA, p=0.295; 3 subjects 
data unavailable due to equipment failure) (Figure 2) or for percent change in Borg RPE (two-
way ANOVA, p=0.615; 1 subject data unavailable) over days 1, 3 and 5. Next, we evaluated the 
impact of the exercise dosing intervention on acute pain testing. This was done 5 min and 30 min 
immediately following exercise sessions on days 1, 3, and 5. For the 10x/wk dose group, these 










Figure 2. Acute effects of exercise on HR. No significant effect of treatment was found for 
exercise groups on percent change in HR. Data shown as mean +/- SEM. Data acquisition and 
analysis – AMP. Experimental design – AMP, BJK, MK, KS. 
 






























Since pain measurements at 5 min and 30 min represent two distinct dependent measures, 
we first analyzed these data using a MANOVA. A two-way MANOVA was calculated examining 
the effect of treatment (control, 3x/wk, 5x/wk, and 10x/wk) and time (day 1, 3 and 5) on 5 min 
(dependent measure 1) or 30 min (dependent measure 2) QST outcome per body site. No 
significant effects were found for constant heat intensity for the forearm (p=0.500; Wilk’s 
=0.901) or calf (p=0.970; Wilk’s =0.958), constant heat unpleasantness for the forearm 
(p=0.862; Wilk’s =0.938) or calf (p=0.849; Wilk’s =0.936), radiant heat sensitivity for the 
forearm (p=0.578; Wilk’s =0.908) or calf (p=0.180; Wilk’s =0.858), radiant heat pain for the 
forearm (p=0.981; Wilk’s =0.962) or calf (p=0.989; Wilk’s =0.966), pressure pain threshold 
for the forearm (p=0.946; Wilk’s =0.952) or calf (p=0.680; Wilk’s =0.917), constant pressure 
pain intensity for the forearm (p=0.979; Wilk’s =0.962) or calf (p=0.961; Wilk’s =0.955), or 
constant pressure pain unpleasantness for the forearm (p=0.959; Wilk’s =0.955) or calf (p=0.984; 
Wilk’s =0.964). Overall, these data indicate that there is minimal association between the 
treatment or time and the relationship between the dependent variables (5 min versus 30 min post-
exercise testing). 
Next, we evaluated the impact of exercise dose separately on the 5 min and 30 min 
dependent measures.  For the forearm, results of univariate ANOVAs on secondary outcome QST 
are shown in Table 3. We found statistically significant analgesic-like effects for pressure pain 
threshold, intensity, and unpleasantness. Five min pressure pain thresholds were significantly 
increased by day (Figure 3A, two-way ANOVA, **p=0.006). Thirty min constant pressure pain 
intensity was significantly improved by treatment (Figure 3B, two-way ANOVA, **p=0.007). 




improved by treatment respectively (Figure 3C: two-way ANOVA, 5min; **p=0.005, 30 min; 


















Table 3. Acute effects of intervention on forearm QST. **p<0.01. ***p<0.001. Abbreviations: 
PPT, pressure pain threshold; PPi, pressure pain intensity; PPu, pressure pain unpleasantness; 
%BL, percent baseline. Data acquisition – AMP. Data analysis – ALP. Experimental design – 









PPT %BL (5 min) 0.047 
PPT %BL (30 min) 0.356 
Intercept PPT %BL (5 min)       <0.001 
PPT %BL (30 min)       <0.001 
Treatment PPT %BL (5 min)         0.054 
PPT %BL (30 min)         0.214 
Day PPT %BL (5 min)      **0.006 
PPT %BL (30 min)         0.058 
Treat*Day PPT %BL (5 min)         0.902 
PPT %BL (30 min)         0.934 
Corrected 
Model 
PPi %BL (5 min)         0.775 
PPi %BL (30 min)         0.208 
Intercept PPi %BL (5 min)       <0.001 
 PPi %BL (30 min)       <0.001 
Treatment PPi %BL (5 min)         0.207 
 PPi %BL (30 min)      **0.007 
Day PPi %BL (5 min)         0.538 
 PPi %BL (30 min)         0.627 
Treat*Day PPi %BL (5 min)         0.968 
Corrected 
Model 
PPu %BL (5 min)         0.089 
PPu %BL (30 min)         0.010 
Intercept PPu %BL (5 min)       <0.001 
 PPu %BL (30 min)       <0.001 
Treatment PPu %BL (5 min)      **0.005 
 PPu %BL (30 min)   ***<0.001 
Day PPu %BL (5 min) 0.422 
 PPu %BL (30 min) 0.566 
Treat*Day PPu %BL (5 min) 0.778 
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Figure 3. Acute effects of exercise on QST for the forearm and calf. Results of univariate tests 
of between-subjects effects. (A) Acute effect of intervention on pressure pain threshold for the 
forearm, (p=0.006) for DAY at 5 min time point. (B) Pressure pain intensity for the forearm, 
(p=0.007) for Treat at 30 min time point. (C) Pressure pain unpleasantness for the forearm, 
(p=0.005) for Treat at 5 min time point and (p<0.001) for Treat at 30 min time point. (D) Constant 
heat intensity for the calf, (p=0.004) for Treat at 30 min time point. (E) Pressure pain threshold for 
the calf, (p=0.006) for Treat at 5 min time point and (p=0.007) for DAY at 30 min time point. Data 
shown as mean +/- SEM. Data acquisition – AMP. Data analysis – AMP, ALP. Experimental 
design – AMP, ALP, BJK. 
 
For the calf, results of follow-up univariate ANOVAs on QST are shown in Table 4. In 
contrast to our analysis of overall QST effects where we failed to find significant changes in pain 
measures for the calf baseline versus post-intervention, here we found a number of statistically 
significant effects of exercise on acute pain testing. We found that 30 min post-exercise constant 
heat intensity was significantly reduced by treatment (Figure 2D, two-way ANOVA, **p=0.004). 
We also found that 5 min post-exercise pressure pain threshold was significantly increased by 
treatment (Figure 2E, two-way ANOVA, **p=0.006) and 30 min post-exercise pressure pain 





























Table 4. Acute effects of intervention on calf QST. **p<0.01. Abbreviations: CHi, constant 
heat intensity; PPT, pressure pain threshold; %BL, percent baseline. Data acquisition – AMP. 
Data analysis – ALP, AMP. Experimental design – AMP, ALP, BJK. 
 
Cortisol measures 
Raw unnormalized data of participant cortisol samples can be seen in Figure 4A. Due to 
participant scheduling conflicts and study logistics, sample collection was not always consistent 
(i.e. at the same time of day) within subjects. It is also known that, cortisol has a natural circadian 
fluctuation throughout the day (Aardal and Holm, 1995). As a result, Figure 4B represents data 
from subjects in which samples were taken in the same time period as the baseline sample (e.g. 
morning, afternoon, or evening) normalized to baseline. Cortisol samples for days 2 and 4 of the 







CHi %BL (5 min) 0.214 
CHi %BL (30 min) 0.137 
Intercept CHi %BL (5 min)    <0.001 
CHi %BL (30 min)    <0.001 
Treatment CHi %BL (5 min) 0.013 
CHi %BL (30 min)   **0.004 
Day CHi %BL (5 min) 0.443 
CHi %BL (30 min) 0.477 
Treat*Day CHi %BL (5 min) 0.941 
CHi %BL (30 min) 0.978 
Corrected 
Model 
PPT %BL (5 min) 0.034 
PPT %BL (30 min) 0.037 
Intercept PPT %BL (5 min)    <0.001 
 PPT %BL (30 min)    <0.001 
Treatment PPT %BL (5 min)   **0.006 
 PPT %BL (30 min) 0.192 
Day PPT %BL (5 min) 0.030 
 PPT %BL (30 min)   **0.007 
Treat*Day PPT %BL (5 min) 0.966 




come to clinic on those days to complete exercise or rest periods. Because of the statistical criteria 
requiring data for each time point for running a mixed model analysis, these data were excluded 
in Figure 4B. Likewise, data for the singular subject in the 3x/wk dose group was excluded. This 
analysis found no significant effects of treatment (Figure 4B, mixed effect model, p=0.5021), time 
(Figure 4B, mixed effect model, p=0.6905) nor treatment x time (Figure 4B, mixed effect model, 


















































Figure 4. Cortisol levels for study participants at baseline and during intervention. (A) Raw 
data of cortisol samples for each subject before normalization to baseline. (B) No difference in 
cortisol levels between groups. Data shown as mean +/- SEM. Data acquisition and analysis – 
AMP. Preparation and performance of assay – AMP, Megan Atherton, Marisa Johnson. 
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DISCUSSION   
This is the first study to (1) assess the dosing of a specific exercise training regimen on 
sensitivity to experimentally-induced pain and (2) to find evidence that repeated exercise can dose-
dependently change perceived pain. Here, we also demonstrate the applicability of our established 
protocol of reliable QST tests shown in Chapter 1, Section 1. The main findings of this study 
indicate that a moderate dose (5x/wk of 30 minutes/day) of moderate intensity walking (3.6 METs) 
is sufficient to reduce ratings of pressure pain in healthy subjects over a one-week period. Notably, 
although ratings of pressure pain decreased over 7 days, pressure threshold remained the same for 
all groups, and these effects were primarily seen in the forearm. To our knowledge, there are only 
six other primary studies that have specifically evaluated physical activity or exercise dose on pain 
in humans (Koltyn et al., 1996; Koltyn and Arbogast, 1998; Hoffman et al., 2004; Hoeger Bement 
et al., 2008; Ring et al., 2008; Misra et al., 2014). All of these other studies were limited to testing 
the effects of single acute bouts of exercise on acute pain perception or sensation. Therefore, the 
critical question of exercise training dose in pain has been largely unanswered until now.  
Pressure pain intensity and unpleasantness ratings for the forearm were significantly 
improved from the control group for the both the 5x/wk (p<0.01) and the 10x/wk dose (p<0.01) of 
the exercise intervention. It is worth noting that pressure pain tests were among the most reliable 
of our established protocol for sensory testing (Kostek et al., 2016). However, no additional benefit 
was achieved from the 10x/wk dose, suggesting a plateau effect. Such a plateau has been described 
for general health benefits beyond 45-60 minutes of daily moderate intensity exercise (Simon, 
2015). This suggests that for this exercise paradigm, the 5x/wk dose is sufficient to achieve 
maximal analgesic effect, which is consistent with our hypothesis and exercise recommendations 




choice of dose in this study was focused on frequency of training bouts per week, but other aspects 
of dose may be important in exercise dosing (Wasfy and Baggish, 2016). A recently published 
meta-analysis of exercise dosing in chronic pain by our group found that changing frequency is 
predicted to lead to the greatest changes in analgesic effect compared to changes in total minutes 
per week or study duration (number of weeks of study) (Polaski et al., 2019a). However, we did 
not observe a similar plateau effect in the current study as we did in manipulating frequency using 
our multivariate model. Nonetheless, the potential variability in dosing of exercise therapy is likely 
to contribute significantly to differences between exercise studies.  
It is important to note that the 10x/wk dose of exercise includes additional dose variables 
that the 3x/wk and 5x/wk do not account for. For example, since this regimen requires 10x of 
exercise on 5 days per week, the sessions are back to back (with a short break in between sessions) 
on assigned exercise days. Because of this, the total time of the individual sessions are doubled 
compared to the other two dose groups. Furthermore, it appeared that the 10x/wk dose was more 
strenuous for participants towards the end of their daily sessions. Although there were no 
significant changes in Borg RPE or HR variability between groups, there were noticeable trends 
in cortisol levels that may support this claim (Figure 4B). 
Statistically significant differences were found for pressure pain VAS ratings of intensity 
and unpleasantness (i.e. pain perception), but not for pressure pain threshold for the forearm after 
one week of exercise training. These data suggest a disconnect between perception and sensation. 
Figure 1D represents a model for average pressure pain thresholds and subsequent average pain 
intensity ratings (VAS) for the respective threshold (connected by a black arrow) for the 5x/wk 
and 10x/wk dose exercise groups. For both groups, pressure pain threshold slightly increases from 




their baseline pressure threshold substantially less painful than their previous rating. These data 
suggest that while this exercise paradigm was unable to significantly alter pain threshold, it 
significantly changed pain perception. Similar paradoxical effects have been shown in sustained 
aerobic exercise, where increases in pain tolerance were found despite no changes in pressure pain 
threshold following training (Jones et al., 2014). In our study, since both pressure threshold and 
constant pressure pain tests involve the same mechanosensitive afferents (Giordano, 2005), it is 
likely that the effect we see here is predominantly due to a central mechanism. Pain threshold is 
believed to primarily reflect muscle nociception (Scholz and Woolf, 2002). Alternatively, pain 
tolerance or pain perception also involve a strong psychological and behavioral element (Baker 
and Kirsch, 1991). This suggests a psychological adaptation to exercise training. 
Interestingly, this difference between threshold and perception is reversed for acute pain 
tests. Acute exercise data largely shows increases in pain threshold following acute bouts of 
exercise (Koltyn, 2002). When we evaluated the acute effects of exercise in our study at the 5 min 
time point (post-exercise), we also found that pressure pain thresholds increased with exercise 
compared to control. Overall these data suggest alternative mechanisms are responsible for acute 
EIH versus sustained exercise training-induced changes in pain.  
Somewhat surprisingly, we found robust analgesic effects shown in pre-post pressure 
ratings for the forearm, but no effect in the calf. One explanation for the null effect in the calf may 
be delayed onset muscle soreness (DOMS) having a masking effect on any analgesic effects of the 
exercise intervention. Irrespective of an individual’s general fitness level, physical activity of even 
a moderate intensity to which an individual is unaccustomed to can result in DOMS, which is 
known to persist for up to 5-7 days post-exercise (Armstrong, 1984). We hypothesize that if this 




revealed. A second explanation for the null effect in the calf pressure data is due to the decreased 
number of sensory nociceptors and innervation density in the calf region as opposed to the forearm. 
Whole-body mapping of spatial acuity for pain has revealed that the volar surface of the forearm 
has dramatically lower two-point discrimination thresholds than the midcalf, indicating that the 
forearm is an area of higher spatial acuity for pain (Mancini et al., 2014). It is possible that the calf 
region was not sensitive enough to detect robust changes in pain perception. Robust effects in the 
forearm provide evidence of systemic hypoalgesia after exercise training, where pain perception 
decreased in the untrained limb. This agrees with previous findings of increases in pain tolerance 
in nonexercised limbs in healthy adults (Anshel and Russell, 1994; Jones et al., 2014).  
Interestingly, the control group trended to have an increase in pressure pain intensity and 
unpleasantness ratings from baseline unlike the exercise groups, which exhibited overall decreases 
in pain ratings for the forearm (see Figure 1A and 1B). It is possible that repeated probing of the 
pressure algometer to the same area of the forearm caused invisible micro-hematomas irrespective 
of treatment group. If this were the case, we might have expected hypersensitivity in pressure pain 
thresholds; this was not observed. We hypothesize that the repeat testing with the pressure 
algometer led to negative anticipation across patients leading to worsening perception of the 
stimulus. At the same time, the exercise regimen was able to reverse the increased pain perceptions 
in the exercise groups leading to an overall hypoalgesic benefit of exercise. 
Cortisol data revealed no significant effect of treatment or time for subjects included in the 
analysis. We hypothesized that exercise could have an acute decreased effect on cortisol levels 
that may be dose dependent over time. Our data is not indicative of this trend. Notably, the raw 
data reveals higher levels of cortisol for the control group compared to exercise groups. These 




1995). This may be due to insufficient randomization at the start of the trial, placing more subjects 
in the control group. Patients enrolled at the beginning of the enrollment period were mostly tested 
by the male experimenter (AMR). Gender of the experimenter relative to the subject has been 
shown to affect experimental findings and has been widely documented (Chapman et al., 2018). It 
has previously been shown that females tested by male experimenters in the context of the TSST 
showed higher subjective stress ratings (Kirschbaum et al., 1993). This factor may have attributed 
to these higher markers of stress in control subjects.  
A limitation to the present study included the initial lack of adequate randomization 
techniques. As noted in the methods, participants were randomly allocated to control, 3x/wk and 
5x/wk dose exercise groups until the 10x/wk dose group was later added to the study. This 
introduced a small source of selection bias in the study design. Due to the nature of the 
intervention, it was not possible to blind participants to their treatment group, which may 
contribute to performance bias in our study. Related to that, outcome assessors were not blinded 
to treatment group which may be a source of detection bias. Finally, each assay was performed in 
order of least invasive to most invasive to body tissue. Because the order of testing lacked 
randomization, this may lead to additional sources of biases on our outcomes. 
This trial was represented by a fairly homogenous sample of participants demographically. 
This homogeneity also likely enhanced internal validity, reduced statistical and biologic variance 
and thus may have aided in the detection of significant differences. Although age inclusion was 
18-40, the average age of participants was 21.6 years of age. Therefore, the implications of this 
study’s results may not be generalizable to older populations with chronic pain. Healthy female 




differences in sensitivity to pain and pain perception related to exercise dose and the implications 
in different chronic pain conditions are unknown.  
In conclusion, the results of this study demonstrated that a moderate dose (5x/wk of 30 
min/day) of moderate intensity treadmill walking is sufficient to reduce perception of pressure pain 
in healthy individuals and that a higher dose (10x/wk) does not necessarily provide any observable 
benefit in these measures. These results could provide a framework for developing a starting 
exercise training dose for individuals experiencing chronic musculoskeletal pain. This is one of 
the only studies to test different doses of exercise training on sensitivity to pain in healthy subjects 
or chronic pain participants. Additional studies must be done to determine appropriate prescription 
of exercise respective to exercise modality. This intervention is currently being tested in trials 





MATERIALS AND METHODS 
This study is registered with ClinicalTrials.gov under ID: NCT03642938 (08/22/2018).  
Participants 
Forty healthy female subjects between the ages of 18 and 40 were recruited from the 
Duquesne University (Pittsburgh, PA, USA) community for this study. Study recruitment initially 
was open to both sexes, but later became exclusively female, due to unintended disproportionate 
recruiting of female participants (only 4 male participants were recruited). Nonetheless, we view 




the higher prevalence of musculoskeletal pain conditions in females (Fillingim et al., 2009). 
Inclusion criteria included 1) a normal BMI (18.5-25), 2) a resting heart rate between 60 and 100 
bpm, and 3) a resting blood pressure less than or equal to 140/90mmHg. Exclusion criteria included 
1) a history of cardiac, respiratory, neurological or musculoskeletal disease, 2) acute pain, 3) 
chronic pain condition, 4) diabetes, 5) regular participation in high intensity athletic/sporting 
activities, 6) sedentary lifestyle, 7) anxiety or depression disorders, and 8) currently pregnant 
individuals.  
Study Design 
This study was a pseudo-randomized controlled trial on the effect of multiple doses of 
moderate intensity walking exercise on experimentally-induced pain following a 5-day 
intervention in healthy adults. This trial was pseudo-randomized between the control, 3x/wk and 
5x/wk dose groups of exercise using a random number generator until data was collected for 19 
total subjects, at which point the study was fully randomized to include a 10x/wk dose group in 
order to obtain sufficient power per group. Study coordinators (AMP (primary) & AMR 
(secondary)) were responsible for generating random allocation sequence, enrolling participants 
and assigning participants to interventions. A power analysis of pain outcome for control versus 
exercise indicated that a minimum of 10 people/group to be sufficient to detect statistical 
differences in our primary dependent variable (% baseline pain sensitivity) with an alpha of 0.05, 
power of 0.80, and effect size of 1.25 using data from the exercise literature. All procedures were 
approved by the Duquesne University Institutional Review Board (Protocol #2014-04-22) and 
written consent was obtained from each participant prior to testing. All methods were performed 






Each trial was conducted at Duquesne University’s Exercise Physiology Laboratory over 
the course of 7 days. After screening and informed consent was obtained, participants were 
enrolled in the study. On the first day of testing, participants completed a series of questionnaires 
and underwent a sequence of quantitative and qualitative baseline sensitivity and pain assessments. 
Following baseline testing, treatment assignments were disclosed to the participants. One day 
following baseline assessments, subjects returned to the clinic to undergo their respective treatment 
assignment for the next 5 days. These sessions included either exercise or rest followed by pain 
assessment on days 1, 3 and 5 only. Twenty-four hours following each subject’s final exercise 
session, pain and sensitivity thresholds were assessed. At baseline, prior to and following rest or 
exercise, samples of saliva were taken as a measure of cortisol. Subjects performed exercise either 
3x per week (low dose); 5x per week (moderate dose) or 10x per week (twice a day for 5 days) 
(high dose). Subjects in the control condition rested during this time.  
Questionnaires 
 All participants completed four validated questionnaires pertaining to their general health, 
physical activity levels and anxiety levels. These included the AHA/ACSM Pre-participation 
Screening Form (Balady et al., 1998), the Physical Activity Readiness Questionnaire (PAR-Q and 
YOU) (Thomas et al., 1992), the International Physical Activity Questionnaire (IPAQ-long) (Craig 
et al., 2003), and the Social Interaction Anxiety Scale (SIAS) (Mattick and Clarke, 1998). 
Exercise Protocol 
Subjects in exercise groups performed 30 minutes of moderate intensity walking exercise 
on a treadmill. Moderate intensity walking exercise was defined at the speed of 3.5 mph, at a 0% 




following exercise, each experimental intervention participant rated their perceived exertion levels 
using the Borg RPE scale (Borg, 1982). Each session began with a 2-minute warm-up at 2.5 mph 
and concluded with a 2-minute cool-down at 2.5 mph. In addition to monitoring perceived 
exertion, participants wore a heart rate monitor during exercise sessions in order to ensure exercise 
was being performed at a moderate-intensity. If heart rate was above 65% of predicted maximum 
heart rate, the treadmill speed was decreased. Participants in the 3x/wk and 5x/wk dose groups 
exercised for single 30-minute sessions each day (either 3 days total for the 3x/wk group or 5 days 
total for the 5x/wk group). Participants in the 10x/wk dose group exercised for two 30-minute 
sessions per day with 5-10 minutes in between the two exercise sessions.  
Quantitative Sensory Testing (QST) 
Quantitative sensory testing was done on the bare skin of the participant’s forearms and 
calves at specific testing sites, as previously shown (Kostek et al., 2016). For each test, the subjects 
were instructed to close their eyes and/or turn their head for the duration of the stimulus 
presentation. These assays assessed each subject’s cutaneous mechanical sensitivity (threshold for 
mechanical detection to 0.008g, 0.02g, 0.04g, 0.07g, 0.16g, 0.4g, 0.6g and 1.0g Touch Test 
filaments in 3 of 5 trials for filament), constant heat pain (45C 3cm x 5cm heating block 
(Benchmark Scientific) applied for 3 seconds followed by 10cm Visual Analog Scale (VAS) for 
rating the intensity and unpleasantness of pain), radiant heat sensitivity (temperature ramp from 
30C to 50C over 60 seconds with participant defined cutoff in temperature (C) at “sensitivity 
threshold”; Thermal Stimulus Apparatus (IITC Woodland Hills, CA, USA) with custom heated 
glass), radiant heat pain (temperature ramp from 30C to 50C over 20 seconds with participant 
defined cutoff in temperature (C) at “pain threshold”; Thermal Stimulus Apparatus), pressure pain 




cutoff in kg at “pain threshold”; Wagner Instruments, Greenwich, CT, USA) and constant pressure 
pain sensitivity (2 second pressure stimulus at participant defined threshold followed by VAS for 
rating the intensity of pain and unpleasantness of pain) as previously described (Kostek et al., 
2016). 10cm VAS scales were numbered at 0 and 10. Score was measured to the nearest mm. 
Testing was performed on baseline and 24 hours following the last exercise session to measure the 
overall change in sensitivity across the entire study. Testing was also performed on days 1, 3, and 
5 of the trial at both 5 minutes- and 30 minutes following exercise or rest to assess the acute effects 
of exercise on sensitivity and pain. One trial of each assay was performed per body site at each 
time point indicated. Testing was performed in the order listed above (least invasive to most 
invasive test) to avoid acute tissue damage and increased sensitization. Assays were performed on 
the subject’s forearms first, followed by testing on the calves. Each test was performed 
approximately 2 minutes apart to avoid desensitization of testing area.  
Saliva Samples  
Saliva samples were collected at baseline, and before and after each intervention session 
on days 1, 3 and 5 for each subject using Salivette (Sarstedt, Code Blue, Cat. #51.1534.500). 
Following collection, samples were centrifuged at 1,000 x g for 2 min and stored at -80 oC until 
ready for processing.  An EIA kit (Arbor Assays, Cat. #K003-H1) was used to elucidate cortisol 
levels for each sample. A microplate reader (BioRad, Model 3550) was used to calculate optical 
density (OD) of each sample. Parameters for OD wavelength were set to 450 nm without 
automixing. 
Calculation of standard curve: Averages of duplicate standards were taken and averaged NSB 
(non-specific binding) counts were subtracted from those averages. These values were then divided 




multiplied by 100 to obtain the percent bound. [% bound = (Average Sample – Average NSB) / 
(Average 0 ng/mL – Average NSB ) x 100]. Percent bound was plotted (x-axis) versus the 
concentration of cortisol (ng/mL; y-axis) to determine the standard curve. The trendline was 
determined using a 4th order polynomial. The equation from the trendline was used to determine 
the concentration of the controls (using percent bound for the controls calculated like the standard 
samples. 
Calculation of experimental samples: Samples were done in singlicate. NSB counts were 
subtracted from them. These values were divided by the corrected zero calibrator value (i.e. 
average 0 ng/mL calibrator – average NSB) and multiplied by 100 to obtain the percent bound. 
The percent bound value in the equation for the standard curve was used to obtain an inflated 
concentration of the sample. The concentration of the sample was multiplied by the dilution factor 
(4) to obtain the actual concentration of each sample.  
Statistical Analysis 
Prior to analysis, an a priori statistical plan was developed. Descriptive statistics were 
calculated using the IBM SPSS Version 25. Normality of the data was assessed. Nonparametric 
inferential statistics were used for data that were not normally distributed.  
The primary outcome was defined as a change in QST 24 hours post-intervention versus 
baseline. This included a series of 8 quantitative sensory tests measured at baseline and at the 
completion of the 1-week intervention period. These tests were measured at two sites (forearm and 
calf). One-way ANOVAs were used to identify significant differences between groups, comparing 
percent change from baseline for parametric data. Given the number of statistical tests that were 
performed for the primary outcome measurements, a p-value of p<0.01 was utilized for each body 




each site using p<0.05. For analysis of primary outcomes, we were interested in looking at percent 
change, however the raw data values for constant pressure pain intensity and unpleasantness 
ratings for the forearm can be found as Appendix B for full interpretation. 
The secondary outcomes for this study include 1) HR during exercise, 2) Borg RPE before 
and after exercise and 3) measuring “acute” effects of exercise on QST testing. Two-way 
ANOVAs were used to examine percent change of HR and Borg RPE for the 3 treatment groups 
(low, moderate, high) from start of exercise (post-exercise/pre-exercise) across time (day 1, 3, 5) 
with an adjusted p-value of p<0.03. Two-way MANOVAs were used to assess percent change 
from baseline (post-exercise/baseline test across the three days (day 1, 3, 5) and at the 5 minute 
and 30 minutes time point between groups for the 8 QST). Analyses were grouped separately for 
tested body site. Given the number of statistical tests (n=8) required for the QST secondary 
outcome measurements, a p-value of p<0.01 was utilized for each body site.  
The following demographic variables were collected and compared between groups to 
further check against potential bias: age, handedness, body mass index (BMI), baseline heart rate 
(HR), baseline blood pressure (BP), baseline IPAQ-long, and SIAS (social interaction anxiety 
scale).  A significant difference in the proportion handedness was tested using the Chi-Square test 
where a p<0.05 was considered significant.  All other continuous variables were tested using a 
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The text contained within this chapter is not adapted from a published work.  
 
Holly Furnari assisted with data acquisition and analysis for data generated in Table 1, Figure 1 
and Figure 2. Connor Evans assisted with data acquisition and analysis for data generated in Table 
1, Figure 2 and Figure 3. Connor Evans also assisted with development of the study protocol. 
Anna Polaski was responsible for methodology, study management, data acquisition and data 
analysis. Original discussion of experimental question came from Matthew Kostek, Kimberly 


























Management of psychological disorders such as anxiety is vitally important for those 
suffering from severe chronic or acute pain. Anxiety is difficult to treat and pharmacologic 
interventions are often ineffective, expensive, or can have undesirable side effects. Aerobic 
exercise is a known method of anxiety relief. However, exercising in a public setting can induce 
stress, which lessens the therapeutic and psychological benefits of exercise. The aim of this study 
was to develop and test a new measure of social stress that models social observation experienced 
in an exercise setting. This was done in healthy participants. Subject participation included an 
intake session which involved obtaining of informed consent and eligibility screening. This was 
followed by 30 minutes of moderate intensity treadmill walking either alone (control) or closely 
watched (intruder). Physiologic and psychologic measures of anxiety were examined.  We 
hypothesized that physical and psychological measures of stress would increase in the presence of 
the anxiety-inducing confederate, such as more dramatic increases in heart rate, increased levels 
of the stress hormone cortisol, and higher state anxiety. Results of this pilot study showed no 
significant differences in state or trait anxiety, heart rate variability or cortisol levels. Examining 
the relationship between anxiety and exercise is vital in understanding exercise as a modality for 
treating pain, given the mutual dependency between the psychological and biological components 











Anxiety has been known to increase symptoms of pain (Cornwall and Donderi, 1988), and 
many pain patients tend to experience increased levels of anxiety (Jordan and Okifuji, 2011). 
Social apprehension and evaluation is one source of this anxiety. Social anxiety disorder can be 
classified as excessive physiological and affective arousal in response to social interaction (Milad 
and Rauch, 2007). As described in previous chapters, it is well known that exercise is an 
efficacious intervention for the treatment of depression and pain. However, it has been suggested 
that individuals high in social anxiety may benefit less while exercising in public and may avoid 
working out in a gym (Levinson et al., 2013). Thus, the social aspect of exercise may lead to 
avoidance of exercise and potentially may exacerbate negative physical and mental health 
outcomes. Chronic pain patients may experience increased anxiety and pain if instructed to 
exercise in a public setting, such as a gym, especially around people that they are not familiar with. 
As a result, patients will be less likely to adhere to such exercise programs. Overall, knowledge of 
how social evaluation anxiety is associated with exercise is pertinent for clinical application in an 
outpatient treatment setting.  
The primary objective of the full experimental protocol was to determine the effect of 
experimentally-induced social evaluation anxiety on the efficacy of exercise-induced analgesia in 
healthy participants. All groups would be assigned an identical exercise condition and one of three 
different social conditions. Social conditions consist of (1) exercising alone (control), (2) 
exercising with a same-sex friend, or (3) exercising with a same-sex stranger (i.e. social evaluation 
anxiety condition). After exercise, control and experimental groups would undergo pain testing in 
order to determine their pain and sensitivity thresholds. These data would be analyzed and 




analgesic effects of exercise. Our hypothesis was that anxiety would have a negative impact on 
exercise’s ability to reduce pain, while exercising with a “friend” may actually improve exercise 
training. However, before we could test this specific question, we first had to validate a model of 
anxiety in humans. 
 One of the most widely used laboratory stress tests that has reliably been able to induce 
anxiety in human participants is the Trier Social Stress Test (TSST) (Kirschbaum et al., 1993). A 
meta-analysis revealed that studies that included tasks with a social-evaluative threat, with an 
uncontrollable performance outcome, provoked the largest cortisol changes (Dickerson and 
Kemeny, 2004). In this analysis, the TSST was found to be the most appropriate standardized 
protocol for stress hormone reactivity (Dickerson and Kemeny, 2004). This model has been 
modified to accommodate various laboratories, but the general protocol consist of a waiting period 
upon arrival, anticipatory speech preparation, and judged performance (Birkett, 2011). For the 
purposes of our pilot study, we chose to develop a similar but less extensive protocol that focused 
on stress related to exercise performance.  
 Our pilot study tested the effect of performance-judged exercise compared to exercise 
alone on physiological and psychological measures of anxiety in healthy human subjects. Here, 
participants exercised in the presence of a stranger or alone for 30 minutes. Our primary outcome 
was the change in levels of the stress hormone cortisol from pre- to post-intervention. Secondary 
outcomes included heart rate variation during exercise and self-reported “state” anxiety measured 
at pre- and post-intervention. We hypothesized that subjects exercising in the presence of a stranger 
intruder would display higher levels of stress post-intervention compared to a control “alone” 







   Thirteen healthy volunteers with an average age of 22 years participated in this study. 




Table 1. Participant characteristics. Data are mean (SD). Abbreviations: BMI, body mass index; 
BPs, systolic blood pressure; BPd, diastolic blood pressure; IPAQ, International Physical Activity 
Questionnaire; SIAS, Social Interaction Anxiety Scale. Data acquisition and analysis – AMP, CE, 
HF. Experimental design – AMP, BJK, MK, KS. 
 
Primary outcome: Intervention effects on salivary cortisol levels  
We first analyzed the impact of treatment (presence of an intruder versus alone) during 
treadmill walking on baseline versus post-intervention salivary cortisol. The standard curve that 
was used to calculate our results had an R2=0.9767. For all subjects, there was no statistically 
significant effect of treatment on salivary cortisol levels (Figure 1A, two-way ANOVA, 
p=0.2450). We also analyzed this data by sex and found no significant effects of treatment for 











Age (yrs) 23.0 (3.6) 21.0 (1.5) 21.9 (2.8) 
BMI 24.5 (2.8) 24.7 (1.9) 24.6 (2.2) 
Resting HR (bpm) 86.3 (21.4) 71.0 (6.3) 76.5 (14.9) 
Resting BPs (mmHg) 120.0 (11.1) 120.3 (7.2) 120.2 (8.5) 
Resting BPd (mmHg) 75.2 (3.3) 73.0 (9.1) 73.9 (7.1) 
IPAQ (MET-min/wk) 4454.4 (5190.6) 7777.4 (4055.1) 6392.8 (4657.7) 





Figure 1. Cortisol levels for participants pre- and post-intervention. (A) No difference in 
cortisol levels between groups for all subjects: control, n=6; intruder, n=7. (B) No difference in 
cortisol levels between groups among female participants: control, n=2; intruder, n=4. (C) No 
difference in cortisol levels between groups among male participants: control, n=4; intruder, n=3. 
Data shown as mean +/- SEM. Data acquisition and analysis – AMP, HF. Experimental design – 
AMP, BJK, MK, KS. 
 
Secondary outcomes: Acute effects of intervention 
 In addition to salivary cortisol, we also evaluated additional measures of anxiety. First, 
there was no significant effect of treatment on HR during exercise (Figure 2, two-way ANOVA, 
p=0.0565), but there was a significant effect of time (Figure 2, two-way ANOVA, ****p<0.0001). 
























































































Figure 2. HR during 30 minute walking exercise session. No significant effect of treatment on 
HR. Data shown as mean +/- SEM. Data acquisition and analysis – AMP, HF, CE. Experimental 













Figure 3. STAI state anxiety pre and post-intervention. No significant effect of treatment on 
state anxiety. Data shown as mean +/- SEM. Data acquisition and analysis – AMP, CE. 















































This pilot study tested the effects of social evaluation during exercise on stress in a small 
cohort of healthy college-aged participants. Overall, there were no significant effects of treatment 
(intruder vs. control) on cortisol levels, HR variability, or state anxiety scores. However, this 
remains an important topic in the clinical applications of prescribing exercise therapy to pain 
patients. Other studies using TSST models have been successful at inducing stress in human 
participants (Goodman et al., 2017). Such protocols induce anxiety by activating the hypothalamic-
pituitary-adrenocortical (HPA) axis. This pathway is initiated by the hypothalamic release of 
corticotropin releasing hormone (CRH), which stimulates the anterior pituitary to secrete 
adrenocorticotropin hormone (ACTH), which triggers the adrenal cortex to release cortisol into 
the bloodstream (Lovallo, 2000). In addition to increased cortisol, TSST models are associated 
with increased HR and increased measures of state anxiety from baseline (Birkett, 2011).  
Null effects of this pilot study can be attributed to several limitations of our study design. 
First, this study was limited by the low number of participants in each group; control group, n=6 
intruder group, n=7. It is worth noting, that among the participants in the intruder group, there was 
a large degree of variability in baseline cortisol levels (Figure 1). Increasing the sample size, may 
have aided in decreasing variability. Importantly, the ranges of cortisol levels for study participants 
were consistent with that of reference ranges for participants aged 21-30 years old during the 
evening period (Aardal and Holm, 1995). 
It is also very likely that the acclimation period before the stressful scenario was not of an 
adequate length to ensure proper habituation to the laboratory setting. A meta-analytical 
assessment revealed that pre-stress acclimation periods should be of at least 15 minutes in duration, 




acclimation (Goodman et al., 2017). This is not true of our protocol, as subjects were completing 
questionnaires during this 15-minute period. This may have attributed to the increased variability 
in cortisol levels at baseline. Although not significant, control group participants overall exhibited 
elevated HR during exercise compared to intruder participants (Figure 2) and slightly increased 
scores on the STAI state anxiety survey (Figure 3). It is possible that exercising alone in a 
laboratory setting was not a true control condition, and may have produced stress through 
uncertainty. Lastly, it is most likely that our model of anxiety was not “stressful” enough to induce 
changes in our measures of anxiety. Typical models of the TSST last about 20 minutes 
(Kirschbaum et al., 1993) and include multiple components of stress (anticipatory stress period, 
followed by two different performance tasks) which contribute to uncontrollability or a context of 
forced failure that further stresses the participant (Kirschbaum et al., 1996). It is possible that 
subjects that were exercising in the presence of the stranger intruder, acclimated to his or her 
presence before the end of the 30-minute exercise period. Typically, cortisol samples are taken 5 
minutes pre-TSST, and then immediately at the end of the 20-minute TSST period (Birkett, 2011). 
Because of this, it is likely that the timing of the post-intervention cortisol measure was too delayed 
in order to capture peak cortisol levels.  
In the context of exercise, social aspects of performing physical activity in public may lead 
to avoidance behaviors with potentially worsened physical and mental health. One study found 
that gym avoidance was positively correlated with social interaction anxiety, fear of scrutiny and 
fear of negative evaluation among healthy college students (Levinson et al., 2013). This is 
consistent with earlier findings indicating that social anxiety and fear of negative evaluation were 
generally related to social-evaluative fears in sporting or athletic situations (Norton et al., 2000). 




the experience of stress impaired efforts to be physically active (Stults-Kolehmainen and Sinha, 
2014). This has important practical and clinical significance in the context of exercise prescription 
for chronic pain patients with comorbid psychiatric illnesses. Decreased adherence could be 
expected if treatment requires exercise in a public setting, in the vicinity of unfamiliar people. In 
our original study incorporating multiple treatment groups, we hypothesized that exercising with 
a friend, would prevent or decrease stress related to exercise performance. In a cohort of African 
American women, a church-based obesity treatment promoting weight loss and exercise improved 
adherence compared to their counterparts undergoing treatment at a university setting (Sbrocco et 
al., 2005). These data suggest that treatment setting may play a critical role in treatment adherence, 
which is consistent with our hypothesis. Finally, the role of social evaluation anxiety in exercise 
program adherence still remains a critical component of patient care in effectively treating chronic 















MATERIALS AND METHODS 
Participants 
Thirteen healthy subjects between the ages of 18 and 40 were recruited from the Duquesne 
University (Pittsburgh, PA, USA) community for this study. Inclusion criteria included: 1) a 
normal BMI (18.5-25), 2) a resting heart rate between 60 and 100 bpm, and 3) a resting blood 
pressure less than or equal to 140/90mmHg. Exclusion criteria included: 1) a history of cardiac, 
respiratory, neurological or musculoskeletal disease, 2) acute pain, 3) chronic pain condition, 4) 
diabetes, 5) regular participation in high intensity athletic/sporting activities, 6) sedentary lifestyle, 
7) anxiety or depression disorders, and 8) currently pregnant individuals.  
Study Design 
This study was a randomized controlled trial on the effect of an intruder or control 
condition on measures of stress during moderate intensity treadmill walking in healthy adults. This 
trial was randomized between the control and intruder groups of exercise using a random number 
generator. Data was collected for 13 total subjects. Study coordinators (AMP, CE & HF) were 
responsible for generating random allocation sequence, enrolling participants, and assigning 
participants to interventions. All procedures were approved by the Duquesne University 
Institutional Review Board (Protocol #2014-04-22) and written consent was obtained from each 
participant prior to testing. All methods were performed in accordance with the relevant 
international and local guidelines and regulations for human research.  
Procedures 
Single-day sessions were conducted at Duquesne University’s Exercise Physiology 
Laboratory. After screening and informed consent was obtained, participants were enrolled in the 




Following screening, eligible subjects were oriented to the study protocol and were prepared for 
their exercise session. Prior to and following exercise, samples of saliva were taken as a measure 
of cortisol. During exercise, participants’ treatment included either exercise alone (control) or 
exercise with a confederate present (intruder). Following the 30-minute exercise session, 
participants completed the STAI survey and were debriefed.  
Questionnaires 
 All participants completed four validated questionnaires pertaining to their general health, 
physical activity levels and anxiety levels. These included the AHA/ACSM Pre-participation 
Screening Form (Balady et al., 1998), the Physical Activity Readiness Questionnaire (PAR-Q and 
YOU) (Thomas et al., 1992), the International Physical Activity Questionnaire (IPAQ-long) (Craig 
et al., 2003), and the Social Interaction Anxiety Scale (SIAS) (Mattick and Clarke, 1998). 
Exercise Protocol 
All subjects performed 30 minutes of moderate intensity walking exercise on a treadmill. 
Moderate intensity walking exercise was defined at the speed of 3.5 mph, at a 0% grade which 
falls between 3.0-5.9 MET range for moderate intensity physical activity. Prior to and following 
exercise, each experimental intervention participant rated their perceived exertion levels using the 
Borg RPE scale (Borg, 1982). Each session began with a 2 minute warm-up at 2.5 mph and 
concluded with a 2 minute cool-down at 2.5 mph. In addition to monitoring perceived exertion, 
participants wore a chest-strap heart rate monitor (Polar, H10) during exercise sessions to 
potentially measure fluctuations in stress response. All participants performed a single 30-minute 
exercise sessions on the same day as the intake session.  




Saliva samples were collected before and after the intervention session using Salivette 
(Sarstedt, Code Blue, Cat. #51.1534.500). Following collection, samples were centrifuged at 1,000 
x g for 2 min and stored at -80 oC until ready for processing.  An EIA kit (Arbor Assays, Cat. 
#K003-H1) was used to elucidate cortisol levels for each sample. A microplate reader (BioRad, 
Model 3550) was used to calculate optical density of each sample (OD). Parameters for OD 
wavelength were set to 450 nm without automixing. 
Calculation of standard curve: (See Materials and Methods of Chapter 3, Section 1). 
Calculation of experimental samples: (See Materials and Methods of Chapter 3, Section 1). 
Intruder Condition 
After orientation, the experimenter led the subject to the treadmill to prepare for exercise. 
Participants in the intruder group were informed that another experimenter (the “intruder”) would 
enter the room to monitor them during their intervention period. Intruders were sex-matched to 
participants. The experimenter asked the subject if they have any questions before they began and 
left the room. At this time, the intruder entered the room and sat in a chair positioned adjacent to 
the treadmill so that the subject could see the confederate and vice versa. While in the room, the 
intruder projected a confident demeanor and body language, expressed neutral facial expressions, 
and said nothing during his/her time in the room with the subject. The intruder wrote down notes 
for the first five minutes, then used a stopwatch to time arbitrary aspects of the participant’s actions 
(i.e. steps, eye blinking) stopping every minute to record notes. Just before the exercise was 
completed, the intruder left the room and the experimenter returned to administer surveys and 





Since this experiment was a pilot study, an a priori stats plan was not developed. The 
primary outcomes were defined as changes in cortisol levels from pre- to post-INT and changes in 
state anxiety scores on the STAI from pre- to post-INT. Two-way ANOVAs were used to identify 
significant differences between groups. The secondary outcomes for this study include 1) HR 
during exercise and 2) trait anxiety measures from pre- to post-INT. Two-way ANOVAs were 
































Examining the effect of a combined nonpharmacological 












The majority of the text contained within this chapter is adapted from the following manuscript 
submitted for publication: 
Polaski AM, Phelps AL, Smith TJ, Helm ER, Morone NE, Szucs KA, Kostek MC, Kolber BJ. 
2019. Integrated meditation and exercise therapy: A randomized controlled trial of a combined 
non-pharmacological intervention reduces disability and pain in patients with chronic low back 
pain. Submitted for publication.  
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D’Acunto and Allison Morgan (Figure 1). Financial acknowledgement: Duquesne FDF to KS and 
FDF to BJK/MK. Funding for this work was supported by the National Institutes of Health through 
Grant Number UL1TR001857 and through a Pain Research Challenge Grant supported by the 
Clinical and Translational Science Institute at the University of Pittsburgh and the Virginia 
Kaufmann Foundation. AMP was responsible for ultimate participant screening, study 
management, data acquisition, data analysis, original draft writing. ALP was responsible for 
statistical analysis development, consultation and running of select statistical analyses. The 
Clinical and Translational Science Institute at the University of Pittsburgh hosted advertising for 
the trial and a call center for initial telephone-based screening. TS was responsible for conducting 
psychological intake sessions/trainings with study participants. ERH was responsible for 
participant screening. NM, KS and MK were involved with original study development, 
methodology and draft editing. BJK was responsible for performing QST sessions, original study 






Integrative and complementary non-pharmacological treatments have proven efficacious 
in treating both the physiological and psychological symptoms of chronic pain conditions but the 
potential of many combined therapies is unknown. This study examined the effects of a combined 
intervention of mindfulness meditation followed by aerobic walking exercise in chronic low back 
pain (cLBP) patients. We hypothesized that meditation before exercise would reduce disability 
and pain by increasing mindfulness prior to physical activity. Thirty-eight adults completed either 
meditation and exercise treatment (MedExT) (n=18) or an audiobook control condition (n=20). 
Over a 4-week period, participants in the MedExT group performed 12-17 minutes of guided 
meditation followed by 30 minutes of moderate intensity walking exercise 5 days per week. 
Measures of disability, pain, mindfulness and anxiety were taken at baseline and post-intervention. 
Ratings of pain were also assessed by participant self-report, before and after each intervention 
session. Following MedExT, participants showed significant improvement in our primary outcome 
of disability compared to the control group. From pre to post-intervention, MedExT also increased 
mindfulness, but had no significant effect on quantitative sensory testing on the low back. Mean 
ratings of low back pain intensity and unpleasantness significantly improved with MedExT from 
before the study to during participation. Overall, four weeks of MedExT produced substantive 















 Low back pain is the most common reported type of pain (Deyo et al., 2006) and the second 
leading cause of physician visits and disability among U.S. adults (Ehrlich, 2003). Globally, 25% 
of adults report having low back pain over any one month (Hoy et al., 2012). Often due to non-
specific causes and complicated by comorbid symptoms (Ehrlich, 2003), low back pain remains 
difficult to treat. Current treatments include NSAIDS, muscle relaxants, opioids, psychological 
therapy, physical therapy chiropractic manipulation, injections and surgery (Ehrlich, 2003; 
Abraham et al., 2016). Chronic low back pain is further complicated by the potential for comorbid 
anxiety disorders (Kroenke et al., 2013). In particular, musculoskeletal pain is often associated 
with fear-avoidance anxiety behavior and kinesiophobia (Lundberg et al., 2011). This 
kinesiophobia or fear of movement can further exacerbate pain and subsequent disability. 
Kinesiophobia may also impede the likely benefit of physical treatments in patients by increasing 
state anxiety before and during therapy. In treating chronic pain, a major gap exists in not only 
treating the physiological condition, but also addressing the interaction with psychological 
disorders.  
Due to the risk of adverse side effects, addiction and misuse, many pharmacological 
approaches to treating low back pain, including opioid therapeutics, have not been found to be 
superior to complementary treatment methods (Pedersen and Fredheim, 2015). There has been a 
significant push in the last 20 years to identify and understand complementary and integrative 
therapies to supplement pharmacology. Nonpharmacological therapies include aerobic exercise, 
tai chi, yoga, mindfulness-based stress reduction (MBSR), progressive relaxation, 
electromyography biofeedback, operant therapy, cognitive behavioral therapy, multidisciplinary 




significant improvements (Chou et al., 2017). There has been considerable interest in programs 
that combine elements of multiple therapies to treat chronic pain. One of most well-established 
integrative programs that involves elements of stress reduction, exercise, and meditation is the 8-
week MBSR system, which has been found to improve pain, depression and quality of life (Hilton 
et al., 2017). However, this program requires extensive training and may not be easily accessible 
to some persons with cLBP. In the current study, we examined a more feasible pilot program of 
introductory mindfulness meditation that novice meditators could easily put into practice prior to 
aerobic walking exercise. Both meditation and exercise have been independently investigated in 
the context of back pain therapy.  
Exercise interventions have proven to have beneficial outcomes on pain severity, physical 
disability, psychological function and health-related quality of life across various chronic pain 
conditions (Geneen et al., 2017). Mechanistically, aerobic exercise at a level of at least 70% of the 
maximum aerobic capacity generates the production of endorphins and elicits other pain inhibitory 
mechanisms driven by the central nervous system (Millan, 2002; Bender et al., 2007). In addition, 
aerobic exercise has been shown to reduce fatigue and improve peak oxygen uptake, and physical 
fitness (Dinler et al., 2009; Hauser et al., 2010).  
Similar to exercise, studies incorporating mindfulness meditation have largely shown to 
improve pain and depression symptoms, quality of life, well-being and increase mobility and 
functioning (Hilton et al., 2017; Majeed et al., 2017). Mechanistically, mindfulness meditation has 
been associated with decreased levels of cortisol (Jacobs et al., 2013), increased signaling 
connections in the brain (Tang et al., 2012), improved pain processing and emotional control (Kerr 
et al., 2013), and altered amygdalar response to emotional stimuli (Desbordes et al., 2012). As 




Meditation and Exercise to Treat chronic low back trial (MedExT) tested the effects of a 4-week 
intervention of a guided mindfulness meditation program combined with moderate intensity 
walking exercise performed 5 days per week in chronic low back pain (cLBP) patients. We 
hypothesized that this intervention would improve disability (primary outcome), pain, anxiety and 
increase mindfulness compared to control participants. This specific therapy combination has not 























Fifty-two adult volunteers with chronic low back pain were enrolled in this trial and thirty-
eight participated in its entirety. 14 participants dropped out of the study after enrollment. This 
included 10 due to scheduling conflicts, 3 due to newly discovered ineligibility (e.g. neurological 
disorder), and 1 due to inability to complete minimum required 80% sessions per week. See Figure 
1 for flow-chart diagram. Recruitment of participants began in January 2018 and ended February 
2019. Demographic characteristics of subjects are presented in Table 1. No significant group 
differences were found for any of the demographic variables (Table 1, t-test, p>0.05). No 
significant relationships comparing treatment group to sex and also to handedness were found 
(Fisher’s exact test, p>0.05). Using ActiGraph watch data, we compared the average number of 
steps taken per day for participants in both groups. After subtracting steps taken by the MedExT 
group during their 30-minute exercise session, we found no statistically significant difference 































































Figure 1. Flow diagram of subject enrollment. Participant screening – AMP, EH, KD, AM. 
Experimental design – AMP, BJK, MK, KS. 
 
Assessed for eligibility (n=115) 
Excluded  (n=63) 
    Not meeting inclusion criteria 
(n=56) 
    Declined to participate (n=7) 
 
Analysed  (n=18) 
 Excluded from sub-analysis (n=5) 
Discontinued intervention (n=3) 
 Newly discovered ineligibility (n=2)  




Allocated to MedExT (n=26) 
 Received allocated intervention (n=21) 
 Did not receive allocated intervention (n=5) 
 Discontinued due to scheduling conflicts 
Discontinued intervention (n=1) 
 Newly discovered ineligibility (n=1) 
 
Allocated to control (n=26) 
 Received allocated intervention (n=21) 
 Did not receive allocated intervention (n=5) 
 Discontinued due to scheduling conflicts 
 
Analysed  (n=20) 
















Table 1. Participant characteristics. Data are mean (SD). Abbreviations: BMI, body mass index; 
BPs, systolic blood pressure; BPd, diastolic blood pressure; IPAQ, International Physical Activity 
Questionnaire; RMDQ, Roland-Morris Disability Questionnaire. Data acquisition and analysis – 
AMP. Experimental design – AMP, BJK, MK, KS. 
 
Primary outcome: Intervention effects on Disability 
 Our primary a priori outcome was the effect of treatment on post-intervention scores of 
disability as measured by the Roland Morris Disability Questionnaire (RMDQ). There was a 










Age (yrs) 36.3 (14.1) 38.7 (16.8) 37.6 (15.4) 0.6432 
BMI 24.5 (2.9) 26.3 (2.7) 25.4 (2.9) 0.0603 
Resting HR (bpm) 71.3 (12.4) 72.4 (12.0) 71.9 (12.0) 0.7892 
Resting BPs (mmHg) 116.2 (10.7) 115.5 (8.8) 115.8 (9.6) 0.8208 
Resting BPd (mmHg) 75.2 (8.1) 77.5 (6.2) 76.4 (7.2) 0.3331 
IPAQ (MET-min/wk) 2731 (2463) 2906 (2428) 2821 (2413) 0.8285 
Steps/day 10778 (2518) 12029 (3514) 11437 (3107) 0.2198 
















Figure 2. Post-intervention effect of MedExT vs. control treatment on primary outcome: 
disability as measured by the Roland Morris Disability Questionnaire (RMDQ). MedExT 
participants show statistically significantly lower disability levels compared to control 
participants. Data shown as mean +/- SEM. RMDQ min score=0, max score=24. *p<0.05. Data 
acquisition and analysis – AMP. Experimental design – AMP, BJK, MK, KS.  
 
 Post-hoc analyses: Analysis comparing mean change or difference score for RMDQ 
revealed no significant difference between the control and MedExT groups (Figure 3, t-test, 
p=0.1699). Analysis of both control and MedExT pre and post disability scores reveal no overall 
effect of treatment (Figure 4, two-way ANOVA, p=0.0598), time (Figure 4, two-way ANOVA, 
p=0.0904) or time x treatment (Figure 4, two-way ANOVA, p=0.1699), but multiple comparisons 


































Figure 3. Intervention effect of MedExT vs. control treatment on disability difference score: 
as measured by the RMDQ. No significant difference between groups. Data shown as mean +/- 





















Figure 4. Intervention effect of MedExT vs. control treatment on disability scores, pre and 









































at post-intervention. Data shown as mean +/- SEM. Data acquisition and analysis – AMP. 
Experimental design – AMP, BJK, MK, KS. 
 
Secondary outcomes: Mindfulness, Fear Avoidance, Anxiety, and Pain 
 The FMI was administered to determine if there were any changes in mindfulness that 
developed during the trial. Analysis revealed a significant increase in mindfulness for the MedExT 
group from pre to post-intervention (Figure 5A, t-test, *p=0.0141). For the psychological 
inventories, we tested whether the MedExT treatment would influence a mean change in response 
from pre to post-intervention. No significant differences were found between pre and post 
measures for the MedExT group for the FABQ (Figure 5B, t-test, p=0.6812), STAI state anxiety 
(Figure 5C, t-test, p=0.2577), or STAI trait anxiety (Figure 5D, t-test, p=0.8049).  
  
 
Figure 5. Pre to post-intervention effect of MedExT on secondary outcomes: (A) MedExT 
participants demonstrated statistically significant increases in mindfulness (FMI) (*p<0.05) 
compared to baseline values. No significant changes were observed for (B) fear avoidance 
behavior (FABQ) and (C) state and (D) trait anxiety (STAI), p>0.02. FMI score range=14-56, 
FABQ=0-96, STAI=20-80. Data shown as mean +/- SEM. For psychological inventories (FABQ, 








































































Post-hoc analysis: Analysis of control group comparisons at pre and post-intervention for 
the psychological inventories revealed no significant differences for FABQ (Figure 6A, t-test, 
p=0.3050), STAI state anxiety (Figure 6B, t-test, p=0.2309), or STAI trait anxiety (Figure 6C, t-
test, p=0.6968). 
 
Figure 6. Pre to post-intervention effect of control treatment on psychological inventories: 
No significant changes were observed for (A) fear-avoidance behavior (FABQ) and (B) state and  
(C) trait anxiety (STAI), p>0.02. FMI score range=14-56, FABQ=0-96, STAI=20-80. Data shown 
as mean +/- SEM. For psychological inventories (FABQ, STAI), p>0.02. Data acquisition and 
analysis – AMP. Experimental design – AMP, BJK, MK, KS. 
 
 
For quantitative measures of pain (QST), we analyzed mean response changes from pre to 
post-intervention on the participant’s low back and non-dominant forearm to determine any 
significant differences between groups. Body site specific data for each test are shown in Table 2. 
For the low back and forearm, there were no significant effects of treatment for constant heat pain 























































intensity or constant pressure pain unpleasantness (Table 2, t-test, p>0.005). Additionally, there 
were no significant differences between treatment for mechanical sensitivity or mechanical pain 







Table 2. Intervention effects on QST pain measures for MedExT and control groups. For all 
QST, p>0.005. Data acquisition and analysis – AMP. Experimental design – AMP, BJK, MK, 
KS.  
 
 For VAS repeated measures of on-going back pain, we found analgesic effects of the 
intervention that appear to accumulate over time (Figure 7). Analysis revealed a significant effect 
of time (Figure 7A, mixed effects model, ***p=0.0008) and time x treatment (Figure 7A, mixed 
effects model, **p=0.0012) for intensity ratings on each day before undergoing the intervention 
session. For unpleasantness ratings pre-intervention, there were significant effects of treatment 
(Figure 7B, mixed effects model, *p=0.0330), time (Figure 7B, mixed effects model, 
**p=0.0022) and time x treatment (Figure 7B, mixed effects model, ****p<0.0001). Analysis of 
acute day to day effects of intervention indicated no significant effects for intensity (Figure 7C, 
mixed effects model, p>0.05), but a significant effect of treatment (Figure 7D, mixed effects 
model, **p=0.0049) for unpleasantness post – pre-measures. That is, the intensity VAS measured 
immediately after the ~45-minute session was not significantly different from the VAS measured 
immediately before that day’s session. The lack of an effect here illustrates the potential 
 T-test/Mann-Whitney, P 
QST Low Back Forearm 
Mechanical Sensitivity 0.6107 0.1361 
Mechanical Pain 0.1078 0.4259 
Constant Heat VAS Intensity 0.2519 0.7210 
Constant Heat VAS Unpleasantness 0.0635 0.4789 
Pressure Pain Threshold 0.9236 0.2104 
Constant Pressure VAS Intensity 0.0746 0.9141 




































































Low Back VAS Unpleasantness
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Low Back VAS Intensity
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Figure 7. Intervention and acute effects of MedExT intervention compared to control. Data 
shown as mean +/- SEM with “analgesic” responses being values lower than “0” on y-axes. 
Intervention effects are shown in A-B comparing VAS measurement taken immediately prior to 
each day’s session versus the baseline VAS measurement taken on intake day. Statistically 
significant analgesic effects were seen in the MedExT group for (A) VAS intensity (Time 
(***p=0.0008), time x treatment (**p=0.0012)) and (B) VAS unpleasantness (Treatment 
(*p=0.0330), time (**p=0.0022), time x treatment (****p<0.0001)). Acute intervention effects 
shown in C-D comparing VAS taken after each day’s intervention to the VAS taken immediately 
before the intervention. No significant differences were found for  (C) VAS intensity (n.s.) while 
(D) a small effect of Treatment (**p=0.0049) was found for VAS unpleasantness. Data acquisition 
and analysis – AMP. Experimental design – AMP, BJK, MK, KS.  
 
An additional measure of low back pain was assessed at the exit session. Patients were 
asked to recall their average pain intensity and unpleasantness before the study (i.e. at baseline) 
and also across the last month of being in the trial (i.e. at exit session). Analysis revealed significant 
mean change differences between study groups for both intensity ratings (Figure 8A, t-test, 
*p=0.0167) and unpleasantness ratings of low back pain (Figure 8B, t-test, *p=0.0144) with the 
MedExT group showing significant improvement in their subjective evaluation of the intensity 









Figure 8. Average pain ratings for MedExT vs. control. Statistically significant decreases in 























control participants. Scores represent a change from before the start of the intervention to after 
participation. Data shown as mean +/- SEM; negative values indicate a reduction in VAS pain 
score. *p<0.025. Data acquisition and analysis – AMP. Experimental design – AMP, BJK, MK, 
KS.  
 
Sub-analyses: Fully compliant patients only 
 A priori, we determined that we would evaluate all participants that completed 80% of each 
week’s sessions. This value was determined by whether participants completed a daily Qualtrics 
survey before/after their session. However, we reasoned that there may have been individuals in 
the MedExT experimental group that completed the survey, but did not actually complete the 
intervention. To potentially account for this non-compliance, we re-evaluated the ActiGraph 
GT9X watch data. We were able to monitor activity of all subjects in-clinic, as well as outside of 
the clinic to estimate compliance with the exercise protocol. Using walking step data from in-clinic 
sessions as comparison, in addition to Qualtrics survey daily log input from participants (time start 
and finish completed intervention), we were able to estimate participation in the walking exercise 
portion of the intervention for at-home sessions. We used this data to run a sub-analysis on the 
data. We re-ran the full data analysis on our primary and secondary outcomes for subjects that 














Table 3. Sub-analysis of participants that completed 80% or more sessions per week. Data 
acquisition and analysis – AMP. Experimental design – AMP, BJK, MK, KS.  
 
Consistent with the full analysis, we found that for the primary outcome, there was a 
statistically significant improvement in RMDQ scores between the MedExT and the control group 
(Table 3, t-test, *p=0.0199). Similarly, FMI scores for the MedExT group significantly increased 
from pre to post (Table 3, t-test, *p=0.0427). For the psychological inventories, analysis revealed 
no significant differences from pre to post for the MedExT group for FABQ (Table 1, t-test, 
p>0.02), STAI state (Table 1, t-test, p>0.02) or STAI trait (Table 1, t-test, p>0.02). Similar to our 
full data set, no significant differences were found between groups for QST for the low back or 
non-dominant forearm (Table 1, t-tests, p>0.005). In contrast to the full analysis, for average 
change in low back pain ratings there were no significant differences between groups for intensity 







STAI state  0.3535 
STAI trait 0.3275 
QST Low Back Forearm 
Mechanical Sensitivity 0.7889 0.3609 
Mechanical Pain 0.0262 0.4551 
Constant Heat VAS Intensity 0.2289 0.6966 
Constant Heat VAS Unpleas. 0.0471 0.4153 
Pressure Pain Threshold 0.7198 0.4615 
Constant Pressure VAS Intensity 0.1925 0.4670 
Constant Pressure VAS Unpleas. 0.0652 0.9629 
Average low back pain Intensity Unpleas. 




Exit Survey Data 
At the exit session, all patients were asked to complete a continued patient compliance 
survey that we developed. The results of these outcomes are shown in Figure 9. This survey sought 
to identify the need for pain treatments during the study (Figure 9A), the likelihood of continued 
compliance post-study (Figure 9A), any barriers to continuing the combined treatment (Figure 
9B) and the most beneficial aspect of the intervention between meditation, exercise, or the 
combination (Figure 9C). We found qualitatively that MedExT participants reported a greater 
decrease in pain medication use and seemed fairly likely to continue the intervention. Importantly, 
when MedExT experimental participants were asked to identify the most beneficial aspects of the 
intervention (i.e. meditation, exercise or both) a majority of participants stated that “Both” 















































During my participation in this study, my need 
for pain treatments (perscription medications, 
over the counter medications) decreased.
Now that my study participation is complete, 
I will continue this combined intervention on my 




















































































































































































Figure 9. Continued patient compliance data. Shown below are the qualitative results of each 
outcome. (A) Box plots are shown to represent data. Box represents IQR (bottom line=Q1, 
middle=median, top=Q3. Whiskers represent range of data (min and max). (A) [Median=Q1 for 
MedExT and Control for question 1]. (B) Self-reported barriers to continued treatment are shown 
for the MedExT participants. (C) MedExT participants identified what the most beneficial aspect 
of the intervention was between three choices: Meditation only, Exercise only, or Both combined. 







In the current study, we assessed the effect of a combined intervention of mindfulness 
meditation followed by aerobic walking exercise in chronic low back pain. The main findings of 
this study indicate that meditation and exercise together were able to reduce disability, increase 
mindfulness and decrease self-reported ratings of low back pain. To our knowledge, this specific 
therapy combination has not yet been tested in chronic low back pain patients.  
While the present study took a unique approach to combined mindfulness and aerobic 
exercise, there is a robust literature suggesting that such an approach could work. First and 
foremost, previous studies have tested MBSR (Morone et al., 2009; Esmer et al., 2010; Banth and 
Ardebil, 2015; Schmidt et al., 2015; Cherkin et al., 2016; Morone et al., 2016) and mindfulness 
meditation (Zgierska et al., 2016) alone, as well as aerobic walking exercise programs (Turner et 
al., 1990; Barker et al., 2003; Koldas Dogan et al., 2008; Kell and Asmundson, 2009; Hartvigsen 




Overall, these studies found improved disability, sleep quality, psychological function, depression, 
affective pain perception, fitness, pain severity, and reduced need for pain medications. One 
important aspect of the mindfulness used in the present study was the accessibility of the 
mindfulness. Beyond the introductory 45-minute session with a clinical psychologist, our 
participants were naïve meditators. Nonetheless, using only five short recordings repeatedly, their 
mindfulness increased as assessed by the FMI. Gains seen in this study via the FMI compare to 
more intensive training exercises (Chandran et al., 2019). Although the recordings used here were 
curated for their emphasis on mindfulness, they were not specifically recorded for this intervention. 
We would hypothesize that the development of a mindfulness recording that specifically prepared 
participants for the subsequent exercise could be even more beneficial. The benefits seen here with 
a brief meditation program are consistent with more recent data showing that only 4 days of 
mindfulness-based mental training can reduce pain (Zeidan et al., 2015; Zeidan et al., 2016; Zeidan 
and Vago, 2016). Importantly, these previous studies were done in healthy participants with 
models of acute nociception, while here we are showing gains in mindfulness in a chronic patient 
population.  
 In our previous work, we have elucidated that increasing the frequency component of 
exercise dose to be the most likely to have a positive effect on chronic pain patients (Polaski et al., 
2019a) (Chapter 2, Section 1). We tested these predictions in a trial with multiple doses of 
moderate intensity treadmill walking exercise in healthy subjects (Chapter 3, Section 1). Treadmill 
walking exercise was chosen because it was easy to implement, required little to no training and 
had more precision in controlling dosage. In this study, we found that the moderate dose, or 5x of 
30 minutes/day of this exercise regimen in one week proved to be the most optimal for reducing 




intervention was a good starting dose for reducing pain outcomes. In addition, this prescription 
aligns with that of ACSM’s recommendation for physical activity for healthy individuals which is 
150 MET minutes per week (Garber et al., 2011).  
Although, some subjects reported no change in disability (Figure 3) or scores of “0” on 
the RMDQ post-intervention (Figure 2), we observed a significant difference in post-intervention 
disability between groups. Notably, we did not have criteria for  baseline levels of disability for 
participant inclusion as some studies require (Morone et al., 2016). Morone et al. recruited patients 
that had functional limitations related to their chronic low back pain. This was defined as a score 
of 11 or above on the RMDQ. For the purposes of our study, we chose not to have a defined cutoff 
for disability, in order to recruit a wider sample of patients and also due to the more physical nature 
of our intervention.   
Surprisingly, while MedExT participants rated lower disability along with lower on-going 
pain and lower average pain compared to the start of trial, they failed to show any changes in fear 
avoidance behavior or anxiety. This result is in contrast to data generated from a similar study that 
implemented combined mindfulness and exercise in the context of major depression (Alderman et 
al., 2016). That study found 8 weeks of 60-minute twice a week mental and physical training 
significantly reduced depressive symptoms and ruminative thoughts. It is possible that the lack of 
a significant effect on fear and anxiety in the present study was driven by the lower starting anxiety 
and fear levels in our cohort of participants. We anticipate that the anxiolytic effects of the 
combined intervention may only present itself in the context of higher baseline anxiety and fear 
avoidance behavior or with longer duration studies (i.e. 8 vs 4 weeks).     
 During the trial, participants rated pain before and after each session. Thus, we were able 




potential for acute analgesic effects of the intervention itself. Analysis of day to day pre-
intervention ratings of on-going low back pain revealed significant effects of time and time x 
treatment for intensity (p=0.0144, p=0.0012) and unpleasantness (p=0.0237, p<0.0001), 
respectively. Acutely however, there were no significant changes comparing pre-intervention to 
post-intervention on single days. Taken together, these data are indicative of a time dependent 
effect of the intervention with beneficial outcomes resulting from cumulative repeated treatment 
sessions. Interestingly, the data do not begin to show separation across time between the groups 
until about day 8 for pain intensity ratings and day 10 for pain unpleasantness ratings. This suggests 
that for this specific intervention, sustained analgesic benefit can only be achieved after 8-10 
sessions or about two weeks of effort.   
Our data show significant differences in qualitative ratings of low back pain, but no 
significant effects with QST. Interestingly, we do see trends for decreased ratings of pain 
unpleasantness (p=0.0338) in response to a noxious constant pressure stimulus applied to the low 
back. Although, subjects’ pressure pain threshold was unchanged from baseline, their perception 
of that same pain declined. These paradoxical effects are consistent with that of a previous study 
that tested aerobic treadmill walking exercise on painful QST in healthy participants (Polaski et 
al., 2019b). Similar effects have also been shown in sustained aerobic exercise, where training 
induced increases in pain tolerance, but unaltered pressure pain threshold (Jones et al., 2014). 
Using daily Qualtrics survey monitoring and wrist-worn activity trackers, we were able to 
estimate compliance from participants beyond self-report. Results from a sub-analysis for fully 
compliant patients only (MedExT; n=13, Control; n=20) shows significant improvements in 
disability and an increase in mindfulness for MedExT subjects, which is consistent with our 




estimated to be noncompliant (n=5) still exercised at least 7 days. Overall, this analysis suggests 
that compliance was not a major confound of the reported results.   
Results of our continued compliance survey given during the exit session shows favorable 
outcomes for the combined meditation and exercise intervention. In particular, the finding that a 
majority of MedExT group participants found the most beneficial component of the intervention 
was the combination of the exercise and meditation suggests the potential for synergistic effects 
in this study. The need for pharmacological pain treatments trended to decrease for the MedExT 
group compared to control subjects, which suggests analgesic benefit of a solely 
nonpharmacological source. MedExT participants also indicated that they would be likely to 
continue the combined intervention on their own to manage their back-pain symptoms.  
Strengths and Limitations 
 Notable strengths to this study included a low risk of detection bias through blinding of the 
outcome assessor for QST, and a lack of confounding demographic variables. The average age of 
study participants was 37.6 years, which accurately represents the range of our inclusion criteria 
(18-60). Additionally, after subtracting intervention walking steps, there was no statistical 
difference in average steps per day between control and MedExT subjects. The most significant 
limitation to this study is the lack of all possible study arms. Without exercise-only and meditation-
only groups, the hypothesis of synergy between the individual therapies cannot be specifically 
tested. This study had a higher risk of performance bias due to lack of blinding of participants. 
However, blinding is very difficult due to the nature of the interventions. Also, the order of QST 
assessment was not randomized, which could contribute to additional outcome bias. These tests 
were performed from least invasive to most invasive, to avoid increased sensitization. Patients in 




reported to be more prevalent among women (Hoy et al., 2012). According to our continued 
compliance survey, the most prominently identified barriers to continuing this treatment after 
conclusion of the trial included time and motivation to complete both interventions. Notably, no 
patients reported increased pain with both meditation and exercise. Thus, while we cannot state 
conclusively that there was synergy between the treatments, we can be confident that the therapies 
are not overtly antagonist. Other reported barriers included lack of access to a treadmill or guided 
meditations. Although, it is worth noting that access to additional meditations were provided to 
interested patients following their completion of the trial.  
Clinical Implications 
 The results of this study demonstrate that a combined therapy approach of mindfulness 
meditation followed by moderate intensity treadmill walking provides a significant benefit to 
disability, mindfulness and perception of low back pain. Patients in this treatment group also report 
less need for pain medications, and favorability for the combined approach as opposed to 
meditation or exercise therapy alone. This is the first study testing this treatment combination in 
chronic low back pain patients. Because synergistic benefits could not be definitely determined 
from this trial, future studies must be done to conclude the most efficacious combination of this 
treatment regimen.  Nonetheless, we feel the potential for this combined approach to improve 
outcomes in chronic low back pain is high. As exercise and meditation (as practiced in this study) 
are low cost, easy to implement, and carry few negative side-effects, we are optimistic about the 







MATERIALS AND METHODS  
Participants 
Participants were 52 adults (age 18-60) with chronic low back pain (>6 months) with no 
evidence of neuropathic pain, radicular pain (i.e. sciatica), or referred somatic pain. Participants 
were recruited using in-clinic recruitment to the University of Pittsburgh Department of Physical 
Medicine and Rehabilitation Research Registry (PMR3) and the University of Pittsburgh Clinical 
and Translational Science Institute (CTSI) patient registry, Pitt+Me. Initial pre-screening was 
completed during recruitment to the Pitt+Me database with phone follow-up by AMP Full 
inclusion criteria included 1) a BMI within the normal to overweight range (18.5-29.9), 2) a resting 
heart rate between 60 and 100 bpm, 3) resting blood pressure less than or equal to 140/90mmHg, 
and 4) the ability to independently ambulate community distances without external support (i.e. 
walker, cane). Exclusion criteria included 1) cardiovascular or respiratory disease, 2) neurological 
disease, unrelated to low back pain, 3) diabetes mellitus, Types 1 and 2, 4) diagnosis of chronic 
pain condition unrelated to low back pain, 5) acute pain, 6) regular participation in high intensity 
athletic/sporting activities, 7) sedentary lifestyle, 8) currently pregnant individuals, 9) current 
cigarette smokers, 10) individuals with on-going litigation associated with back pain, 11) regular 
participation in meditation techniques or training in mindfulness-based stress reduction.  
Study Design 
 This study was designed as a randomized single-blinded (for QST testing) controlled trial 
with repeated measures testing the effect of a combined treatment of mindfulness meditation and 
aerobic walking exercise (MedExT) compared to a control intervention. The trial was randomized 
between the two groups using a random sequence generator. MK was responsible for generating 




interventions. QST outcome assessor (BJK) remained blinded to treatment assignment. A power 
analysis indicated that a minimum of 21 subjects/group to be sufficient to detect statistical 
differences in our primary dependent variable, disability measured with the Roland Morris 
Disability Questionnaire (RMDQ) (alpha=0.05, effect size=0.8, power=0.80) using the G-power 
calculator based on previously published work using MBSR and low-back pain. All procedures 
were approved by the Duquesne University Institutional Review Board (Protocol #2017-05-12) 
and written consent was obtained from each participant prior to testing. All methods were 
performed in accordance with the relevant international and local guidelines and regulations for 
human research. This study is registered with ClinialTrials.gov under ID: NCT03324659 
(10/30/2017). Participants were compensated for participation.  
Procedures 
 In-clinic sessions were conducted at Duquesne University’s Exercise Physiology 
Laboratory over the course of the 4-week intervention period between January 2018 to April 2019. 
For participants meeting phone screening criteria, informed consent was obtained and participants 
were enrolled in the study. An initial clinical screening exam was performed by three clinicians 
(EH or two trained Physician Assistants). During this screening (~15 minutes), patients were 
evaluated for strength, lumbar range of motion, reflexes and sensation in relation to their low back 
pain. This screening was done to verify back pain inclusion (e.g. exclude radicular patients) and 
to determine safety of participation in the exercise portion of the intervention. Of 55 patients 
recruited, no patients were excluded during this screening. Following clinical screening patients 
were scheduled to start the actual intervention. The average time between consent and start of trial 
was 26 days. At the start of the full trial (after clinical screen), participants came in for an intake 




oriented to the general study protocol. The intake session consisted of a sequence of quantitative 
sensory tests and baseline assessments of pain (see QST section below). BJK performed all QST 
blinded to the treatment group of the participants and remained blinded to treatment until after the 
final pain assessments were completed. Participants were blinded to treatment assignments for 
baseline intake testing. Following baseline testing, treatment assignments were disclosed to the 
participants. 
Within one week of performing baseline pain assessments (average time between baseline 
and first intervention session = 5 days), participants completed their first in-clinic intervention 
session. At the start of this session, patients received approximately 35-45 minutes of meditation 
or stress training by a clinical psychologist (TS). These sessions discussed either the potential of 
and use of mindfulness and meditation (MedExT group) or general stress management and 
wellbeing for chronic pain (control group). Sessions were standardized by using a script developed 
by TS (see document, Appendix C). Following this session, subjects completed their first 
intervention session, either combined meditation and exercise (MedExT) or the control condition. 
Participants had the option to complete intervention sessions at-home or in-clinic. Interventions 
were performed 5 days per week for 4 weeks. In-clinic intervention sessions were typically 
attended once per week. During these sessions two experimenters were present and did a check-in 
with the participants to ensure that they were not experiencing any difficulty completing the 
assigned intervention. 48 hours after the end of the 4-week period, participants attended the exit 
session, where they again completed surveys and underwent QST. 
Meditation and Exercise Protocol 
For subjects in the MedExT experimental group, guided meditation recordings with a focus 




Brach, 2019). A selection of five different recordings were utilized; each recording was listened 
to one time per week and lasted between 12-17 minutes (see Appendix D for URLs to recordings). 
Recordings were selected by TS along with clinical psychologist Ian C. Edwards for their focus 
on mindfulness and overall length. Participants were given an mp3 player (SanDisk) loaded with 
each of the five meditation recordings to borrow. During the weekly in-clinic session, subjects 
practiced the meditation portion of the intervention session in our interdisciplinary meditation 
room which was a quiet space with low lighting and comfortable seating options. For at-home 
intervention sessions, subjects were encouraged to perform meditation in a quiet comfortable 
setting.  
Immediately following meditation, participants performed 30 minutes of moderate 
intensity walking exercise on a treadmill. Prior to the first exercise session, resting heart rate and 
age was used to calculate a heart rate that corresponded to 50% heart rate reserve (HRR) for each 
participant (Pollock, 1998). We used the 50% HRR estimate as the target heart rate for moderately 
intense exercise with a range of 40-60% HRR calculated for each participant. Heart rate monitors 
(Polar H1) were worn for each in-clinic exercise session to monitor exertion levels. During the 
first in-clinic exercise session, trial coordinator AMP would manipulate the speed and grade of the 
treadmill in order to achieve the calculated heart rate for an individual participant. Average grade 
was 2.4% and speed range was 2.2-3.8 mph. Once reached, this speed and grade combination was 
used as the walking prescription for subsequent exercise sessions for that particular participant. 
Prior to and following exercise, each MedExT experimental intervention participant rated their 
perceived exertion levels using the Borg RPE scale (Borg, 1982). Each exercise session began 
with a 2-minute warm-up at 2.5 mph and concluded with a 2-minute cool-down (total time 30 





 Participants in the control group listened to an audiobook for 12-17 minutes followed by a 
30-minute rest period 5 times per week for 4 weeks. Each session was time-matched to the 
experimental intervention group. Subjects were given an mp3 player with 20 (one for each day) 
recordings of The Natural History and Antiquities of Selborne (White, 1908), which has been 
previously used and validated as a neutral comparison for guided relaxation interventions (Cropley 
et al., 2007; Ussher et al., 2009). During the resting period, participants were free to read, watch 
television, listen to music or other activity that was less than moderate physical effort and not 
stressful.  
Survey Instruments and Administration 
 All surveys were administered using Qualtrics XM Research Core software (Qualtrics, 
2019) either via a tablet for in-clinic sessions or via email for at-home sessions. All subjects 
completed the following questionnaires at baseline and exit: the Roland Morris Disability 
Questionnaire (RMDQ) (Roland and Morris, 1983), the State-Trait Anxiety Inventory (STAI form 
Y) (Speilberger, 1994), and the Fear-Avoidance Beliefs Questionnaire (FABQ) (Waddell et al., 
1993). The AHA/ACSM Pre-participation Screening Form (Balady et al., 1998) and the 
International Physical Activity Questionnaire (IPAQ-short) (Booth, 2000) were also completed at 
baseline to assess eligibility for enrollment. The Freiburg Mindfulness Inventory (FMI) (Walach, 
2006) was administered prior to the mindfulness training session and again at the exit session for 
MedExT experimental intervention subjects.  
Pain was assessed using quantitative sensory testing methods (described below), as well as 
self-report measures of pain using a visual analog scale (VAS) consisting of a 10cm line with the 




intervention, participants received reminder emails with a URL link to the daily VAS survey, on 
which subjects would rate pre and post-intervention VAS pain intensity and unpleasantness. This 
survey was able to capture time stamps of survey progress, allowing for monitoring of protocol 
compliance.  
Throughout the 4-week trial period, participants in both groups wore ActiGraph GT9X 
Link devices in order to monitor physical activity (steps per day). During the exit session, 
participants were also given an exit survey that was used to identify likelihood of continued 
adherence (for MedExT group) and any barriers to this intervention. This survey was qualitatively 
analyzed.  
Quantitative/Qualitative Sensory Testing (QST) 
Done as described in Chapter 3, Section 1. Testing was performed at baseline and post-
intervention following our established protocol (Chapter 1, Section 1) to measure the overall 
change in sensitivity across the entire study.  
Statistical Analysis 
Prior to analysis, an a priori statistical plan was developed (ClinialTrials.gov under ID: 
NCT03324659). Descriptive statistics were calculated using the IBM SPSS Version 25 and 
graphed with either SPSS or GraphPad Prism (Version 6.0). Normality of the data was assessed. 
Nonparametric inferential statistics were used for data that were not normally distributed. For 
analysis of primary and secondary outcomes, we were interested in looking at mean change, 
however the raw data values can be found as a table (see Appendix E). A priori, we determined 
that participants had to complete 80% of the weekly sessions (> 4 of 5 sessions per week) for 





The primary outcome was defined as the comparison of post-intervention RMDQ scores 
between the MedExT and the control groups. A two-sample t-test was used to identify a significant 
difference between groups using p<0.05. This questionnaire was chosen as the primary outcome 
measure because it was recently used in both a pilot study and large-scale assessment of MBSR in 
chronic low back pain patients (Morone et al., 2009; Morone et al., 2016). 
Post-hoc analyses: Analysis of difference score data was done on RMDQ scores for the 
MedExT and control groups. Here, a two-sample t-test was used to identify a significant difference 
between groups using p<0.05. An additional comparison of the full data-set including pre and post 
scores for both groups was performed using a two-way ANOVA. 
Secondary Outcomes 
Five groups of secondary outcomes were measured and analyzed. P values were adjusted 
for each group of analyses based on the number of tests in that group. The first analysis tested 
whether the MedExT group would significantly increase mean scores on the Freiburg Mindfulness 
Inventory as determined by a two-sample t-test (p<0.05). The second explored whether the 
MedExT treatment would significantly influence a mean change in responses on three 
psychological inventories administered: 1) the Fear-Avoidance Beliefs Questionnaire, 2) the STAI 
state anxiety inventory and 3) the STAI state trait anxiety inventory. These were analyzed using 
two-sample t-tests where p<0.02 was considered significant.  
Post-hoc analysis: Analysis of control group comparisons at pre and post-intervention for 
the psychological inventories were done. A two-sample t-test was used where a p<0.02 was 
determined a significant difference. 
The third group of secondary outcomes measured mean response changes in the series of 




and non-dominant forearm. Analyses were grouped separately for tested body site. Significant 
mean pre/post differences between groups were identified using two-sample t-tests. Mann-
Whitney-Rank-sum tests were used for mechanical sensitivity and mechanical pain at each site. 
Given the number of statistical tests (n=7 per body site) required for the QST secondary outcome 
measurements, a corrected p<0.005 was utilized for each body site to determine statistical 
significance.  
Fourth, we assessed current back pain using VAS during each day of the trial. These VAS 
measurements were repeatedly made throughout the study taken at baseline and on each 
intervention day, pre and post-session. These measures were the VAS pain intensity score and the 
VAS pain unpleasantness score. In our original stats plan, a repeated measures MANOVA was to 
be utilized to determine if the vector of timed responses was significantly different between the 
two study groups. Due to missing data from some days, the MANOVA statistical plan was 
modified to using a mixed error-component model during analysis of data. JMP was used to 
perform this analysis. Participants were instructed to evaluate their on-going back pain at the time 
of the measurement. We looked at this in two ways: (1) The overall effect of the 4-week 
intervention on intensity and unpleasantness ratings (each day’s pre-intervention measurement 
minus baseline) and (2) the acute effect of each day’s session on VAS ratings (post-intervention 
VAS minus pre-intervention VAS). 
Fifth, a final secondary outcome assessed “the average” pain that a participant experienced 
using intensity and unpleasantness VAS scales. During the exit session, participants evaluated 
VAS ratings of average low back pain intensity and unpleasantness that they remembered 
experiencing before the start of the study and after the 4 weeks of the intervention period. 




To correct for the number of comparisons, p<0.025 was considered a significant difference 
between groups.  
Demographic Variables 
The following demographic variables were collected and compared between groups to 
further check against potential bias: age, sex, handedness, body mass index (BMI), baseline heart 
rate (HR), baseline blood pressure (BP), baseline IPAQ-short, and mean number of steps taken per 
day over the 4-week intervention period. This was done using two-sample t-tests.   
Post-hoc analysis: A two-sample t-test was also done to compare baseline levels of 
disability (RMDQ) between groups. 
Difference in the proportion of sex and handedness was tested using the Fisher’s Exact test 
where p<0.05 was considered significant. All other continuous variables were tested using two-






















































This dissertation examined the role of exercise dosing and integrative treatments in the 
context of chronic pain with psychological outcomes. Specifically, exercise dosing variables had 
proven to have a significant effect on pain outcomes. Initially, following a preliminary literature 
analysis, a more rigorous meta-analysis was employed to investigate the individual effects and 
probable interaction mechanisms of exercise frequency, time (minutes per week), and duration or 
number of weeks that the intervention lasted. In classifying studies by chronic pain type, neck pain 
studies showed a significant positive correlation with pain effect size indicating studies that lasted 
for longer durations, were likely to induce more pain relief. Multivariate modeling provided us 
with a formula to make testable predictions for exercise prescriptions. Using this model, we were 
able to predict that increasing the frequency of exercise per week, while holding other exercise 
variables constant with the average values of other studies, was the most likely to increase pain 
effect size. Future studies could use this model as a basis for designing exercise trials in the context 
of chronic pain.  
Furthermore, this dissertation tested dose frequency of exercise per week on quantitatively 
measured pain. Although other methods exist for measuring pain such as blood biomarker 
expression (Niculescu et al., 2019), galvanic skin response (Harrison et al., 2006; Jha, 2017) and 
cortisol levels (Tennant, 2013), we employed a protocol of manual tests that we have deemed to 
be reliable and accessible. Additionally, these assessments allowed for self-report and a subjective 
account of each patient’s pain perception. Our results revealed that the moderate dose of exercise 
(exercising 5x per week) was the most optimal to improve pain outcomes in healthy participants. 




physical activity in healthy individuals in order to maintain adequate cardiovascular health (Garber 
et al., 2011). This speaks to the applicability of this recommendation outside the context of 
cardiovascular outcomes. This ‘moderate’ dose served as a safe starting point, to test exercise 
studies in chronic low back pain patients. Future work could incorporate this dose in interventions 
in the context of other chronic pain conditions and in tandem with other non-pharmacological 
therapies.  In developing and implementing exercise programs, it is important to consider the social 
aspects of performing physical activity in a public setting. Although we were unable to find 
significant effects of our anxiety model in our pilot study, the social factors influencing the 
outcomes of exercise are well-known. Careful consideration of individual patient needs is crucial 
to developing the best treatment practices and to promote exercise adherence. 
Finally, the work in chronic low back pain patients elucidated that less extensive 
mindfulness interventions combined with our already established exercise prescription, was 
capable of improving chronic low back pain symptoms. Results of this study showed that patients 
undergoing the MedExT intervention exhibited decreased disability, increased mindfulness and 
improved perceptions of low back pain. Perhaps most importantly, this therapy regime decreased 
the need for pain medications among patients. These results have significant implications in 
managing chronic pain, especially in the case that this treatment may be capable of totally replacing 
pharmacological methods in applicable patients. Although, this combined intervention proved to 
be effective in managing chronic pain symptoms, we were unable to test which aspect of the 
intervention was the most beneficial and if there was an additive effect of the combined treatment. 
Future experiments could test this question by incorporating additional study arms (i.e. meditation 
only and exercise only). Additional future studies could test this combined intervention in the 




 Overall, this body of work highlighted the efficacy of utilizing exercise and mindfulness 
meditation in pain studies.  Hopefully this dissertation can provide a framework for clinical 
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For our preliminary analysis, a literature review was performed using PubMed. Keywords 
included exercise, treatment, therapy, dose, pain. Articles were used to cross-reference original list 
of articles to verify that major articles were not left out of analysis. Relevant reviews and original 
research articles were organized based on treatment modality and chronic pain condition. Chronic 
pain conditions were defined by persistent pain lasting 3 months or longer (Merskey and Bogduk, 
1994). A total of 214 research articles were discovered in the search (Figure 1). Of these studies, 
49 met the following criteria in order to be included in the analysis: (1) means or medians with 
SDs or SEM values for all  pain data must be reported (SEM values were converted to SD), (2) 
measurement of pain must be reported at baseline and post-intervention or percent change values 
must be reported (3) studies must use one or more pain-related outcome measure (e.g. Visual 
analog scale (VAS) and McGill Pain Questionnaire (MPQ)) (4)  all studies were published in 
English, (5) studies were published in peer-reviewed journals. In order to maintain a sufficient 
amount of data for analysis, studies that included control non-exercising control groups (i.e. 
sedentary) groups as well as studies without sedentary control groups were both included. 
Exclusion criteria included the following: (1) studies focusing on non-prescription pedometer-
driven exercise programs were omitted since these studies typically report data on individual 
participants and do not allow for easy between group comparisons, (2) studies that used a combined 
therapy technique, (3) studies that utilized individualized exercise prescriptions, and (4) studies 






Figure 1. Flow chart diagram showing reference screening and study selection. Screening and 
organization – AMP.   
 
Calculation of effect size and statistical analysis. Following study selection, articles were 
systematically organized based on exercise modality and diseases state. For each study, baseline 
and post-intervention means and SD were extracted from each pain-related outcome measure 
reported in the study. Accepted pain-related outcome measures included: Visual Analog Scales 
(VAS) (Price et al., 1983), a numerical ratings scale (NRS) (McCaffery, 1994), McGill Pain 
Questionnaire (MPQ) (Melzack, 1975), Multidimensional Pain Inventory (Kerns et al., 1985), 
Studies identified from database
search (Pubmed), n= 214
Screened by title and abstract,
n=214
Full-text articles assessed for 
eligibility,  n= 147
Studies excluded after screening,
n= 67















Patient Pain Questionnaire (PPQ) (Ferrell et al., 1991a; Ferrell et al., 1991b; Ferrell et al., 1991c), 
Arthritis Impact Measurement Scale 2 (AIMS2) (Guillemin et al., 1997), Western Ontario 
McMaster Osteoarthritis index (WOMAC) (Bellamy et al., 1988), Manniche’s Low Back Pain 
Ratings Scale (Manniche et al., 1994), the Fibromyalgia Impact Questionnaire (FIQ) (Burckhardt 
et al., 1991), the Short Form-36 Health Survey (SF-36) for bodily pain (Ware and Sherbourne, 
1992), pressure pain threshold (McCarthy et al., 1965), the number of trigger points (neck pain; 
(Baldry, 2002)), number of tender points (fibromyalgia; (Wolfe et al., 1990)), and a self-efficacy 
scale for pain (Lorig et al., 1989). These data were used to calculate a percent change (i.e. effect 
size) for each outcome measure ((post-intervention – pre-intervention)/ pre-intervention) x 100). 
The average effect size for all pain-related outcome measures was calculated to produce an “overall 
analgesic effect size” for each study. These data were used to evaluate Pearson’s correlation 
coefficients (PCC) between the dose of exercise and the overall analgesic effect. Because of the 
inherent variability in performing this analysis across multiple outcome measures, we also 
evaluated correlations of exercise dose with effect sizes for the most common single pain outcome 
measure across studies. We have determined that VAS was the most used outcome measure in our 
cohort of studies. The analysis of Pearson’s correlation between VAS effect size and dose of 
exercise was performed for all disease states. 
The dose of exercise was analyzed in three distinct methods. First, dose was defined as 
being the frequency (i.e. number of bouts) at which the exercise was performed within one week 
(FREQUENCY). Second, dose was defined as the total amount of time (minutes) that the exercise 
was being completed per week (TIME). Finally, dose was defined as the duration (weeks) that the 




Overall, studies were compared based on the type of exercise (e.g. walking, aquatic 
exercise, etc). Data were combined across pain condition for each type of pain condition to 
determine whether dosing effects of exercise are generalizable across pain conditions. A distinct 
analysis of exercise dose within each disease state is challenging due to the low number of 
available studies for certain patient populations. Where possible, we evaluated effects within 
specific patient groups whenever at least three studies existed for a given exercise and patient 
population. 
Walking exercise dose versus analgesic effect 
 In the reviewed body of literature, 20 studies with and without controls (see Table 1) 
evaluated walking exercise for a wide array of chronic pain conditions, including fibromyalgia  
(Lemstra and Olszynski, 2005; Holtgrefe et al., 2007; Rooks et al., 2007; Bircan et al., 2008; Kayo 
et al., 2012), low back pain (Ferrell et al., 1997; Machado et al., 2007; Koldas Dogan et al., 2008; 
Hurley et al., 2009; Rasmussen-Barr et al., 2009; Hartvigsen et al., 2010; Shnayderman and Katz-
Leurer, 2013), neck pain (Kang et al., 2015), and osteoarthritis of the knee (Bautch et al., 1997; 
Evcik and Sonel, 2002; Dias et al., 2003; Messier et al., 2004; Miller et al., 2006; Schlenk et al., 
2011). Data from each of these disease states was combined to look at correlations between the 



































































































OA (Knee)  
OA (Knee)  
OA (Knee) 
Low back pain 
OA (Knee)  
OA (Knee) 




supervised walking low 
intensity walking graded 
treadmill walking graded 
treadmill walking graded 
walking 
walking plus weight loss diet 
moderate intensity walking 
treadmill walking supervised 
walking graded          
walking 
supervised low intensity walking 
graded indoor/outdoor walking 
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waste-high warm water exercise 
deep water running 













Gusi, N., et al. (2006). 
Assis, M. R., et al. (2006). 







20 min 1x -21.67 Fibromyalgia qigong Y 12 12 0 Mannerkorpi, K. and M. Arndorw (2004). 
75 min 1x 35.1 Low back pain yoga Y 92 62 30 Sherman, K. J., et al. (2011). 
80 min 2x 24.37 Low back pain tai chi Y 80 63 17 Hall, A. M., et al. (2011). 














comprehensive yoga program 













Stephens, S., et al. (2008). 
Carson, J. W., et al. (2010). 
Wang, C., et al. (2009). 
THERAPY 120 min 2x 43.65 Fibromyalgia tai chi (yang style) N 33 28 5 Wang, C., et al. (2010). 
135 min 1-2x 42.78 Neck pain qigong Y 41 36 5 Rendant, D., et al. (2011). 
160 min 7x 39.99 Neck pain yoga N 25 21 4 Cramer, H., et al. (2013). 
180 min 2x 22.17 Fibromyalgia tai chi (yang style) Y 51 47 4 Jones, K. D., et al. (2012). 











unspecified 1-2x 26.32 Low back pain lumbar strengthening N 128 56 72 Petersen, T., et al. (2002). 
20-40 min 1-2x 36.17 Low back pain low motor control exercise N 35 19 16 Aasa, B., et al. (2015). 
30-45 min 3-6x 57.17 Low back pain McKenzie exercise N 80 41 39 Long, A., et al. (2004). 
30-60 min 1-2x 45.95 Low back pain McKenzie exercise N 132 62 70 Petersen, T., et al. (2002). 
30-60 min 1-2x -41.20 Low back pain motor control exercise N 77 45 32 Costa, L. O., et al. (2009). 
60 min 2x 27.21 Low back pain strengthening exercise N 49 30 19 Mannion, A. F., et al. (2001). 
90 min 2x 25.18 Fibromyalgia moderate weight bearing N 35 35 0 Gavi, M. B., et al. (2014). 
90 min 2x 60.00 Low back pain 
lower body strengthening and 
stabilization 
N 27 12 15 Aure, O. F., et al. (2003). 
105 min 7x 67.80 Low back pain abdominal strengthening N 21 12 9 O'Sullivan, P. B., et al. (1997). 
105 min 7x 46.88 Low back pain graded stabilization N 36 18 18 Rasmussen-Barr, E., et al. (2009). 
EXERCISE 60-120 min 1-2x 48.84 Low back pain high load lifting N 35 20 15 Aasa, B., et al. (2015). 
120 min 3x 58.77 Low back pain lumbar stabilization N 12 7 5 Yoon, J. S., et al. (2013). 
140 min 7x 25.53 Low back pain spinal stabilization N 32 21 11 Mannion, A. F., et al. (2009). 
180 min 3x 24.01 OA (Knee) low intensity weight bearing Y 15 - - Bautch, J. C., et al. (1997). 
180 min 3x 50.12 Fibromyalgia upper and lower body strengthening Y 30 30 0 Kayo, A. H., et al. (2012). 
180 min 3x 64.67 Low back pain stabilization exercise N 15 - - Hosseinifar, M., et al. (2013). 
unspecified 5x 52.00 Low back pain lower body stabilization N 1 1 0 Meziat Filho, N., et al. (2009). 











unspecified 7x 52.97 OA (Knee) 
isometric and isotonic quadriceps 
exercise 
Y 27 18 9 Evcik, D. and B. Sonel (2002). 





Table 1. Characteristics of included studies. M = males, F = females. Screening and data 
compilation – AMP. Experimental design – BJK, AMP. 
 
First, we estimated the correlation between overall analgesic effect and the dose of 
exercise. In the context of this exercise paradigm, FREQUENCY is positively significantly 
correlated with the average analgesic effect for all chronic pain disease states (Figure 2A, PCC 
R2=0.4785, ****p=0.0001). Similarly, TIME is positively significantly correlated with the overall 
analgesic effect (Figure 2B, PCC R2=0.4090, ***p=0.0008). In contrast, DURATION of the 
exercise intervention versus average analgesic effect shows no significant correlation (PCC 
R2=0.04572, p=0.3157). In addition, we did a sub-analysis on the most common pain measure, 
VAS. We evaluated VAS effect size with exercise dose for all disease states. In the case of 
FREQUENCY, VAS effect size is positively correlated (Figure 3A, PCC R2=0.5944, 
**p=0.0090). However, TIME (Figure 3B, PCC R2=0.3290, **p=0.0090) and DURATION of 
exercise (PCC R2=0.3001, p=0.1011; data not shown), show weaker correlations with VAS effect 
size.  
 
Figure 2. Average analgesic effect vs. dose of walking exercise for all disease states. (A) 
Dose=FREQEUNCY of exercise per week, n=25. (B) Dose=TIME exercising per week (min), 
n=24. R2 value represents Pearson’s correlation coefficient. Dotted line represents line of best fit. 
Solid triangles = cLBP, open circles = neck pain, closed circles = fibromyalgia, and open triangles 
= OA patients. Data analysis – AMP. Experimental design – BJK, AMP. 
 











































































Figure 3. VAS effect size vs. dose of walking exercise for all disease states. (A) 
Dose=FREQUENCY of exercise per week, n=10. (B) Dose=TIME exercising per week (min), 
n=10. R2 value represents Pearson’s correlation coefficient. Dotted line represents line of best fit. 
Solid triangles = cLBP, open circles = neck pain, closed circles = fibromyalgia, and open triangles 
= OA patients. Data analysis – AMP. Experimental design – BJK, AMP. 
 
In the context of fibromyalgia pain, published data illustrates positive correlations between 
exercise dose and overall analgesic effect sizes. The FREQUENCY of exercise is positively 
significantly correlated with the average analgesic effect size (Figure 4A, PCC R2=0.7588, 
**p=0.0048). TIME is also positively significantly correlated with the average analgesic effect size 




































































Figure 4. Average analgesic effect vs. dose of walking exercise for fibromyalgia patients. (A) 
Dose=FREQUENCY of exercise per week, n=7. (B) Dose=TIME exercising per week (min), n=7. 
R2 value represents Pearson’s correlation coefficient. Dotted line represents line of best fit. Data 
analysis – AMP. Experimental design – BK, AMP. 
 
Aquatic exercise dose versus analgesic effect 
 In the literature, aquatic exercise is typically applied to patients experiencing widespread 
chronic pain as typified by fibromyalgia (Assis et al., 2006; Gusi et al., 2006; Ide, 2008). This 
analysis included three studies with and without controls all in fibromyalgia patients (see Table 
1). First, data was extracted to evaluate the correlation between the overall analgesic effect and 
dose of aquatic exercise. For aquatic exercise programs, FREQUENCY is positively significantly 
correlated with the average analgesic effect (Figure 5A, PCC R2=0.8965, *p=0.0146). Likewise, 
TIME is positively significantly correlated with the average analgesic effect (Figure 5B, PCC 
R2=0.8965, *p=0.0146). However, DURATION of aquatic exercise versus the average analgesic 




Figure 5. Average analgesic effect vs. dose of aquatic exercise for fibromyalgia patients. (A) 
Dose=FREQUENCY of exercise per week, n=5. (B) Dose=TIME exercising per week (min), n=5. 

















































R2 value represents Pearson’s correlation coefficient. Dotted line represents line of best fit. Data 
analysis – AMP. Experimental design – BK, AMP. 
 
Additionally, VAS effect size correlations with exercise dose were evaluated for aquatic 
exercise interventions. In the case of dose FREQUENCY, VAS effect size is positively 
significantly correlated (Figure 6A, PCC R2=0.9070, *p=0.0124). Comparably, TIME is also 
positively significantly correlated with VAS effect size (Figure 6B, PCC R2=0.9070, *p=0.0124). 
Exercise DURATION additionally shows a positive correlation that is not statistically significant 
(PCC R2=0.5493, p=0.1518). 
 
 
Figure 6. VAS effect size vs. dose of aquatic exercise for fibromyalgia patients. (A) 
Dose=FREQUENCY of exercise per week, n=5. (B) Dose=TIME exercising per week (min), n=5. 
R2 value represents Pearson’s correlation coefficient. Dotted line represents line of best fit. Data 
analysis – AMP. Experimental design – BK, AMP. 
 
Meditative movement exercise versus analgesic effect 
Meditative movement therapies have been proven as an effective treatment option for 
several chronic pain conditions including low back pain (Hall et al., 2011; Sherman et al., 2011; 
Tekur et al., 2012), neck pain (Rendant et al., 2011; Cramer et al., 2013), fibromyalgia (Stephens 
et al., 2008; Carson et al., 2010; Wang et al., 2010; Jones et al., 2012), and osteoarthritis of the 















































knee (Wang et al., 2009). 12 studies with and without controls were evaluated (see Table 1). 
Meditative movement therapies evaluated in this analysis included yoga, qigong, and tai chi. Since 
these exercises are similar in methodology and a limited number of studies were found for each 
therapy type, all modalities were combined to have a sufficient n for analysis. Two studies using 
qigong exercise were found to be ineffective in reducing pain and disease symptomology, but were 
nonetheless included in the analysis (Mannerkorpi and Arndorw, 2004; von Trott et al., 2009) (see 
Table 1). 
For meditative movement therapies, FREQUENCY and TIME are positively significantly 
correlated with the average analgesic effect and are statistically significant (Figure 7A, PCC 
R2=0.2600, *p=0.0306) and (Figure 7B, PCC R2=0.4097, **p=0.0056). DURATION versus 
analgesic effect has a weaker positive correlation that is not statistically significant (PCC 
R2=0.1106, p=0.1774). VAS effect size correlations with exercise dose were also evaluated. In this 
analysis, FREQUENCY and DURATION have weaker positive correlations that are not statistically 
significant (PCC R2=0.1902, p=0.1190)  and (PCC R2=0.1787, p=0.1321). However, TIME is 


















Figure 7. Average analgesic effect vs. dose of meditation movement exercise for all disease 
states. (A) Dose=FREQUENCY of exercise per week, n=18. (B) Dose=TIME exercising per week 
(min), n=17. R2 value represents Pearson’s correlation coefficient. Dotted line represents line of 











Figure 8. VAS effect size vs. dose (TIME) of meditation movement exercise for all disease 
states. Dose=TIME exercising per week (min), n=13. R2 value represents Pearson’s correlation 
















































































Strengthening exercise versus analgesic effect 
 Interventions focused on muscle strengthening and stabilization and effective in several 
chronic pain conditions including fibromyalgia (Valkeinen et al., 2008; Hooten et al., 2012; Kayo 
et al., 2012; Gavi et al., 2014), knee osteoarthritis (Bautch et al., 1997; Evcik and Sonel, 2002), 
low back pain (O'Sullivan et al., 1997; Mannion et al., 2001; Petersen et al., 2002; Aure et al., 
2003; Long et al., 2004; Ferreira et al., 2007; Mannion et al., 2009; Meziat Filho et al., 2009; 
Rasmussen-Barr et al., 2009; Hosseinifar et al., 2013; Yoon et al., 2013; Aasa et al., 2015; 
Tomanova et al., 2015), and neck pain (Ylinen et al., 2006; Beltran-Alacreu et al., 2015; Kang et 
al., 2015). Twenty effective exercise treatments were evaluated (see Table 1). A motor control 
exercise to treat chronic low back pain (Costa et al., 2009) was found to be ineffective in reducing 
symptoms of pain but was still included in the analysis (see Table 1). 
 For strengthening exercises, FREQUENCY and TIME are positively correlated with the 
average analgesic effect and are close to statistical significance (FREQUENCY; PCC R2=0.2169, 
p=0.0595) (TIME PCC R2=0.2622, p=0.0612). DURATION was also positively correlated with the 
average analgesic effect, but was not statistically significant (PCC R2=0.1350, p=0.0846) 
Additionally, VAS effect size correlations with exercise dose were evaluated. Significant positive 
correlations were shown with VAS effect size with respect to exercise FREQUENCY (Figure 9A, 
PCC R2=0.2712, *p=0.0466) and TIME (Figure 9B, PCC R2=0.4430, *p=0.0130;). However, 
DURATION had a weak positive correlation with VAS effect size that was not statistically 





Figure 9. VAS effect size vs. dose of strengthening exercise for all disease states. (A) 
Dose=FREQUENCY of exercise per week, n=15. (B) Dose=TIME exercising per week (min), 
n=13. R2 value represents Pearson’s correlation coefficient. Dotted line represents line of best fit. 
Data analysis – AMP. Experimental design – BK, AMP. 
 
 
Other/ungrouped therapies  
There were several other studies discovered in the literature search that were not used in 
the above analysis, but were still found to be effective in reducing pain symptoms. Exclusion 
criteria included studies that utilized a combined therapy technique, individualized exercise 
prescriptions, or particular therapy modalities that had too few studies to group for analysis.  Such 
treatments included multimodal or combined exercise therapies (Andreasen et al., 2013; Kim et 
al., 2013; Makino et al., 2014; Sevier and Stegink-Jansen, 2015; Monticone et al., 2016; Ogston et 
al., 2016), aerobic exercise programs (Mannion et al., 2001; Stephens et al., 2008; Hooten et al., 
2012; Sanudo et al., 2012; Beltran-Carrillo et al., 2013), pedometer-driven programs (Talbot et al., 
2003; Brosseau et al., 2012; Hiyama et al., 2012; McDonough et al., 2013), and an individualized 
exercise prescription (Kaleth et al., 2013); used to treat a wide scope of conditions including 
chronic neck pain, fibromyalgia, later elbow tendinopathy, foot pain, craniocervical pain, knee 
osteoarthritis and low back pain.  














































As described above, we have correlated the percent benefit or analgesic effect seen in 
patients with the prescribed dose to address this clinically-relevant question. Overall, across 
different types of exercise, we find that the amount of time that a patient exercises per week (TIME) 
and the number of times a patient exercise per week (FREQUENCY) are positively correlated with 
analgesic effect across pain conditions. Interestingly, we failed to find many statistically 
significant correlations between the duration of the exercise prescription and the benefit to the 
chronic pain patient. This is surprising because we do find this significance in the results of our 
full meta-analysis (see Chapter 2, Section 1). 
The best dose correlation with respect to analgesia was found in aquatic exercises. This 
exercise paradigm was used to treat fibromyalgia pain only. Here, the strongest correlations were 
found between frequency of exercise per week and VAS effect size as well as, time (minutes) 
exercising per week and VAS effect size both of which were statistically significant. Likewise, 
aquatic exercise had strong correlations with both time and frequency and average analgesic effect. 
One caveat to this analysis was the small cohort of studies used for this correlation. Walking 
exercise also showed good statistically significant correlations with strong effect sizes in with 
respect to exercise frequency and time spent exercising per week; the strongest correlation being 
between frequency of exercise per week and VAS effect size. 
On the other hand, the weakest effects were seen in meditative movement therapies. For 
these analyses, different modes of therapy (i.e. yoga, tai chi and qigong) were combined to 
collectively represent meditative movement therapies. This was done in order to have a sufficient 
amount of studies for analysis. However, likely because of the inherent variability between these 
interventions, there are weaker correlations between dose of exercise and effect size. Likewise, 
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strengthening exercises also have shown weak effects. Similar to meditative movement therapies, 
this group of exercises combined all strengthening and stabilization exercise protocols into one 
collective group. It is possible that this variability amongst specific exercise programs can be 
attributed to the weak correlations with dose and effect size. 
Overall, strong statistically significant correlations were found in respect to most exercise 
paradigms with that of frequency of exercise and time spent exercising per week showing the 
strongest link with effect sizes. This connection was not seen with respect to the duration of the 
exercise intervention. In all exercise paradigms, we see weaker positive trends for duration of the 
intervention with effect sizes. This is important to consider when developing and prescribing 
exercise programs to patients. These findings suggest that decreasing time spent sedentary may 
also prove to be beneficial as increased sedentary behavior has been previously reported to 
compromise metabolic health (Owen et al., 2010). Although duration of the exercise intervention 
may still be relevant to long-term outcomes for chronic pain patients, these preliminary results 
indicate that this aspect of the exercise dose is less critical to developing acutely effective treatment 
plans. 
 In addition to evaluating the average analgesic effect for each study, we separately 
evaluated just the VAS effect size as this is the most common method to evaluate pain. In most 
cases, there were no large differences between correlations of dose with overall analgesic effect 
vs. correlations with VAS effect size. Correlations from these two analyses were similar in the 
context of time and frequency of exercise dose for walking and aquatic exercise, all contexts of 
dose for meditative movement therapies, and most aspects of dose for strengthening exercises. 
Correlations from these two analyses were dissimilar in the context of walking duration, aquatic 
exercise duration and strengthening exercise time per week. Major differences were noted in the 
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statistical significance of such correlations. This was likely a result of smaller or larger cohorts of 
studies respective to particular analyses. We completed these two separate analyses to account for 
the variability that existed amongst pain outcome measures. Because there were no major 
differences between the two analyses, this is indicative of a few things: (1) the VAS effect size 
was not solely driving the effects we have seen in respect to average analgesic effect and, (2) VAS 
is likely a reliable pain outcome measure that should be considered for all studies to assess pain. 
 The disease states that were the focus of most studies identified with the most varied 
exercises were overwhelmingly fibromyalgia and low back pain. Fibromyalgia was found to have 
the most variety in treatment plan options. Effective therapies were found across all major 
modalities analyzed including walking, aquatic, meditative movement therapies, strengthening 
exercise as well as other types of aerobic exercise not included in the meta-analysis. Also of note, 
low back pain therapies were found to be focused primarily on strengthening and stabilization 
exercises of the muscles of the back.  
 Although we have seen positive associations with exercise dose and therapeutic benefits, 
there were a few studies that show negative or low effect sizes (Mannerkorpi and Arndorw, 2004; 
Costa et al., 2009; von Trott et al., 2009). One study that tested motor control strengthening 
exercises to treat low back pain found short term improvements in activity, but no improvements 
in pain (Costa et al., 2009). In our analysis this study was reported to have an overall negative 
analgesic effect of -41.2%. Other studies which looked at qigong as a meditative movement 
therapy were reported to have low and negative effect sizes (Mannerkorpi and Arndorw, 2004; 
von Trott et al., 2009). Possible explanations for these results could be that, (1) these studies are 
incorporating a dose of exercise that is too low to provide analgesia (2) the specific mode of 
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therapy may be an ineffective treatment method, or (3) inadequate pain outcome measures were 
used.  
With the exceptions of the studies just discussed, most of the studies identified for this 
review do show positive benefits of exercise on pain outcomes. There are two reasons for this. 
First, it is possible that null or harmful results for exercise-based therapy are not published with 
the same frequency as positive outcomes (Fanelli, 2011). Second, exercise of any type may 
typically be beneficial. However, even in the context where the exercise is beneficial, the lack of 
dosing knowledge may mean that we are subjecting patients to unnecessarily high levels of 
exercise or missing the opportunity for additional therapeutic benefit.  The lack of dosing data 
within single studies may also lead to reduced patient compliance if patients are prescribed a less-
than-efficacious exercise therapy (Jack et al., 2010). We hypothesize that, with special 
consideration for those persons with musculoskeletal pain, beginning exercise therapy at a lower 
intensity and subsequently increasing physical activity as tolerated may be the most beneficial. 
Although we see significant correlations showing that higher doses of exercise provide greater 
pain relief, starting chronic pain patients at these higher doses, who are not accustomed to 
exercising at a high level, may actually increase pain and subsequently decrease adherence rates. 
The low and slow approach to therapy may permit patients to be more liable to adhere to exercise 
protocols. In addition, patients that were previously sedentary may be more likely to be active 
thereby reducing the chance that too much exercise could be harmful.  
While our analysis does provide valuable data regarding exercise dosing in chronic pain, 
this preliminary meta-analysis has drawbacks. Studies included here were carried out at different 
institutions using multiple enrollment and monitoring methods. Some studies used survey and 
VAS analysis of pain while others employed quantitative sensory testing to evaluate benefits in 
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the paradigm. A number of the studies selected included “no-therapy” control groups while others 
employed simple pre-post analysis of a therapy for the experimental group. Nonetheless, our 
findings of positive correlations of exercise dose with pain relief do suggest that exercise, similar 
to pharmacologic approaches, shows evidence of dose-dependent effects that may be complicated 
by patient demographics, type of pain condition, and other factors. We argue that systematic 
studies of different exercise doses in specific pain conditions are valuable to the entire research 
and medical community.  As this was a preliminary review, it was lower methodological quality 
including inconsistent assessment points and a lack of risk of bias assessment, but the preliminary 
results did suggest to us that this research question had merit. We explored the question further 
using a human studies experimental approach (see Chapter 3, Section 1 and Chapter 2, Section 2) 
and by completing a rigorous meta-analysis of the literature with modeling and a full risk of bias 
























Appendix B. Raw data values of participants’ baseline and post-intervention measures for the 














































Constant Pressure VAS 
Post-intervention  
Constant Pressure VAS 







0.7 1.5 1.8 1.8 
1.3 3.4 2.9 4.8 
3.1 1.4 2.2 3.2 
1.2 2.1 2.6 4.2 
5.9 5.4 4.8 3.1 
1.6 3.7 3.0 4.3 
2.2 1.1 2.5 2.0 
0.9 3.2 1.1 1.9 
2.6 4.9 5.1 5.7 









1.6 3.4 2.2 4.0 
2.6 3.3 4.0 4.2 
2.9 1.9 5.4 4.2 
3.3 5.0 2.9 3.6 
6.9 5.9 4.5 3.5 
0.8 0.7 0.4 0.3 
2.7 3.6 3.4 4.0 
3.5 3.0 1.2 2.3 
7.6 7.1 2.2 2.4 












0.9 0.5 0.2 0.1 
2.8 2.5 1.6 1.1 
4.3 5.3 0.4 0.5 
0.8 2.1 0.6 0.6 
3.5 4.4 1.5 1.8 
2.4 4.4 1.1 2.7 
2.3 2.5 1.1 1.1 
2.7 4.5 2.0 4.0 
2.0 1.0 1.0 0.3 









2.0 3.4 0.3 0.5 
3.9 4.2 2.0 1.6 
3.2 4.0 0.9 0.9 
0.4 1.5 0.9 0.9 
5.6 4.3 0.7 0.5 
1.8 1.6 0.1 0.1 
1.9 1.4 0.1 0.7 
1.5 1.8 3.1 3.0 
3.8 6.7 2.0 2.9 
1.7 1.9 1.2 1.0 
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Appendix C. Psychological Consultation Intake Script curated by Thomas J. Smith, Ph.D. (See 
Chapter 2, Section 2). 
 
Mindfulness Intake Script 
Thomas J. Smith, Ph.D. 
Introduction 
 Introduce myself professionally and my role. 
 Recap participant’s experience so far with having completed consents and pain testing.  Acknowledge 
participant is in the meditation plus exercise group. 
 Inform him or her that I am conducting a thirty to forty-five minute intake on mindfulness meditation, 
and that mindfulness is part of meditation on which I will focus.  Inform that I will be talking about 
mindfulness in general to provide information if they want to continue practice after study but that I 
am aware of specifics of the practice in the study: meditating five days per week using audio before 
exercising.  Share that I had listened to meditations they will use in the study. 
 Ask where he or she is going meditate before exercise: car, gym, campus.  Ask if he or she has ever 
practiced meditation before. 
 Remind participant that the audio will be walking them through the meditation and that the 
information I am providing gives background details that does not need to be memorized but is just to 
provide context. 
Mindfulness & Its Impact 
 Mindfulness is a form of bodymind training. 
 Mindfulness has been demonstrated to: reduce stress; increase feelings of calm, relaxation, and 
harmony; decrease feelings of anxiety and depression; reduce the discomfort of pain; lower blood 
pressure; increase learning capacity, IQ, and creativity; awaken higher states of consciousness.   It’s 
like a steroid for human activities in general, from the ordinary mundane to the enlightened spiritual.  
 This power practice goes back at least 2,500 years, and humanity has continued to use it that long 
simply it because it works. 
 Most Western media reports about mindfulness have indeed followed one similar to that used in a 
2014 cover story by Time magazine. Here they focused on the voluminous amount of scientific 
evidence showing the many positive benefits of mindfulness in virtually all areas of human life, and 
emphasizing that it is particularly recommended in today’s crazy hustle-and-bustle world, with 
technological distractions making it harder and harder to focus clearly on almost anything.  
 
 
Basics & Details  
 And what is the practice, exactly? Well, essentially, all you do is sit in a comfortable position, relax 
the mind, and then bring attention to bear on the present moment, whatever is arising. 
 Here are some basic elements of the practice of mindfulness that will be covered in detail, and then I 
will pull them all together at the end. 
Time   
 First, find a time to deliberately devote to mindfulness meditation.  In this experience, you will need 
around fifteen minutes, ranging from twelve to seventeen minutes.  Some of the times will be dictated 
by when you are scheduled to come here.   
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 However, beyond that, chose a time that will be easiest for you to devote to mindfulness practice.  A 
lot of people like practicing first thing in the morning to start the day off, while some other people like 
to practice at the end of the night to find calm before going to bed.  People also just find a time of day 
where they can fit the practice in, like lunch.   
 Practice can thus be planned at a particular time, or can be fit it in each day.  The main point is to 
make time for mindfulness practice five days a week. 
Place 
 Next, find a place to meditate.  Again, the place will already be established when you come here.   
 At home, when you first start practicing, practice inside rather than outside and practice away from 
other people who are not meditating.  The main issue is to avoid things that may distract you when 
you are beginning to develop basic mindfulness skills. 
Posture 
 To begin meditating, you’ll want to make yourself comfortable. Wear loose, comfortable clothing, 
making sure there is no tightness.   
 You can choose to sit on the floor.  Experienced practitioners use a lotus or half-lotus posture that you 
see depicted in the media, while others use the perfect position, all of which are standards in yoga 
practice.  For this practice, you can just sit on the floor with your legs crossed.  If you would prefer, 
you may rest your back against the wall, while maintaining an upright posture. If your back begins to 
hurt, you may change positions. Sometimes a meditation bench is used that helps you to kneel in an 
upright posture.  If sitting or kneeling is not available at this time, it is acceptable to meditate sitting in a 
comfortable chair or even lying down.  You should never force yourself to meditate in a certain 
position that is chronically painful.   
 You can then rest your hands in your lap or thighs, or even place your hands palms up, one one top of 
the other, and rest them in your lap.   
 You may be instructed to relax different parts of your body at the beginning of a sitting.  You are 
scanning your body systematically and then attempting to relax to dissipate any tension.  In addition, 
guided imagery may be used and you may be instructed to imagine an image, such as a ‘smile in your 
heart,’ which further serves to help you relax and be open.  
 The important thing is to sit a position in which you are both upright and relaxed.  Sitting upright will 
facilitate the focus on breathing and the relaxed posture will help to not overstrain the body.  The 
dynamic between opposites, sitting upright yet relaxed when practicing, is a key component of 
mindfulness since the practice combines aspects that appear to be opposite to the mind but can be 
integrated. 
Breathing 
 Usually, you will be to close your eyes, which is preferable to begin with, but practicing with your 
eyes open is okay if closing your eyes is too anxiety provoking.  
 You will also be instructed to pay attention to one particular item at a time-your breathing is by far 
the most common.  The idea here is to be aware of your breath as you breathe in, then notice the 
pause, then pay attention to the breathing out, the pause, the following in-breath, and so on.  The 
breath thereby serves as an anchor to ground attention and to having something to bring attention 
back to.   
 
 210 
 Pick a spot where you can easiest perceive the act of breathing.  You may chose a point on the 
nostrils where you feel the cool air enter your nose, or chose a place around the throat or chest where 
you can sense the air moving into the lungs.  You may also pick to focus on the rising and falling of the 
stomach as the diaphragm expands and contracts.   
 At times, you may be instructed to count your breath up to five or ten, and then start over again.  At 
other times, you may be instructed to repeat phrases such as ‘calm’ on the in breath and ‘ease’ on the 
out breath.  Such notation and phrases are in the background like a whisper with your breath in the 
foreground.   
  If you lose track of attending to your breathing-if you find yourself thinking of the past or future, or 
your current life (something annoying at works last week, or an exciting event happening tomorrow, or 
difficulties in your present relationship), just gently drop those thoughts and return to following the 
breath.  
 Then simply rest with attention focusing on the breath and now moment, and with calm clarity, 
notice whatever is happening, both inwardly and outwardly.  These are the two parts of mindfulness, 
first mindfully attending to the breath and then also mindfully attending to your inward and 
outward experience. 
 
First Part: Coming Back 
 With regard to the first part, you are being instructed to come back to yourself.  Mindfully attending to 
the breath anchors the scattered mind.  However, once attention is focused on the breath, the mind 
will inevitably get drawn to other thing and you will start attending to your thoughts, feelings, bodily 
sensations, and outward perceptions.  This is inevitable.  You may start thinking that you are not 
doing it right, start thinking about the future and what you need to do after meditation, or start thinking 
about something that occurred earlier in the day or sometime in the past.  You may start feeling bored 
just sitting here or start feeling anxious about not doing something.  Your attention also may be drawn 
to a bodily sensation or pain.  You may hear something in another room or may even start to smell 
something in the room you are in, thereby drawing your attention to outward perceptions.   
 This is inevitable.  You will mindfully focus on the breath and your attention will wonder elsewhere.  
Thus, this change is not a sign that you are failing but is actually the place where mindfulness begins.  
Mindfulness is about mindfully focusing on the breath, mindfully attending to inward and outward 
experiences, noticing the change in focus, and bringing the attention back to the breath.  The key here 
is how to bring attention back to the breath. 
 Typically a person tends to be hard on him or herself when developing a new skill.  Thus, when a 
person notices they have lost focus, he or she may bring focus back to the breath in a harsh way like a 
strict teacher or coach.  There may even be the tendency to get upset at yourself for loosing focus.  
However, the practice of encourages initially bringing focus back to the breath in a kind and non-
judgmental way.  You may even want approach your mind like you are working with a riley puppy. 
Heartfulness   
 Although the practice is called mindfulness, which highlights the facet of attending in an intentional 
way, the practice could easily be described as heartfulness, which highlights approaching yourself in 
a non-judgmental and compassionate way.  One instruction you may be given when you find your 
mind wondering from the breath is to name the experience.  You may name the experience generally 
such as ‘thinking,’ ‘feeling,’ ‘sensing,’ or perceiving.’  You may also name the experience more 
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specifically such as ‘judging,’ ‘anxious,’ ‘pain,’ or ‘noise.’  Again, the internal naming of experience 
is recommended to occur in a kind and non-judgmental way.  The internal naming also serves to help 
us recognize the change in focus and the experience.  However, it occurs as a background whisper to 
help us adjust attention to the present moment and to the breath, and not as an occasion to analyze 
our thoughts, feelings, sensations, and perceptions. 
 
Second Part: Being Here 
 After the first phase of mindfulness practice that entails coming back to yourself through mindfully 
focusing on the breath, you will then be able to access the second moment that entails you being there 
with your experiences in a mindful way.  The first part of coming back helps you to adjust from a 
mode of doing both in action and in thought to a mode of being.  You feel more centered and focused.  
In this phase, you can start to attend to thoughts, feelings, bodily sensations, and perceptions that 
are calling for your attention.  Since your mind is not as scattered, you can be more mindful of what 
you are experiencing.  Maybe you notice that you are feeing sad, and can mindfully experience how 
exactly sadness feels.   
 Usually when we encounter internal pain, be it the emotional pain or physical pain, it is experienced 
as aversive.  We may try to escape by thinking about it or distracting our attention to something else 
externally.  When pain is accompanied by resistance, this typically contributes to suffering.  The 
internal pain emotional or physical is just pain, but when we try to resist it we begin to suffer. 
 In this phase, you are starting to recognize your experience you may also start to accept it.  Again, you 
are practicing both mindfulness and heartfulness.  When you mindfully attend to your breath and 
then to your experience, you start to experience more spaciousness and at times more compassion. 
Pain & Resistance  
 In particular, bodily sensations such as pain may draw your attention away.  When you experience 
such pain, you may mindfully attend to what the experience is like.  Is the pain sharp or dull?  Is the 
pain consistent or pulsing?  Is the pain concentrated or diffuse?  What you may find is that the pain 
itself is not experienced like a thing but intensifies and lessens and also has less solidity.   
 You may find it helpful to ‘breath in’ to your pain, imagining your breath coming in and down from 
your lungs into that part of your body.  You may also find it helpful to ‘breath with’ your pain, 
creating a sort of spaciousness that surrounds your pain and compassion as you approach your pain. 
Attachment & Striving 
 In addition to helping us approach aversive experiences, mindfulness helps us to attend to experiences 
to which we become attached.  We usually become attached to pleasant internal states that feel good.  
These states may be associated with something external that is not good for us, possibly even 
something that is addictive.  You can start to become mindful of urges to pursue such activities.  
Mindfulness practice helps you to develop a space to respond to such urges rather than to simply 
react and pursue them. 
 We may also become attached to pleasant internal states experienced when practicing mindfulness 
such as feeling calm or happy.  This attachment can become part of an overall project of striving.   
 Thus, in the early stages of your meditations practice, it is important to know that this is not something 
you can measure in terms of success or failure. Meditation is a process, a journey. Do not try to calm 
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the mind, or stop all thoughts. Be kind to yourself and do not try to force yourself to be mindful. 
Meditation is about acceptance and letting go. 
Expanding Practice 
 The practice starts in these actual sitting sessions.  However, they can extend to other areas of life. 
 You may experience fear of movement or exercise associated lower back pain.  By listening to 
meditation audio before exercise, you are also bring mindfulness to that fear and seeing what you can 
do.                
 The practice is encouraged to be used when exercising, although it will be a modification.  When 
exercising, you be by grounding yourself in the in-flow and out-flow of your breathing.  You can then 
mindfully attend to your body in motion.   
 You may become mindfully aware of your bodily limitations.  The key is to approach these 
limitations without overstepping them.  You are listening to your body to inform you what you can 
do without presuming that you cannot do this or that exercise.  You are also listening to your body to 
inform you what you cannot do and not ignoring these signs. 
 Exercise is just one domain in which you can become mindfully aware in your life.  You are 
encouraged to pause and start to bring mindful awareness to many facets of your life, one at a time.  
You can commit to mindfully eating a meal each day mindfully, or mindfully completing one specific 
activity each day. You can also insert five minute mindfulness practices during the day, perhaps 
being mindful of your breathing and body when you wake up, before you go to bed, or at different 
parts of the day when you are transitioning or need to pause. 
 Ultimately the practice of mindfulness starts in your dedicated sitting sessions but will extend to 
practicing mindfulness throughout the day and throughout your life. 
Review 
 In review, when considering mindfulness as practices, you are developing two interrelated skills: 
mindfulness and heartfullness.  In terms of mindfulness, you are developing meta-cognition which is 
the ability to focus in an intentional and mindful way on your experiences.  Meta-cognition is an 
awareness developed through mindfulness practices that is aware of experience but not dispersed in 
that experience.  People feel they are not as lost in their thoughts or caught up with their feelings, and 
have some space from which to attend to themselves, and also respond rather than react.  In terms of 
heartfulness, you are developing compassion which is the ability to approach your experiences even 
the most difficult ones in a kind and non-judgmental way.  
 In pull the elements of practice together succinctly, you will devote a time and space to practice daily.  
Remember to dress comfortably and sit in a way that is both upright and relaxed.  Start the practice 
by coming back to yourself and mindfully focusing on your breath, going in and out at the present 
moment.  Then when you mind wonders, non-judgmentally bring your focus back to your breath, 
perhaps naming the experience to help you recognize it and refocus.  Once you have adjusted from a 
doing to being mode, you can bring that mindful awareness to any thoughts, feelings, bodily 
sensation, or perceptions you have, always bringing your attention back to the breath if you get lost.  
You are attending to your experiences both mindfully and heartfully. 
Conclusion 
 Sounds simple, doesn’t it? In a sense, it is, quite simple. Until you try it. Then you’ll notice just how 
unhelpful your mind actually is in this task, and how essentially little control you actually have over 
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your own thoughts. You will find that you lose track of the breath constantly; wild thoughts and 
images will flood your awareness; sometimes powerful and unpleasant feelings will overwhelm you; 
at other times incredibly positive, even blissful, feelings will cascade through you.  
 You will start to realize how little of your own mind, your own interiors, you have actually been 
aware of. It will start to dawn on you powerfully that if thoughts are what guide behavior, then these 
jumbled, erratic thoughts that are your standard condition right now are leading to jumbled, erratic, 
problematic behavior. Virtually every area of your life is being lived with much less success, 
coherence, quality, harmony, achievement, caring, and excellence than you could possess. And 
that’s every area-because this jumbled, erratic “monkey mind” is with you in virtually every area, 
underlying and driving behavior.  
 In the areas that you can indeed already manage to focus clearly, coherently, and freely-often in what 
are called flow states. These flow states of coherence allow you to do whatever you’re doing in the 
very best way that you could possibly do them (and hence, usually quite successfully)-whether at 
work, or in relationships, or raising kids, or simple relaxing. Well, mindfulness meditation is a way 
to make your entire life of a flow state.  Mindfulness practice may occur at a specific time and place, 




Wellbeing Intake Script 
Thomas J. Smith, Ph.D. 
Introduction 
 Introduce myself professionally and my role. 
 Recap participant’s experience so far with having completed consents and pain testing.  Acknowledge 
participant is in the audio book group, and that I am aware that participation consists of listening to 
the audio book on birds. 
 Share that since the participant is not engaging in a specific activity in the study with regards to pain 
management that this intake will not cover any activity in particular.  However, the collaborators 
wanted to provide the participant something else in this intake that may be helpful. 
 Inform him or her that I am conducting a thirty to forty-five minute intake on the relationship between 
chronic pain and stress, and different stress management and wellbeing practices.  Inform that I will 
be talking about wellbeing in general to provide information if they ever want to engage in such 
practices. 
 Acknowledge that the participant may have tried some practices to manage stress and pain, and may 
have had a greater or lesser success with these practices.  
Stress Impacts Pain & Types of Stresses 
 A person’s experiences of stress contribute to the intensification of chronic pain.  Stress also impact a 
person’s sense of wellbeing.  When considering experiences of stress, both internal stresses and 
external stressors need to be considered.   
 Some types of internal stresses include physical health issues such as irritable bowel syndrome, 
vertigo, etc.  Internal stress also includes mental health issues such as anxious and depressed moods.  




Pain Impacts Stress & Facets of Mutual Impact 
 Chronic pain in turn does not exist in isolation.  It is experienced by a person within his or her life.  
The chronic pain impacts the person’s life.  In turn, the person’s life impacts the chronic pain.   
 There are different facets of a person to consider when thinking about the relationship between 
chronic pain and stress.  Such facets to consider are the body, emotions, thoughts, behaviors, work, 
and relationships. 
 These different facets are impacted by chronic pain.  They can also serve to increase experiences of 
stress, and can thereby intensify the experience of chronic pain.  Thus, each facet separately and 
together can create loops that sustain the experience of stress and chronic pain.  On the other hand, 
they can cultivate the better management of stress and pain, and enhance an overall sense of 
wellbeing. 
Body 
 The body is the most logical place to begin as chronic pain is a physical sensation.  Chronic pain is 
stressful to endure.  In turn stress can intensify chronic pain.  Chronic pain does not only occur in 
isolation.  It can be accompanied by other physical pains ranging from gastrointestinal issues to 
headaches.  These other physical pains can further add to a person’s overall stress level. 
Emotions 
 Emotions are the next most important thing to consider since physical pain is connected to emotional 
suffering.  Distressful emotions such as experiences of anxious, angry, and/or depressed moods can 
add to a person’s stress level.   
 Further, distressful emotions follow pathways that serve to worsen a person’s experience of pain.  
Emotions such as anxiety and anger can arouse the body’s flight, flight, freeze mechanism.  The 
emotions are preparing the body for action.  Such a state of emotional activation is accompanied by a 
bodily state of activation consisting of tension as a person prepares to fight or flee.  The tensing of the 
body, including the part of the body in pain can add to already existing chronic pain. 
 Emotions such as sadness and depression can intensify the perception of physical pain, perceiving 
aches and pains more acutely.  The pain then in turn can contribute to further stress and distressful 
emotions. 
Thoughts 
 Negative thoughts are significant to consider as a person in chronic pain tends to think a lot about the 
pain and as negative thoughts serve to sustain emotions and stress levels. 
 A person may think what if the pain last forever or what if the pain obstructs my work and/or my 
relationships, sustaining feelings of anxiety.  A person may also think that enduring chronic pain is 
unfair and think that other people have life easier, sustaining feelings of anger.  A person may finally 
think that pain will never cease and think that there is nothing that can be done to feel better, 
sustaining feelings of depression.  
 As mention already, these distressful emotion are sustained by thought patterns.  They can contribute 
to and intensify experiences of chronic pain.  Greater experiences of pain can in turn serve as evidence 
that support negative thought patterns.  A person may then think that there is proof that the pain will 




 Behaviors and habits need to be addressed since a person with chronic pain may engage in behaviors 
that add to overall stress or may not engage in behaviors that could help with stress and pain 
management. 
 A person experiencing chronic pain may turn to various addictive behaviors from over-eating to 
drinking too much alcohol to using drugs.  Addictive behaviors may serve as a temporary escape from 
pain.  However, such behaviors when they become habitual change a person’s reward system and 
change levels of chemicals in the brain that may actually intensify pain perception.  Behaviors also 
contribute to the distressful emotions.  When such habits become established, a person may almost 
automatically turn toward such addictive behaviors when in pain thereby sustaining the loop. 
 In addition, a person in pain may be less likely to engage in behaviors that help with the management 
of pain.  For instance, a person with chronic pain may be hesitant to exercise in fear that the exercise 
will worsen the pain.  
Work & Relationships 
 Work and relationships lastly are considered since a person with chronic pain does not exist in 
isolation.  A person experiencing chronic pain may not be able to function as well as work.  A person 
may not be as engaged in relationships with friends and family.  In addition, work and relationships 
may serve as a further source of stress.  
 Doing well at work helps with feelings of mastery.  Feeling connected with others may help to feeling 
supported, which may lead to positive emotional states.  However, possible decreased ability to 
function at work or connect with other people may contribute negative emotions.  The person may 
feel less self-confident at the job and more isolated with other people.  These areas of a person’s life 
add stress.  In turn, negative emotions and stress may lead to more intensified experience of pain.   
Pain Management & Stress Management 
 As you can see, chronic pain and stress have a mutually influential relationship.  Thus, pain 
management that focuses on the management of chronic pain only addresses one facet of the 
individual.  Stress management is an integral part of pain management.  
 Stress management involves making time for activities that help a person feel relaxed.  It is usually 
individualized in that certain activities may help one person to feel relaxed but not for others.  There 
are many common stress management activities.   
 Some ways to manage stress include doing something to relax such as going for a walk, taking a bath, 
or listening to music.  Other ways to manage stress involve engaging with something that you enjoy 
such as a hobby like going fishing, playing an instrument, or baking.  Yet other stress management 
activities involve spending time with others be it other people who are supportive, people who share 
similar interests, or even volunteering to help others. 
 The key to stress management is identifying and trying out many activities and then scheduling time 
to stick with them.   
 Stress management is usually thought about as self-care in that a person is caring for him or herself by 
engaging in relaxing activities.  Self-care also includes caring about the self through getting enough 
sleep, eating consistently, and exercising, all of which can help to manage stress. 
Stress Management V. Wellbeing Practices 
 In thinking about stress management though, we focus on stress, which sometimes inadvertently 
contributes to stress.  If a person is focusing solely on relieving stress, then a person is constantly 
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thinking about internal stress and the stresses of life.  For instance, if I ask you not to think about a 
pink elephant and I keep encouraging you not to think about a pink elephant, you naturally tend to 
think about a pink elephant.   
 Thus, another way to think about stress management, and pain management would be within the 
paradigm of wellbeing and wellbeing practices.  Such a paradigm focuses attention on what it means 
to be healthy and happy.      
Wellbeing 
 Wellbeing is a term that has been utilized by countless health experts to signify that being healthy is 
not of a one-dimensional or singular in nature.  Rather, to be healthy from a wellbeing perspective is 
to suggest that there are multiple aspects of the self that need to be nurtured.  It is to indicate that the 
person is more than just body, mind, or spirit but is body, mind, and spirit.   
 Thus, when taken together and considered integrally, the person cannot be reduced to any one 
particular part or aspect of self but must be considered and encountered holistically.  A holistic 
approach to the human person is synonymous with wholeness, which in turn is synonymous with 
wellbeing.  To be well is ultimately to be whole.  Wellbeing-based practices and techniques are taken 
together and practiced as part of a comprehensive training program are fundamentally about 
cultivating a way of being and a sense of wholeness.  
 
Eudamonia 
 Wellbeing can be understood as an English translation of what Ancient Philosophers referred to as 
eudaimonia.  Eudamonia has been translated as “happiness” or “contentment” among other terms.  
Yet, it is more all-encompassing. 
 The term itself is active rather than static in nature.  It is a movement of the “eu-daimon,” literally, the 
“good spirit.”  Spirit is not meant to be necessarily religious, but can be thought of as being inspired by 
a greater life project and the process of unfolding of such a project. 
 It implies virtue and wisdom.  This wisdom that is lived from the source.  When such a wisdom is 
lived, what occurs is flourishing for self, others, and community, which is the idea that corresponds 
best to wellbeing as eudaimonia.    
Body 
 Wellbeing-based practices may start with the body as that is where pain is experienced.  Exercise is 
one facet of wellbeing practices in the bodily domain.  As with any wellbeing practice, but especially 
with exercise, consultation with a physician, physical therapist, occupational therapist, or any other 
member of a team is essential so not to exacerbate pain. 
 Anaerobic activities and strength training help to build power.  Aerobic activities help to build 
endurance.  Proper nutrition, such as eating and drinking well, help to provide the fuel for the body.  
Consultation with a book or with a nutritionist may help to gather information when knowledge is 
lacking.  Exercise and nutrition can enhance a sense of physical wellbeing.  They can decrease 
experiences of stress. 
Mind & Light Side 
 Wellbeing-based practices continue for the domain of the mind.  Intellectual study based off of 
interests helps a person to learn and cultivate understanding and insight.  A person may be interested 
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in learning more about the self, others, the world, culture, and/or history.  Such interests can be 
pursued through reading, watching, writing, and even taking classes. 
Mind & Shadow Side 
 Wellbeing-based practices mentioned so far in this domain of the mind center on the light: that which a 
person may know or want to know.  However, wellbeing practices may also address the shadow, 
those negative thinking-feeling-behaving loops that contribute to stress, pain, and suffering about 
which a person may know little or want to know little.  These wellbeing practices may be aided by a 
self-help book, or individual or group psychotherapy. 
 A person can learn about the way that thoughts are triggered by a feelings or situations, such as 
feeling depressed and then thinking it will never end or someone not saying hello and thinking that 
they do not like you.  A person can also learn about the way that thoughts can in turn taint the way 
feelings and situations appear, like wearing sunglasses.  With these glasses only negative feelings 
appear and only rejection is seen in the world.  Identifying unhealthy thoughts may help to then 
possibly adjusting them to more positive thinking patterns.  A person may further learn more about the 
emotional landscape, thereby learning to recognize and accept potentially difficult feelings and about 
how to feel better.  A person may finally adjust unhealthy behavior patterns, contrary to wellbeing, 
for instance, giving up smoking or drinking.  
 Taken together, learning about thinking-feeling-behaving patterns helps the person to make 
adjustments to each facet or altogether to change unhealthy patterns, manage stress, and enhance 
overall wellbeing. 
Spirit 
 Wellbeing-based practices also include the domain of the spirit.  Spiritual readings of sacred texts 
and also learning in congregation with others are founding practices.  Above that, wellbeing practices 
in this domain center on contemplative practices such as prayer, yoga, or meditation.  Consulting 
with a priest, pastor, rabbi, or imam may aide such practices.  
 Wellbeing practices in the domain of the spirit may be informed by a religion or religions, but a 
person by no means needs to be religious.  Communing with nature while walking through the woods 
may have profound spiritual value.  The abovementioned practices are transcendent practices that 
help a person to commune with a sense of sacredness and feel part of something greater.  This 
enhances a sense of wellbeing and connectedness.   
Wellbeing of Self & Others 
 Wellbeing as Wholeness is ultimately becoming who you are.  When you reduce yourself to a 
particular function or role, say you see yourself as just a body or mind or see yourself as just your 
occupation or your role in your family, you transform yourself into an object.  When you reduce 
others to their functions or roles, you turn them into objects as well.  Thus, self and others become 
inanimate and therefore can be used, which can be destructive at times.   
 A philosophy of wellbeing brings a sense of aliveness to life.  When you honor yourself and others 
as mind, body, and spirit the world begins to look differently.  A depth is noticed with all forms of 
life that were not necessarily experienced before. 
 Love deepens and compassion widens to include the welfare of all beings, and not only those that are 
similar to you.  You begin to see that your happiness is connected to the happiness of others in the 
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sense that happiness is no longer pursued at the expense of others.  People tend to be happier when 
care of self extends to care of others, and self is not as much of a focus. 
Conclusion   
 Wellbeing is the path of lived wisdom in an ethic of love.  It is evident in the power of community, 
social justice, and the art.  It is a science of caring for self and others in a world of engagement.   
 Being well and being whole is what it means to be fully human.   Personal wellbeing is not separate 
from the wellbeing of others.  The path of wellbeing is a powerful way for you to not only honor the 
depth of your being but that of others and nature as well.  It all begins by simply acknowledging self 
and others as mind, body, and spirit.  If this is reflected upon long enough, miracles are found to 
abound in everyday life and that everyday life is itself miraculous. 
 Thus, these have been some practices for being well and others can be encouraged to do the same for 






































Appendix D. URLs to Guided Meditation Recordings. All recordings are from meditation 
teacher and psychologist Dr. Tara Branch (https://www.tarabrach.com). Participants listened to 
each recording 1x per week for 4 weeks. (See Chapter 2, Section 2). 
 
Recording 1 (16:58): https://www.tarabrach.com/meditation-vipassana-insight/  
Recording 2 (15:58): https://www.tarabrach.com/meditation-quieting-mind/ 
Recording 3 (12:36): https://www.tarabrach.com/meditation-relaxing-back-presence-2/ 
Recording 4 (17:08): https://www.tarabrach.com/meditation-living-presence-3/ 












































Appendix E. Raw data for participants in MedExT study (see, Chapter 2, Section 2). 
 
    
MEASURES TAKEN BASELINE BASELINE QST 
          
  
  
LOW BACK QST 
Subject 





























Pressure Pain - 
Unpleasantness 
MEx-010 Control 4 36 47 22   1.00 6.0 1.8 0.1 6.3 1.3 1.4 
MEx-021 Control 1 20 23 25   1.00 15.0 2.7 2.0 8.2 1.1 1.4 
MEx-333 Control 0 27 34 18   0.40 15.0 2.2 5.9 3.2 1.0 1.6 
MEx-437 Control 2 38 48 11   0.40 10.0 3.1 2.1 6.2 1.8 2.9 
MEx-468 Control 3 25 27 8   0.40 180.0 1.4 1.1 6.6 1.0 1.0 
MEx-471 Control 8 26 37 20   0.60 300.0 4.5 7.7 8.6 6.4 4.7 
MEx-476 Control 15 48 53 44   0.40 300.0 7.5 7.8 2.8 5.7 3.3 
MEx-480 Control 3 48 44 58   0.40 6.0 3.5 2.9 4.4 3.6 4.1 
MEx-520 Control 4 40 43 20   0.60 6.0 4.7 1.7 3.4 4.5 1.9 
MEx-601 Control 6 45 39 38   0.40 2.0 4.9 6.6 2.5 2.7 6.8 
MEx-664 Control 2 20 22 1   0.16 6.0 1.4 1.8 7.9 3.5 3.8 
MEx-738 Control 9 20 25 12   0.40 15.0 9.4 9.1 5.3 5.9 6.0 
MEx-740 Control 1 41 59 8   0.40 8.0 3.1 4.7 4.9 1.4 0.9 
MEx-773 Control 8 42 32 15   0.70 180.0 1.0 1.1 3.6 3.7 3.9 
MEx-776 Control 2 33 37 20   1.00 10.0 3.4 3.8 3.6 3.0 4.3 
MEx-820 Control 4 56 64 23   0.60 60.0 0.9 2.1 3.4 1.3 1.8 
MEx-885 Control 5 47 51 2   0.40 2.0 2.9 0.1 2.3 2.5 2.3 
MEx-888 Control 5 20 29 6   0.40 1.0 0.7 0.1 3.2 1.8 1.8 
MEx-918 Control 8 22 29 27   0.40 0.6 4.0 6.6 4.3 3.1 0.7 
MEx-953 Control 3 37 37 4   0.40 6.0 5.5 2.4 3.4 1.2 3.4 
MEx-103 MedEx 2 30 44 27 40 0.60 300.0 5.1 4.5 9.5 5.2 4.4 
MEx-123 MedEx 12 37 36 35 49 1.28 300.0 2.9 3.2 4.6 2.9 3.1 
MEx-177 MedEx 4 23 25 22 43 0.16 2.0 0.8 1.7 5.5 3.6 4.2 







MEx-187 MedEx 5 29 34 22 35 0.07 15.0 3.1 2.4 4.1 1.5 1.5 
MEx-232 MedEx 1 32 46 30 33 0.40 300.0 4.8 5.8 3.6 3.0 3.2 
MEx-280 MedEx 4 20 23 5 44 1.00 8.0 5.9 5.9 6.0 7.0 5.6 
MEx-369 MedEx 3 21 25 11 46 0.04 2.0 3.3 7.8 3.6 2.3 7.9 
MEx-389 MedEx 0 29 26 14 32 0.16 1.3 3.5 4.6 7.3 3.7 2.5 
MEx-411 MedEx 3 26 22 17 46 0.40 6.0 8.4 9.2 4.7 5.3 5.4 
MEx-415 MedEx 2 36 40 22 32 0.60 60.0 1.9 3.7 6.8 4.5 4.3 
MEx-430 MedEx 2 41 42 26 38 0.60 300.0 0.7 2.2 3.5 2.6 5.1 
MEx-461 MedEx 4 31 45 33 34 0.40 1.3 6.8 8.0 7.4 4.0 5.5 
MEx-566 MedEx 2 35 39 35 37 0.40 180.0 3.9 5.0 8.4 5.6 5.9 
MEx-661 MedEx 2 23 29 14 39 0.40 0.6 6.2 7.9 3.4 4.0 5.7 
MEx-813 MedEx 5 28 30 15 27 1.20 300.0 3.2 1.5 5.5 2.1 0.7 
MEx-932 MedEx 2 34 36 0 26 0.16 6.0 3.9 2.6 4.4 0.9 1.0 



























BASELINE QST VAS PAIN RATINGS 
FOREARM QST 











































0.40 2.0 0.3 0.1 5.0 1.6 1.8 1.5 4.4 2 3.7 1.1 1.9 
0.40 60.0 0.9 0.9 5.0 1.5 1.9 1.2 1.6 1 1.1 0.9 1.1 
0.40 10.0 3.2 7.3 4.0 2.3 6.8 0.1 0.1 3.9 0.2 0.1 0 
0.40 10.0 2.2 1.9 3.6 1.3 2.1 0.1 0.3 0.5 1.2 0.4 1.2 
0.40 300.0 0.5 0.1 4.0 0.3 0.1 0.8 0.3 0.3 0.1 0.2 0 
1.00 300.0 2.8 2.4 4.7 1.4 0.9 5.3 4.8 2.3 0.6 5.9 5.3 
0.40 15.0 3.0 2.0 3.0 2.1 1.8 6.0 4.9 3.8 2.3 2.7 1.4 
1.00 60.0 3.1 4.2 2.7 4.5 4.4 5.6 1.6 4.4 3.1 4.1 3 
0.16 1.0 1.1 0.5 1.7 0.5 0.2 1.7 0.8 2 0.8 1.3 0.5 
0.16 1.3 2.3 2.8 2.3 2.8 7.1 2.2 6.6 1.8 3.8 1.2 1.2 
0.40 300.0 0.1 0.1 7.8 2.3 2.2 2.3 0.9 2 2 1.8 1.8 
0.40 15.0 0.1 0.1 3.4 0.2 0.3 0.9 1.1 2.6 2.5 2.6 2.6 
0.16 6.0 3.5 3.1 3.5 2.7 3.7 2.0 1.7 0.3 0.6 0.2 0 
0.40 100.0 2.2 1.8 2.6 5.3 5.2 6.2 7.3 7.1 6.6 7.8 8.2 
0.60 10.0 1.3 1.6 2.4 0.7 1.6 1.3 1.7 0.2 0.2 2.3 1.3 
0.16 100.0 0.1 0.1 5.1 2.1 3.4 0.8 0.9 0.4 0.1 0.8 2.1 
0.40 2.0 1.5 0.5 2.0 2.5 3.8 2.1 2.3 1.3 0.6 2.5 2.5 
0.60 10.0 0.1 0.1 2.7 0.1 0.9 6.8 5.8 0.6 0.4 0.6 0.6 
0.07 1.0 2.5 4.2 2.6 4.1 2.5 1.5 4.9 2.3 0.1 0.7 0 
0.40 10.0 2.4 0.9 2.6 2.2 0.8 5.0 6.9 3.4 0.7 1.2 0.6 
1.00 60.0 1.7 0.2 3.5 0.1 0.5 2.1 3.7 3.5 3.6 0.7 0 
0.40 180.0 2.2 2.9 3.8 2.5 2.7 5.8 6.7 5 5.2 5.5 6 
0.07 26.0 0.2 0.2 3.4 1.9 3.4 3.3 4.2 2.2 5.7 0.8 3.3 
0.40 180.0 0.1 0.1 3.0 0.4 0.1 1.5 1.8 0.6 1.1 1.3 0.9 







0.16 60.0 1.3 1.3 3.4 3.5 3.9 2.7 2.8 3.5 4.1 4.5 4.6 
0.16 6.0 3.7 3.8 3.2 5.0 3.7 4.3 4.1 4.1 4.2 2.5 2.5 
0.07 1.3 0.8 1.8 4.7 0.8 1.8 1.9 1.5 2.4 5.1 1.5 2.6 
0.07 6.0 2.0 3.2 4.2 4.0 4.0 1.7 3.4 1.8 1.3 3.7 4.4 
0.40 15.0 4.6 4.6 4.5 2.5 2.7 7.2 5.0 3.8 2 1.2 1.7 
0.16 300.0 1.3 0.5 5.6 3.8 4.9 4.2 6.0 5 7.7 3.9 6.1 
0.60 300.0 0.1 0.1 3.3 1.4 3.7 1.1 4.1 1.3 1.3 0.5 0 
0.02 0.4 0.9 1.0 3.8 2.4 3.6 2.8 3.1 2.9 4.4 2.7 3.7 
0.16 100.0 4.5 4.4 4.8 5.2 5.6 4.5 1.6 4.4 4.8 2.5 2.8 
0.40 0.4 0.1 2.3 3.2 2.5 3.5 4.4 0.7 3.1 3.3 1.2 0 
0.16 10.0 1.1 0.4 3.9 2.0 3.4 3.1 1.8 1.9 2.3 1.1 1.4 
0.40 2.0 1.3 1.0 2.7 0.4 0.9 0.7 1.9 0.4 1.2 0.8 0.4 





























VAS PAIN RATINGS 












































0.9 1.6 1.1 1.2 2 2.1 1.8 1.6 1.6 2.4 1.5 2.2 1.6 3.5 2.4 3.4 
0.1 0.1 0.1 0.1 1.7 0.7 0.6 0.5 0.7 0.1 0.5 0.1 0.8 0.8 0.6 0.1 
0.5 1.4 0.5 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.3 
        0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.1 
3.1 2.7 3.2 2.9 3 2.2 5.1 5.1 5.9 6.7 4.9 3.2 3.5 2.4 1.6 0.5 
6.7 6.8 3.6 2.6 3.2 1.8 1.7 1.2 7.3 7.7 8.8 8 3.5 1.5 2.9 1.2 
5.3 6.1 5 4.4 3.9 3.8 4.2 3.3 4.2 3.6 4.6 3.2 3.8 2.9 5 6 
4 2.5 2.7 0.3 4.5 3.8 5.3 2.9 0.2 0.3 0.4 0.1 3.2 1.4 3.3 1.4 
1.9 2.4 1.6 1.6 1.2 1.9 1.1 1.1 1.3 1.8 1.4 1.4 2.9 4.1 2.8 3 
4.2 2.8 3.1 1.3 2.4 2.9 1.7 2 2.2 1.1 1.5 0.6 2 4.2 1.3 1.7 
2 2.7 1.9 2.3 0.4 0.7 0.8 0.9 2.7 2.5 2.1 2.1 4.7 5 3.4 3.5 
0.1 0.1 0.1 0.1 2.5 3.6 2.2 2.6 0.9 0.6 1 0.6 1.9 2 1.7 2.2 
8.3 8.9 0.1 7.9 8.1 7.3 0.1 0.1 7.3 6.6 7.3 6.9 7.9 8.6 8.4 8.8 
0.2 0.1 0.2 0.1 1.4 0.3 1.1 0.1 4.3 3.6 3 1.5 1 0.5 0.9 0.4 
0.6 0.5 0.5 1.1 1.6 1 2 1.4 2.8 4.6 2.5 1.7 0.2 0.1 0.6 0.2 
1.8 2.7 2.2 2.7 2.7 2.2 3 2.3 4 3.9 3.8 3.8 2.4 2.5 2.5 2.4 
1 1.5 1 0.8 0.6 1 1.2 1.9 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 
2.8 3.6 2 3.2 3.1 1 3.5 1.4 10 4.6 0.9 4.1 9.7 6.6 4.6 5.4 
2.1 0.3 1.1 0.6 2.9 0.7 1.7 0.3 4 1.8 3.4 1.1 4.8 3 2.6 0.8 
0.8 1 3 3 1.3 1 0.2 0.2 1.3 0.8 0.1 0.2 0.8 0.7 0.3 0.8 
4.5 5 4.7 5.2 3.8 4.3 3.5 3.3 3.4 3.5 3.5 3.3 4.3 4.4 3.6 3.2 
3.2 5.4 2.1 3.3 3.3 4.9 2.5 3.9 5.3 7.3 3.4 4.8 2 4.4 1.2 1.9 
1.8 2.1 1.5 2.8 1.6 2.5 0.9 0.9 2.4 2.1 1.4 1.2 1 1.1 0.5 0.1 







2.8 2.9 3.5 5 3.4 3.4 3 2.5 3.1 3.5 3.4 5.7 3.7 4.7 4.9 5.7 
3.5 3.5 2.8 2.8 3.6 3.9 2.8 3.1 2.9 3.1 2.7 2.8 2.6 2.7 2.1 2.2 
2.2 5.8 1.3 1.8 5.5 8.5 2.3 5.9 5.7 8.1 1.6 3.4 5.1 8.2 3.3 5 
3.2 2.9 1.2 2.2 2.5 4.5 2.3 4.1 2.4 2.8 3.5 2.4 2 2.3 3.2 2.4 
        2.2 3.3 1.5 1.5 4.2 4.3 2.5 4.2 1.7 0.6 1.3 2.5 
3.8 5.2 3.6 4.9 4.1 7 3.4 5.1         2.8 5.6 6 7.9 
1.2 2.3 0.6 0.5 0.4 0.4 0.1 0.2 1.3 2.3 0.7 0.8 3 4.6 1.9 3.6 
0.2 1.3 2.3 4 1.2 2.4 1.1 2.3 0.4 2.3 0.4 0.9 0.9 1.8 0.6 2 
4 4.3 3.1 3.2 3.2 3.1 3.2 3.1 3.2 3 4.6 3 4.2 4.3 3.3 3.7 
3.8 4.5 2.6 2.2 1.7 3.5 1.5 2.3 3.8 3.1 3.1 2.8 2.6 2 4.4 2.7 
1.8 3.8 1.1 2.3 3 3.2 2.5 1.8 3.5 0.3 2.2 0.1 2.1 2.9 1.8 1.7 
1.5 0.5 2 2.1 0.7 0.8 0.1 0.1 0.8 0.6 1.4 0.6         





























VAS PAIN RATINGS 













































2.7 2.8 2.6 2.8 1.4 1.3 1.5 1.8 3.1 2.2 2.4 2.8         
2.3 0.9 1.8 1.1 1.7 1.7 0.7 0.1 0.8 0.1 0.8 0.1 3.3 3.1 2 1.2 
0.1 0.3 0.2 0.1 0.2 0.3 0.5 0.3 0.6 0.3 0.7 0.3 0.5 2 0.2 0.9 
        0.1 0.2 0.1 0.1 1.7 1.6 1.5 1.2 1.5 1.7 1.4 1.3 
0.1 0.2 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
5.2 2.6 5 3 2.8 2.4 2.3 1.6 6.5 6.7 5.5 4.7 4.6 2.5 5.3 3.4 
6.3 8.5 5.8 4.9 5.7 7.2 3.4 4.5 5.6 7.1 3.5 2.8 8.2 9 5.6 4.7 
5.7 4.6 5.4 5.4 6.2 5.3 5.8 5.5 4 3.1 4.7 4.1 5.1 3.6 5.2 4.1 
3.1 0.3 0.1 0.1 0.2 0.3 0.1 0.1 2.6 1.1 1.3 0.3 0.9 0.5 0.6 0.2 
1.5 2.8 1.7 1.9 0.9 0.7 0.8 0.7 4.1 4.8 3.8 3.9 2.2 2.9 2.1 2 
4.5 2.5 2.3 0.8 1.4 3.8 1.1 2.5 2.9 0.5 2.5 1.5 2.6 0.8 1.9 1.3 
5.9 5.1 1.6 1.7 1.2 1.6 1.7 1.6 5 4.6 4.7 4.7 0.9 1 0.3 0.4 
3.7 3.4 3.3 3.2 1.2 0.6 1.4 0.7 1.7 1.6 1.3 1 0.1 0.1 0.1 0.1 
7.9 6.7 7.6 7.5 8.7 9.4 8.4 9 8 6.2 8 7.3 7.2 7.2 7 6.7 
0.7 0.3 0.4 0.3 1.3 0.5 0.4 0.1 0.3 0.1 0.2 0.1 1.2 0.6 0.8 0.8 
0.7 2.9 1.7 2.9 2.4 3.4 1.5 1.6 0.8 0.7 0.5 0.1 1.5 1.7 1.1 1.2 
2.2 1.5 3.5 3.6 4.7 5.6 3.9 3.4 0.7 0.9 1.7 1.8 3.8 4.2 4.9 5.8 
0.1 0.1 0.1 0.1 0.3 0.3 0.2 0.2 3 4.2 2.2 3.7 2.2 3.3 2.1 3 
3.6 6.5 5.1 7.2         4.4 2 4.1 1.5 4 1.8 3.8 2.6 
1.4 3.6 1.4 2.5 2.2 0.6 1.6 1.4 1.6 0.4 1.8 0.3 1.4 0.3 0.7 0.4 
1.5 1.7 1.1 0.5 3.3 3.2 0.3 0.2 1 2.3 0.1 0.4         
4.5 4.6 3.6 3.6 3.7 3.4 3.1 3.1 3 2.9 2.9 2.8 2.6 2.5 2.2 2.3 
3.1 5.5 1.3 3.6 1.8 3.7 1.7 2.1 2.5 3.2 1.4 1.8 1.1 1.6 0.5 1.5 
0.9 0.7 0.1 0.1 1.1 1.1 0.3 0.2 1.4 1.5 0.3 0.3 0.2 0.2 0.1 0.1 







2.3 2.8 3.3 4.2 2.7 2.6 3.2 3.5 2.3 2.5 4.3 4 2.1 1.9 3 3 
2.4 2.5 2.1 2.2 1.8 2.1 1.6 1.6 2.3 3.1 2 1.9 2.2 2.4 1.7 1.9 
2.3 6.4 1.5 2.7 0.9 4.3 0.6 2 3.5 8.5 1.1 2.6 1.1 3.6 0.3 1.6 
1.5 2.4 1.8 1.8         2.1 3.4 2.5 2.4 2.3 2.2 2 1.6 
2 3.7 2.4 4.8 4.6 1.9 2.5 0.8 1.8 3 5.1 7 2.1 1.8 1.9 1.7 
1.5 1.4 0.7 1 1.3 1.5 0.8 2.7 1.3 1.4 2.2 5.1 2 3.2 1.2 1.3 
1.1 1.4 0.3 0.6 0.7 1.9 0.9 0.1 0.2 0.4 0.3 0.1 0.3 0.2 0.1 0.1 
0.8 2.8 0.6 1.4 0.3 2 0.8 2.3 0.9 2.3 1 2.1 0.4 1.6 1 2.3 
2.7 2.5 3.4 2.6 4.4 4.5 3.5 2.9 4.5 5.4 3.9 4.7 5.5 5.6 5.6 6.4 
3.6 3.7 4.5 4.3 3.7 4 3.3 2.8 5 4.4 5.1 5 5.1 5.9 4.8 5.7 
1.1 0.7 0.7 0.1 2.8 1.3 1.2 1 1.7 0.4 1.2 0.2 1 0.9 0.7 0.6 
1.5 2.7 2.7 2.4 1.8 1.7 1.9 3.6 1.6 1.4 0.8 0.1 0.7 1.2 0.2 0.1 





























VAS PAIN RATINGS 












































2.1 1.9 0.8 1 2.4 4 3 3.5 2.6 3.2 2.4 3.7 2.7 1.7 3 2.2 
0.7 0.3 0.7 0.6 1.5 1.6 2.6 1.8 3.3 2.9 2.4 1.3 2.8 2.2 1.6 1.5 
2.2 3.2 1.4 1.3 0.4 2.5 0.2 1.8 0.2 0.3 0.2 1.3 0.5 1.7 0.2 0.3 
        1.4 1.6 1.2 1.5 0.1 0.1 0.1 0.1 1.2 2.5 1 2 
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
7.2 7.3 7.1 5.8         5.1 3.1 5.3 4.1 6 5.5 5.9 7.2 
4 2.7 2.9 1.7 3.9 2.6 2.4 1.5 1.8 1.2 1.2 0.5 2 1.3 2.9 3.8 
4.5 5.1 4.5 5 4.7 5 5.9 6 5.9 3.9 5.4 5.2 4.9 4.7 5.1 5.3 
1.2 0.3 0.1 0.1 3.2 1.1 3.3 1.3 1.6 0.3 1.3 0.3 1.7 0.3 1.9 0.3 
1.5 1.9 1.7 2 3.6 4.7 3.7 3.8 2.4 2.2 2 1.8 1.5 1.4 1.5 1.5 
2.8 1.6 1.2 1.1 3.1 1.4 1.4 0.2 1.8 0.7 1.3 0.6 1.9 0.4 1 0.2 
0.5 3.1 0.2 4.4 0.5 0.6 0.2 0.8 0.7 0.8 0.1 0.1 1.1 1 1.3 2 
0.1 0.1 0.1 0.1 0.8 0.8 1 1.2 1.3 1.5 1.1 1.6 1.7 1.7 1.1 1.9 
7.2 9.2 8.4 8 9.3 9.6 9 9 8.7 9.3 8.1 9.5 7.9 7.6 8.1 8.3 
0.2 0.1 0.1 0.3 0.6 0.3 0.4 0.3 1.6 0.3 0.8 0.3 0.2 0.1 0.1 0.1 
2.9 5 2.5 2.9 1.8 2.2 2.1 3.3 0.5 0.6 0.5 1.1 1.6 2.4 0.5 1 
        2.8 3.8 3.1 3.1 2.1 2.4 2.6 2.7 2.6 2.6 3.1 2.8 
0.6 1.4 0.6 0.8 0.1 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.5 0.4 0.4 0.6 
2.3 3.2 0.4 2.4 7 7 4.1 6 5.7 5.3 5.5 6.7 4 5.2 4.3 5 
4.1 1 2.1 0.6 2.1 0.4 1.1 0.4 1.7 0.3 1.7 0.3 1.1 0.2 0.7 0.6 
2.8 2.7 0.2 0.4 1.6 1.3 0.4 0.5 0.5 0.4 0.2 0.5 1.3 1.6 0.3 0.4 
        5.3 5.5 3.6 3.4 1.7 1.7 1.4 1.4 1.6 1.7 1.4 1.5 
1.5 3.3 1.6 2.5 3.3 5.4 2 3.7 2.9 4.3 1.6 3.1 2.5 3.9 1.1 2.7 
0.9 1.2 0.5 0.6 0.6 1 0.1 0.2 1 1.8 0.2 0.2 0.2 0.5 0.1 0.1 







2 1.8 3.2 3.1 2.7 2.5 2.4 2.3 2.1 2.3 3.6 3.8 2.9 2.9 3.7 4 
1.9 2.1 1.6 1.8 2.2 2.2 1.5 2 1.9 2 1.6 1.8         
0.7 1.3 1.2 2.6 0.7 1.5 0.3 0.7 1.7 3.8 0.6 2.7 1.7 4.7 0.7 1.9 
2.6 3.5 0.4 1.5 1.8 1 0.6 1         1.3 1.5 0.9 1.5 
3.1 1.8 6 6.3 0.9 1.1 1.2 1.2         4.6 4.6 1.4 3.6 
1.8 3.7 1.3 1.6 2.5 4 1.8 2.7 1.4 2.6 1.1 1.3 1.3 1.8 0.4 0.4 
0.2 0.2 0.1 0.1 0.8 0.2 0.2 0.5 0.2 0.2 0.1 0.1 0.5 0.9 0.3 0.5 
1 2.1 0.3 2 0.3 1.1 0.4 1.5 0.2 1.4 0.5 1.6 0.3 1 0.5 1.6 
3.6 3.4 3.8 2.7 3.2 2.8 2.4 2.4 2.7 2.5 2.7 2.5 3.5 3.8 3.6 2.8 
3.8 3.3 3.6 4.2 2.1 0.1 3.8 4.3 0.4 0.1 2.1 2 0.8 0.1 3.1 3.3 
0.5 0.5 0.2 0.4         1.2 0.7 0.8 0.1 1.4 1.1 0.8 1.2 
0.1 0.1 0.6 0.7 0.3 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.6 0.9 0.1 0.1 





























VAS PAIN RATINGS 













































1.8 1.8 2 2.4 2.6 3.3 2.1 2.2 2.1 2.7 2 3.2 2.5 2.7 2.2 1.7 
1.3 0.3 1.4 1.6 2.8 2 2.4 2.2 1.1 1.1 1.1 0.8 0.1 0.1 0.1 0.1 
0.6 3.8 0.2 2.3 0.2 0.4 0.5 0.3 0.2 0.7 0.5 0.4 1 3 0.2 0.3 
2 3.9 1.6 4.2 2.1 1.6 1.6 1.5 0.5 1.9 1.4 1.1 0.1 0.1 0.1 0.1 
0.1 0.3 0.1 0.3 0.4 0.9 0.1 0.2 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.3 
        6.6 5.6 6.2 6 8.4 9.4 7.5 8.5 4.4 4.4 3.9 3.6 
3.5 4 2.4 3.1 2.7 1.6 1.9 1.1 3.3 2.1 1.7 0.9 1.9 2.3 1.8 3 
5.7 4.9 5.2 5.6 4.9 5.1 5.1 4.9 5.4 6.5 4.4 5 5.1 4.9 5.2 5 
0.2 0.3 3.2 1.1 3.2 0.5 1.1 0.3 3 0.3 3.2 0.3 3.9 1.7 3.3 1.8 
1.9 2.8 2.3 2.6 1.7 1.7 1.8 1.6 1.3 1.7 1.6 1.7 1.4 1.7 1.4 1.5 
2.1 0.5 1.5 0.5 4.2 2.9 2.6 1.3 1.2 1 1.3 0.4 1.6 0.1 1.2 0.2 
        6.9 7.1 6.7 7.1 4.3 5.1 7.3 5.8 1.9 3.2 5.1 4.5 
1.5 2.1 0.9 0.8 0.3 0.1 0.8 0.1 1.1 1.5 1 2.1 2.4 1.5 1.5 1.4 
7.3 6.1 6.7 6 6.4 5.1 6.3 6 7.8 6.4 7.8 6.7 7.5 7 7.1 6.7 
0.8 0.3 0.3 0.3 0.6 0.3 0.3 0.1 0.4 0.3 0.7 0.3 0.4 0.1 0.2 0.1 
0.9 0.8 1.7 2.4 3.1 4.7 3.4 5.2 4.3 5.8 3.6 5.1 2 3.8 3.4 4.6 
3.1 2.1 3.1 3.7         2.5 2.2 3.4 2.8 3.6 3.6 3.9 3.3 
0.4 0.7 0.3 1.1 0.7 1.7 0.7 1.6 0.1 0.7 0.6 0.6 0.3 0.6 0.4 0.5 
3.9 5 2.7 2.2 1.8 2.3 0.9 2.1 4.4 5.8 4.4 4.7 5.6 4.9 4.2 5.1 
1.2 0.8 1.9 0.9 3.5 4.2 1.5 1.8 0.5 0.3 1.1 0.4 2 0.3 0.5 0.2 
1.8 3.3 0.3 0.5 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.3 0.2 
1.9 2 1.3 1.3         2.3 2.4 1.4 1.4 1.1 1.1 0.9 0.9 
2.3 3.6 2.1 2.9 2.7 3.7 1.4 2.5 2.9 3.1 1 1.8 3 4.4 1 2.3 
0.6 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1         







2.7 3.8 3.5 3.7 2.3 2.3 2.1 3 4 4.9 4.3 4.5 2.6 2.5 3.5 3.5 
2.1 2.3 1.7 2 1.8 1.8 1.8 1.8 1.9 2 1.4 1.3 1.9 1.9 1.9 2 
1.3 3.6 0.5 1.5         1 2.9 0.8 1.3 1.4 4.1 2 4.8 
2 2.7 2.5 2.9 1.8 1.4 1.7 1.5 3 3.5 2.2 1.7 2.6 2.4 1.8 1 
1.7 3.3 0.7 0.6 0.8 1.1 4.3 3.9 2 2.4 0.2 0.3 4.1 4.4 1.8 1.8 
        1 1.5 0.9 0.9 2.9 5.6 1 1.5 1.7 3.1 0.7 1.4 
0.4 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.6 0.4 0.6 0.5 0.5 1.1 1.9 3.7 
        0.2 1 1.5 3.3 0.4 1.5 0.6 1.6 0.4 1.7 0.6 1.6 
3.1 2.3 2.7 2.7 3.9 3.8 3.1 2.6 3.5 3.3 2.5 1.9 3.2 3.2 2.4 2 
0.2 0.1 1.7 0.6 2.5 1.9 1.7 1.3 2.4 3.3 3.8 4 2.4 1.8 2.9 2.6 
2.5 0.9 2.1 1 1.2 0.5 1.1 0.6         0.9 0.8 1 0.8 
0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.8 1.2 0.1 0.1 0.2 0.2 0.1 0.1 





























VAS PAIN RATINGS MEASURES TAKEN POST-INT 















































2.8 2.1 2.1 2.2 0.2 0.2 0.2 0.2 1.4 0.1 1 0.1 1.7 1.7 0.7 
3.1 3.1 2.5 2.5 2 1.5 1.8 1.4 1.3 1.4 1.8 1.5 1.6 1.6 1.7 
0.1 0.1 0.1 0.1 0.2 0.4 0.2 0.3 0.5 2.4 0.5 0.4 0.5 2.0 0.6 
0.9 1.7 0.6 1.8 1 1.8 1.4 1.3 0.6 1.5 0.4 0.3 0.8 0.8 0.6 
0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.2 0.4 0.0 
2.6 0.9 2.3 0.9 3.7 1.9 4.6 2.8 4.9 4.6 4.9 5.1 6.3 6.5 4.3 
5.5 7.2 3.9 5.4 4.9 6 2.9 3.4 6 6.7 3.6 3 3.9 3.2 4.7 
5.1 5.3 4.5 4.9 5.1 4.1 4.5 6.1 5.7 6.4 4.8 5.2 4.4 6.3 4.8 
1 0.6 0.2 0.3 1.6 0.3 0.2 0.1 2.1 0.9 0.7 0.3 1.7 0.5 0.9 
1.8 1.9 1.7 1.7 1.7 1.5 1.4 1.4 1.7 1.8 1.6 1.8 3.3 5.8 1.7 
1.4 0.8 0.6 0.1 2.2 1.2 1.8 0.6 1.2 0.6 1.4 0.4 4.5 4.1 1.0 
8.2 7.2 4.1 3.9 2.2 2.3 1.4 1.8 1.2 1.6 1.5 1.7 1.5 1.8 3.0 
2 2 1.5 1.6 1.3 1.4 1.8 2 2.5 1.9 1.7 1.5 1.5 1.1 1.7 
6.7 6.3 6.3 5.9 7.6 7.3 7 6.9 6.9 8.4 6.9 8 9.4 8.9 8.3 
0.5 0.6 0.3 0.1 0.5 0.3 0.8 0.1 0.6 0.3 0.2 0.1 0.8 0.3 0.7 
2 3.6 2.2 3.2 1.5 1.8 1.7 2 2.8 3.8 1.8 2.2 2.5 2.9 1.5 
4.2 3.9 3.6 4.5 3.1 3.3 3.8 3.9 2.8 2 2.3 1.2 3.0 2.6 3.1 
0.1 0.4 0.2 0.3 0.9 1.2 0.9 1.2 0.4 0.8 0.2 0.5 0.6 1.3 0.6 
3.3 4.6 3.6 5.3 3.8 2.4 2.7 5.1 1.9 1.9 3.8 4.1 2.9 2.8 3.3 
1.4 0.6 0.9 0.3 2.2 0.1 0.9 1.7 2.1 0.6 2.5 1.3 2.2 0.9 1.6 
0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.2 1.7 2.4 1.2 3 3.3 3.4 2.0 
0.7 0.7 0.6 0.6 0.5 0.5 0.3 0.4 0.3 0.3 0.1 0.1 6.3 6.3 3.3 
1.8 2.2 1 1.7 2.9 5 1.1 4.1 1.7 2.4 1.5 1.9 3.3 5.0 1.9 
0.5 0.2 0.3 0.1 1.1 1 0.1 0.1 1.4 2.1 0.3 0.2 1.0 1.3 0.6 







2.2 2.4 3.1 3.2 2.2 2.3 3.6 3.5 2.1 2 2.6 2 3.3 3.3 3.2 
2.4 2.4 2 2.2 2.7 2.9 2.2 2.1 2.1 2.3 1.8 2 2.7 2.9 1.8 
1.6 4.1 0.8 2 0.9 2.1 0.9 2.5 1.1 2.7 1 2.2 3.1 6.7 1.7 
3.5 2.9 2.4 2.5 2.8 1.3 0.4 1 1.8 3.1 1.8 0.6 2.7 3.0 1.2 
2 1.6 0.9 0.1 1.7 0.2 1.1 0.2 0.7 0.6 1.6 1.6 4.7 5.2 1.9 
2.1 3.5 1.3 1.7 2.4 3.5 2.2 3.1 1.5 2.9 1.2 1.9 2.7 6.9 1.3 
0.8 1.5 0.7 0.7         0.3 0.4 0.2 0.3 1.5 2.4 0.6 
0.5 1.4 0.8 1.5         0.3 0.8 0.7 1.3 1.6 3.5 0.5 
        3.9 4.4 3.2 3.6 4.3 4.6 3.7 3.1 4.5 4.5 3.5 
4 3.7 3.1 3.5 1 0.2 2.4 2 0.7 0.1 0.2 0.1 3.9 3.3 3.5 
0.8 0.6 0.6 0.3 0.9 0.6 0.5 0.5 0.9 0.5 1.1 0.4 1.2 1.0 0.6 
0.1 0.1 0.3 0.2 0.1 0.7 0.1 0.1 1.1 1.1 0.3 0.3 2.2 2.0 0.5 





























MEASURES TAKEN POST-INT POST-INT QST 
  
          LOW BACK QST 
During study: 
Average pain 






























Pressure Pain - 
Unpleasantness 
0.1 4 45 54 24   0.40 15.0 1.9 0.1 5.5 2.1 1.0 
1.3 0 24 23 34   0.60 15.0 4.6 4.3 7.3 2.8 2.7 
1.6 1 29 27 11   0.60 15.0 0.5 3.5 5.8 1.1 2.2 
0.9 1 42 47 25   0.60 6.0 1.4 0.7 5.5 0.4 0.5 
0.1 0 30 25 4   0.04 180.0 0.7 1.2 3.9 0.4 0.6 
3.1 9 27 31 24   1.00 300.0 5.8 7.9 8.4 4.9 4.7 
5.3 16 42 55 39   0.40 6.0 6.2 7.4 4.3 2.0 1.9 
4.8 4 33 33 53   0.40 60.0 2.8 4.8 4.9 3.6 4.8 
0.0 5 44 49 29   0.60 15.0 4.5 0.7 4.1 2.2 1.3 
2.8 9 41 38 27   0.40 1.0 5.5 6.8 4.5 3.3 4.2 
0.5 0 19 20 3   1.00 15.0 1.6 2.5 9.4 2.5 3.4 
3.0 4 34 33 28   0.40 60.0 6.1 5.8 2.5 4.6 4.4 
1.5 0 36 65 10   0.04 6.0 3.3 3.5 5.0 0.5 1.1 
8.1 1 34 34 4   0.16 300.0 8.6 8.2 3.2 7.6 9.0 
0.4 4 26 31 7   0.60 8.0 1.5 1.7 3.4 2.2 1.4 
2.0 5 65 62 44   0.40 10.0 0.9 1.2 4.5 1.0 1.2 
3.2 3 51 58 0   0.07 1.0 2.7 0.9 3.2 1.7 1.7 
1.2 8 28 36 9   0.40 8.0 0.1 0.1 2.4 1.4 2.2 
4.5 9 41 36 31   0.40 1.3 4.7 6.7 4.4 3.2 4.9 
1.1 7 45 33 23   0.40 15.0 1.8 4.2 3.3 2.7 1.4 
1.8 0 34 46 40 45 0.07 6.0 4.0 4.0 5.6 3.8 4.2 
3.1 2 33 35 16 45 0.07 26.0 3.0 3.4 6.2 2.5 2.1 
2.8 1 25 28 14 44 0.07 100.0 0.4 0.8 4.4 0.6 1.3 
0.4 2 32 32 4 44 0.16 15.0 2.6 1.2 6.3 1.5 0.9 







3.2 1 41 49 13 24 0.40 60.0 2.5 3.3 6.4 1.6 2.1 
1.9 1 23 25 4 45 1.00 2.0 4.1 4.0 4.8 3.2 3.2 
3.8 0 24 22 5 55 0.16 6.0 3.3 5.8 6.2 2.3 4.6 
1.9 0 43 31 24 44 1.00 100.0 1.5 2.0 10.0 0.2 0.5 
2.1 5 25 26 16 47 0.16 15.0 7.7 7.9 4.4 4.2 3.9 
3.0 2 45 38 18 41 0.04 26.0 3.3 6.5 7.2 2.4 4.2 
0.7 1 24 24 25 53 0.40 300.0 1.4 0.5 3.6 2.4 5.1 
1.5 3 31 39 25 40 0.60 8.0 0.9 2.5 6.1 0.5 1.6 
3.5 2 25 34 34 41 0.40 180.0 1.4 0.1 4.6 5.0 1.7 
3.7 4 30 32 16 40 0.40 0.6 4.3 7.2 4.6 3.0 2.3 
0.0 4 28 35 21 42 1.00 6.0 3.7 3.7 6.7 1.8 0.8 
0.5 3 35 42 13 26 0.02 6.0 2.9 3.1 3.5 1.3 1.3 
























































Pressure Pain - 
Unpleasantness 
0.40 6.0 0.5 0.1 4.0 1.1 1.4 
0.07 100.0 1.2 0.1 4.0 3.7 3.6 
0.16 10.0 1.5 3.9 4.4 1.0 2.0 
0.40 8.0 1.5 0.7 3.8 0.3 1.3 
0.40 300.0 0.1 0.1 3.6 0.2 0.3 
0.40 300.0 2.6 2.6 5.1 2.3 3.0 
0.40 1.3 2.3 1.6 4.4 0.8 0.7 
0.02 60.0 2.7 3.3 3.2 3.9 3.4 
0.40 60.0 0.4 0.1 3.0 0.7 0.1 
0.40 26.0 1.6 1.7 3.5 3.3 5.1 
0.60 26.0 1.3 0.7 7.8 2.1 1.5 
0.04 26.0 0.3 0.2 3.7 0.2 0.2 
0.04 6.0 3.5 2.8 2.5 1.8 1.8 
0.40 100.0 2.5 1.7 2.9 2.6 5.7 
0.40 8.0 0.4 0.3 2.0 1.3 0.6 
0.07 180.0 0.1 0.1 3.4 0.8 1.6 
0.40 2.0 0.6 0.3 2.4 1.8 1.2 
0.40 26.0 0.1 0.1 2.0 0.6 0.4 
0.16 2.0 2.8 3.7 2.1 2.5 3.2 
0.16 6.0 0.9 0.2 2.8 0.3 0.2 
0.60 8.0 1.3 1.6 3.0 0.9 1.3 
0.70 1.0 3.3 3.6 4.9 4.5 4.9 
0.07 15.0 0.5 1.1 3.4 1.0 2.1 
0.40 8.0 1.3 0.5 3.5 0.7 0.7 







0.07 10.0 1.1 1.1 4.3 1.7 2.5 
0.40 6.0 2.9 3.4 4.6 2.0 2.1 
0.16 8.0 2.5 4.6 5.0 2.2 6.0 
0.16 60.0 0.4 0.7 4.5 0.8 0.8 
0.40 100.0 2.7 2.8 4.5 6.2 5.9 
0.16 180.0 1.5 2.8 5.5 2.9 6.0 
0.40 300.0 0.1 0.1 3.4 0.9 1.2 
0.16 6.0 0.2 0.9 3.7 0.7 0.5 
0.40 300.0 3.4 2.7 4.7 4.3 3.7 
0.07 0.4 0.9 0.1 2.7 1.9 1.7 
0.16 1.3 2.0 1.1 5.4 1.2 2.2 
0.07 1.0 0.3 0.3 3.1 0.1 0.1 
0.16 15.0 2.6 2.9 1.7 2.5 2.0 
 
